interactions:
- request:
    body: null
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://rest.uniprot.org/uniprotkb/P38398.txt
  response:
    body:
      string: "ID   BRCA1_HUMAN             Reviewed;        1863 AA.\nAC   P38398;
        E9PFZ0; O15129; Q1RMC1; Q3LRJ0; Q3LRJ6; Q6IN79; Q7KYU9;\nDT   01-OCT-1994,
        integrated into UniProtKB/Swiss-Prot.\nDT   01-FEB-1995, sequence version
        2.\nDT   28-JAN-2026, entry version 283.\nDE   RecName: Full=Breast cancer
        type 1 susceptibility protein;\nDE            EC=2.3.2.27 {ECO:0000269|PubMed:10500182,
        ECO:0000269|PubMed:12887909, ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:16818604,
        ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20351172};\nDE   AltName:
        Full=RING finger protein 53;\nDE   AltName: Full=RING-type E3 ubiquitin transferase
        BRCA1 {ECO:0000305};\nGN   Name=BRCA1; Synonyms=RNF53;\nOS   Homo sapiens
        (Human).\nOC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
        Mammalia;\nOC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini;
        Hominidae;\nOC   Homo.\nOX   NCBI_TaxID=9606;\nRN   [1]\nRP   NUCLEOTIDE SEQUENCE
        [MRNA] (ISOFORM 1), AND VARIANT BC ARG-1775.\nRX   PubMed=7545954; DOI=10.1126/science.7545954;\nRA
        \  Miki Y., Swensen J., Shattuck-Eidens D., Futreal P.A., Harshman K.,\nRA
        \  Tavtigian S., Liu Q., Cochran C., Bennett L.M., Ding W., Bell R.,\nRA   Rosenthal
        J., Hussey C., Tran T., McClure M., Frye C., Hattier T.,\nRA   Phelps R.,
        Haugen-Strano A., Katcher H., Yakumo K., Gholami Z., Shaffer D.,\nRA   Stone
        S., Bayer S., Wray C., Bogden R., Dayananth P., Ward J., Tonin P.,\nRA   Narod
        S., Bristow P.K., Norris F.H., Helvering L., Morrison P., Rosteck P.,\nRA
        \  Lai M., Barrett J.C., Lewis C., Neuhausen S., Cannon-Albright L.,\nRA   Godlgar
        D., Wiseman R., Kamb A., Skolnick M.H.;\nRT   \"A strong candidate for the
        breast and ovarian cancer susceptibility gene\nRT   BRCA1.\";\nRL   Science
        266:66-71(1994).\nRN   [2]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA].\nRX   PubMed=8938427;
        DOI=10.1101/gr.6.11.1029;\nRA   Smith T.M., Lee M.K., Szabo C.I., Jerome N.,
        McEuen M., Taylor M., Hood L.,\nRA   King M.-C.;\nRT   \"Complete genomic
        sequence and analysis of 117 kb of human DNA containing\nRT   the gene BRCA1.\";\nRL
        \  Genome Res. 6:1029-1049(1996).\nRN   [3]\nRP   NUCLEOTIDE SEQUENCE [MRNA]
        (ISOFORM 3), SUBCELLULAR LOCATION (ISOFORM 2),\nRP   VARIANTS ARG-239 AND
        GLY-1613, AND TISSUE SPECIFICITY (ISOFORMS 1 AND 3).\nRC   TISSUE=Mammary
        gland;\nRX   PubMed=9010228; DOI=10.1038/sj.onc.1200924;\nRA   Wilson C.A.,
        Payton M.N., Elliott G.S., Buaas F.W., Cajulis E.E.,\nRA   Grosshans D., Ramos
        L., Reese D.M., Slamon D.J., Calzone F.J.;\nRT   \"Differential subcellular
        localization, expression and biological toxicity\nRT   of BRCA1 and the splice
        variant BRCA1-delta11b.\";\nRL   Oncogene 14:1-16(1997).\nRN   [4]\nRP   NUCLEOTIDE
        SEQUENCE [MRNA] (ISOFORM 2).\nRC   TISSUE=Testis;\nRA   Holt J.T., Robinson-Benion
        C.;\nRL   Submitted (MAY-1997) to the EMBL/GenBank/DDBJ databases.\nRN   [5]\nRP
        \  NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANT ARG-356.\nRA   Raymond C.K.,
        Paddock M., Subramanian S., Deodato C., Zhou Y., Haugen E.,\nRA   Kaul R.,
        Olson M.V.;\nRL   Submitted (SEP-2005) to the EMBL/GenBank/DDBJ databases.\nRN
        \  [6]\nRP   NUCLEOTIDE SEQUENCE [GENOMIC DNA], AND VARIANTS SER-275; ARG-356;
        ASN-693;\nRP   LEU-871; GLY-1038; ASN-1040; GLY-1140; ARG-1183; GLY-1613 AND
        ALA-1620.\nRG   NIEHS SNPs program;\nRL   Submitted (APR-2003) to the EMBL/GenBank/DDBJ
        databases.\nRN   [7]\nRP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].\nRX
        \  PubMed=16625196; DOI=10.1038/nature04689;\nRA   Zody M.C., Garber M., Adams
        D.J., Sharpe T., Harrow J., Lupski J.R.,\nRA   Nicholson C., Searle S.M.,
        Wilming L., Young S.K., Abouelleil A.,\nRA   Allen N.R., Bi W., Bloom T.,
        Borowsky M.L., Bugalter B.E., Butler J.,\nRA   Chang J.L., Chen C.-K., Cook
        A., Corum B., Cuomo C.A., de Jong P.J.,\nRA   DeCaprio D., Dewar K., FitzGerald
        M., Gilbert J., Gibson R., Gnerre S.,\nRA   Goldstein S., Grafham D.V., Grocock
        R., Hafez N., Hagopian D.S., Hart E.,\nRA   Norman C.H., Humphray S., Jaffe
        D.B., Jones M., Kamal M., Khodiyar V.K.,\nRA   LaButti K., Laird G., Lehoczky
        J., Liu X., Lokyitsang T., Loveland J.,\nRA   Lui A., Macdonald P., Major
        J.E., Matthews L., Mauceli E., McCarroll S.A.,\nRA   Mihalev A.H., Mudge J.,
        Nguyen C., Nicol R., O'Leary S.B., Osoegawa K.,\nRA   Schwartz D.C., Shaw-Smith
        C., Stankiewicz P., Steward C., Swarbreck D.,\nRA   Venkataraman V., Whittaker
        C.A., Yang X., Zimmer A.R., Bradley A.,\nRA   Hubbard T., Birren B.W., Rogers
        J., Lander E.S., Nusbaum C.;\nRT   \"DNA sequence of human chromosome 17 and
        analysis of rearrangement in the\nRT   human lineage.\";\nRL   Nature 440:1045-1049(2006).\nRN
        \  [8]\nRP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 6 AND 7), AND
        VARIANTS\nRP   LEU-871; GLY-1038; ARG-1183; GLY-1613 AND ILE-1652.\nRC   TISSUE=PNS;\nRX
        \  PubMed=15489334; DOI=10.1101/gr.2596504;\nRG   The MGC Project Team;\nRT
        \  \"The status, quality, and expansion of the NIH full-length cDNA project:\nRT
        \  the Mammalian Gene Collection (MGC).\";\nRL   Genome Res. 14:2121-2127(2004).\nRN
        \  [9]\nRP   PROTEIN SEQUENCE OF 6-18 (ISOFORM 1), PROTEIN SEQUENCE OF 18-26
        (ISOFORM\nRP   4), AND ALTERNATIVE INITIATION (ISOFORM 4).\nRX   PubMed=10851077;
        DOI=10.1038/sj.onc.1203599;\nRA   Liu J., Prolla G., Rostagno A., Chiarle
        R., Feiner H., Inghirami G.;\nRT   \"Initiation of translation from a downstream
        in-frame AUG codon on BRCA1\nRT   can generate the novel isoform protein DeltaBRCA1(17aa).\";\nRL
        \  Oncogene 19:2767-2773(2000).\nRN   [10]\nRP   ALTERNATIVE SPLICING (ISOFORM
        5), AND SUBCELLULAR LOCATION (ISOFORM 5).\nRX   PubMed=8972225; DOI=10.1128/mcb.17.1.444;\nRA
        \  Thakur S., Zhang H.B., Peng Y., Le H., Carroll B., Ward T., Yao J.,\nRA
        \  Farid L.M., Couch F.J., Wilson R.B., Weber B.L.;\nRT   \"Localization of
        BRCA1 and a splice variant identifies the nuclear\nRT   localization signal.\";\nRL
        \  Mol. Cell. Biol. 17:444-452(1997).\nRN   [11]\nRP   INTERACTION WITH DHX9.\nRX
        \  PubMed=9662397; DOI=10.1038/930;\nRA   Anderson S.F., Schlegel B.P., Nakajima
        T., Wolpin E.S., Parvin J.D.;\nRT   \"BRCA1 protein is linked to the RNA polymerase
        II holoenzyme complex via\nRT   RNA helicase A.\";\nRL   Nat. Genet. 19:254-256(1998).\nRN
        \  [12]\nRP   INTERACTION WITH BAP1, SUBCELLULAR LOCATION, VARIANTS GLY-61
        AND GLY-64,\nRP   AND MUTAGENESIS OF ARG-71.\nRX   PubMed=9528852; DOI=10.1038/sj.onc.1201861;\nRA
        \  Jensen D.E., Proctor M., Marquis S.T., Gardner H.P., Ha S.I., Chodosh L.A.,\nRA
        \  Ishov A.M., Tommerup N., Vissing H., Sekido Y., Minna J., Borodovsky A.,\nRA
        \  Schultz D.C., Wilkinson K.D., Maul G.G., Barlev N., Berger S.,\nRA   Prendergast
        G.C., Rauscher F.J. III;\nRT   \"BAP1: a novel ubiquitin hydrolase which binds
        to the BRCA1 RING finger and\nRT   enhances BRCA1-mediated cell growth suppression.\";\nRL
        \  Oncogene 16:1097-1112(1998).\nRN   [13]\nRP   INTERACTION WITH RBBP8.\nRX
        \  PubMed=9811458; DOI=10.1038/sj.onc.1202150;\nRA   Wong A.K., Ormonde P.A.,
        Pero R., Chen Y., Lian L., Salada G., Berry S.,\nRA   Lawrence Q., Dayananth
        P., Ha P., Tavtigian S.V., Teng D.H., Bartel P.L.;\nRT   \"Characterization
        of a carboxy-terminal BRCA1 interacting protein.\";\nRL   Oncogene 17:2279-2285(1998).\nRN
        \  [14]\nRP   FUNCTION AS AN E2-DEPENDENT UBIQUITIN-PROTEIN LIGASE, AND CATALYTIC\nRP
        \  ACTIVITY.\nRX   PubMed=10500182; DOI=10.1073/pnas.96.20.11364;\nRA   Lorick
        K.L., Jensen J.P., Fang S., Ong A.M., Hatakeyama S., Weissman A.M.;\nRT   \"RING
        fingers mediate ubiquitin-conjugating enzyme (E2)-dependent\nRT   ubiquitination.\";\nRL
        \  Proc. Natl. Acad. Sci. U.S.A. 96:11364-11369(1999).\nRN   [15]\nRP   IDENTIFICATION
        IN THE BASC COMPLEX.\nRX   PubMed=10783165;\nRA   Wang Y., Cortez D., Yazdi
        P., Neff N., Elledge S.J., Qin J.;\nRT   \"BASC, a super complex of BRCA1-associated
        proteins involved in the\nRT   recognition and repair of aberrant DNA structures.\";\nRL
        \  Genes Dev. 14:927-939(2000).\nRN   [16]\nRP   PHOSPHORYLATION AT SER-1143;
        SER-1280; SER-1387; THR-1394; SER-1423 AND\nRP   SER-1457, MUTAGENESIS OF
        SER-1143; SER-1239; SER-1280; SER-1298; SER-1330;\nRP   SER-1387; THR-1394;
        SER-1423; SER-1457; SER-1466; SER-1524 AND SER-1755,\nRP   AND CHARACTERIZATION
        OF VARIANT BC ALA-1720.\nRX   PubMed=11114888; DOI=10.1101/gad.851000;\nRA
        \  Tibbetts R.S., Cortez D., Brumbaugh K.M., Scully R., Livingston D.,\nRA
        \  Elledge S.J., Abraham R.T.;\nRT   \"Functional interactions between BRCA1
        and the checkpoint kinase ATR during\nRT   genotoxic stress.\";\nRL   Genes
        Dev. 14:2989-3002(2000).\nRN   [17]\nRP   FUNCTION IN DNA DAMAGE RESPONSE,
        PHOSPHORYLATION AT SER-988 BY CHEK2, AND\nRP   INTERACTION WITH CHEK2.\nRX
        \  PubMed=10724175; DOI=10.1038/35004614;\nRA   Lee J.S., Collins K.M., Brown
        A.L., Lee C.H., Chung J.H.;\nRT   \"hCds1-mediated phosphorylation of BRCA1
        regulates the DNA damage\nRT   response.\";\nRL   Nature 404:201-204(2000).\nRN
        \  [18]\nRP   INTERACTION WITH BRIP1, CHARACTERIZATION OF VARIANT OVARIAN
        CANCER\nRP   ARG-1749, AND CHARACTERIZATION OF VARIANT BC ARG-1775.\nRX   PubMed=11301010;
        DOI=10.1016/s0092-8674(01)00304-x;\nRA   Cantor S.B., Bell D.W., Ganesan S.,
        Kass E.M., Drapkin R., Grossman S.,\nRA   Wahrer D.C.R., Sgroi D.C., Lane
        W.S., Haber D.A., Livingston D.M.;\nRT   \"BACH1, a novel helicase-like protein,
        interacts directly with BRCA1 and\nRT   contributes to its DNA repair function.\";\nRL
        \  Cell 105:149-160(2001).\nRN   [19]\nRP   INTERACTION WITH NELFB.\nRX   PubMed=11739404;
        DOI=10.1083/jcb.200108049;\nRA   Ye Q., Hu Y.-F., Zhong H., Nye A.C., Belmont
        A.S., Li R.;\nRT   \"BRCA1-induced large-scale chromatin unfolding and allele-specific
        effects\nRT   of cancer-predisposing mutations.\";\nRL   J. Cell Biol. 155:911-921(2001).\nRN
        \  [20]\nRP   INTERACTION WITH FANCD2.\nRX   PubMed=11239454; DOI=10.1016/s1097-2765(01)00173-3;\nRA
        \  Garcia-Higuera I., Taniguchi T., Ganesan S., Meyn M.S., Timmers C.,\nRA
        \  Hejna J., Grompe M., D'Andrea A.D.;\nRT   \"Interaction of the Fanconi
        anemia proteins and BRCA1 in a common\nRT   pathway.\";\nRL   Mol. Cell 7:249-262(2001).\nRN
        \  [21]\nRP   FUNCTION, PHOSPHORYLATION BY ATM, AND MUTAGENESIS OF SER-1387;
        SER-1423 AND\nRP   SER-1524.\nRX   PubMed=12183412;\nRA   Xu B., O'Donnell
        A.H., Kim S.-T., Kastan M.B.;\nRT   \"Phosphorylation of serine 1387 in BRCA1
        is specifically required for the\nRT   Atm-mediated S-phase checkpoint after
        ionizing irradiation.\";\nRL   Cancer Res. 62:4588-4591(2002).\nRN   [22]\nRP
        \  INTERACTION WITH H2AX.\nRX   PubMed=12419185; DOI=10.1016/s0960-9822(02)01259-9;\nRA
        \  Kobayashi J., Tauchi H., Sakamoto S., Nakamura A., Morishima K.,\nRA   Matsuura
        S., Kobayashi T., Tamai K., Tanimoto K., Komatsu K.;\nRT   \"NBS1 localizes
        to gamma-H2AX foci through interaction with the FHA/BRCT\nRT   domain.\";\nRL
        \  Curr. Biol. 12:1846-1851(2002).\nRN   [23]\nRP   INTERACTION WITH SMC1A.\nRX
        \  PubMed=11877377; DOI=10.1101/gad.970702;\nRA   Yazdi P.T., Wang Y., Zhao
        S., Patel N., Lee E.Y.-H.P., Qin J.;\nRT   \"SMC1 is a downstream effector
        in the ATM/NBS1 branch of the human S-phase\nRT   checkpoint.\";\nRL   Genes
        Dev. 16:571-582(2002).\nRN   [24]\nRP   INTERACTION WITH LMO4.\nRX   PubMed=11751867;
        DOI=10.1074/jbc.m110603200;\nRA   Sum E.Y., Peng B., Yu X., Chen J., Byrne
        J., Lindeman G.J., Visvader J.E.;\nRT   \"The LIM domain protein LMO4 interacts
        with the cofactor CtIP and the tumor\nRT   suppressor BRCA1 and inhibits BRCA1
        activity.\";\nRL   J. Biol. Chem. 277:7849-7856(2002).\nRN   [25]\nRP   FUNCTION,
        AND INTERACTION WITH CHEK1.\nRX   PubMed=11836499; DOI=10.1038/ng837;\nRA
        \  Yarden R.I., Pardo-Reoyo S., Sgagias M., Cowan K.H., Brody L.C.;\nRT   \"BRCA1
        regulates the G2/M checkpoint by activating Chk1 kinase upon DNA\nRT   damage.\";\nRL
        \  Nat. Genet. 30:285-289(2002).\nRN   [26]\nRP   INTERACTION WITH ACACA.\nRX
        \  PubMed=12360400; DOI=10.1038/sj.onc.1205915;\nRA   Magnard C., Bachelier
        R., Vincent A., Jaquinod M., Kieffer S., Lenoir G.M.,\nRA   Venezia N.D.;\nRT
        \  \"BRCA1 interacts with acetyl-CoA carboxylase through its tandem of BRCT\nRT
        \  domains.\";\nRL   Oncogene 21:6729-6739(2002).\nRN   [27]\nRP   FUNCTION,
        UBIQUITINATION, CATALYTIC ACTIVITY, AND INTERACTION WITH BARD1.\nRX   PubMed=12890688;
        DOI=10.1074/jbc.c300249200;\nRA   Wu-Baer F., Lagrazon K., Yuan W., Baer R.;\nRT
        \  \"The BRCA1/BARD1 heterodimer assembles polyubiquitin chains through an\nRT
        \  unconventional linkage involving lysine residue K6 of ubiquitin.\";\nRL
        \  J. Biol. Chem. 278:34743-34746(2003).\nRN   [28]\nRP   FUNCTION, AND CATALYTIC
        ACTIVITY.\nRX   PubMed=12887909; DOI=10.1016/s1097-2765(03)00281-8;\nRA   Vandenberg
        C.J., Gergely F., Ong C.Y., Pace P., Mallery D.L., Hiom K.,\nRA   Patel K.J.;\nRT
        \  \"BRCA1-independent ubiquitination of FANCD2.\";\nRL   Mol. Cell 12:247-254(2003).\nRN
        \  [29]\nRP   INTERACTION WITH BRCC3.\nRX   PubMed=14636569; DOI=10.1016/s1097-2765(03)00424-6;\nRA
        \  Dong Y., Hakimi M.-A., Chen X., Kumaraswamy E., Cooch N.S., Godwin A.K.,\nRA
        \  Shiekhattar R.;\nRT   \"Regulation of BRCC, a holoenzyme complex containing
        BRCA1 and BRCA2, by a\nRT   signalosome-like subunit and its role in DNA repair.\";\nRL
        \  Mol. Cell 12:1087-1099(2003).\nRN   [30]\nRP   FUNCTION, AND INTERACTION
        WITH BARD1.\nRX   PubMed=14976165; DOI=10.1093/hmg/ddh095;\nRA   Morris J.R.,
        Solomon E.;\nRT   \"BRCA1:BARD1 induces the formation of conjugated ubiquitin
        structures,\nRT   dependent on K6 of ubiquitin, in cells during DNA replication
        and repair.\";\nRL   Hum. Mol. Genet. 13:807-817(2004).\nRN   [31]\nRP   RETRACTED
        PAPER.\nRX   PubMed=14990569; DOI=10.1074/jbc.m311780200;\nRA   Ouchi M.,
        Fujiuchi N., Sasai K., Katayama H., Minamishima Y.A.,\nRA   Ongusaha P.P.,
        Deng C., Sen S., Lee S.W., Ouchi T.;\nRT   \"BRCA1 phosphorylation by Aurora-A
        in the regulation of G2 to M\nRT   transition.\";\nRL   J. Biol. Chem. 279:19643-19648(2004).\nRN
        \  [32]\nRP   RETRACTION NOTICE OF PUBMED:14990569.\nRX   PubMed=26341884;
        DOI=10.1074/jbc.a115.311780;\nRA   Ouchi M., Fujiuchi N., Sasai K., Katayama
        H., Minamishima Y.A.,\nRA   Ongusaha P.P., Deng C., Sen S., Lee S.W., Ouchi
        T.;\nRL   J. Biol. Chem. 290:22311-22311(2015).\nRN   [33]\nRP   INTERACTION
        WITH DCLRE1C.\nRX   PubMed=15456891; DOI=10.1128/mcb.24.20.9207-9220.2004;\nRA
        \  Zhang X., Succi J., Feng Z., Prithivirajsingh S., Story M.D.,\nRA   Legerski
        R.J.;\nRT   \"Artemis is a phosphorylation target of ATM and ATR and is involved
        in the\nRT   G2/M DNA damage checkpoint response.\";\nRL   Mol. Cell. Biol.
        24:9207-9220(2004).\nRN   [34]\nRP   INTERACTION WITH CLSPN.\nRX   PubMed=15096610;
        DOI=10.1073/pnas.0401847101;\nRA   Lin S.-Y., Li K., Stewart G.S., Elledge
        S.J.;\nRT   \"Human claspin works with BRCA1 to both positively and negatively
        regulate\nRT   cell proliferation.\";\nRL   Proc. Natl. Acad. Sci. U.S.A.
        101:6484-6489(2004).\nRN   [35]\nRP   PHOSPHORYLATION [LARGE SCALE ANALYSIS]
        AT SER-1336, AND IDENTIFICATION BY\nRP   MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\nRC
        \  TISSUE=Cervix carcinoma;\nRX   PubMed=17081983; DOI=10.1016/j.cell.2006.09.026;\nRA
        \  Olsen J.V., Blagoev B., Gnad F., Macek B., Kumar C., Mortensen P., Mann
        M.;\nRT   \"Global, in vivo, and site-specific phosphorylation dynamics in
        signaling\nRT   networks.\";\nRL   Cell 127:635-648(2006).\nRN   [36]\nRP
        \  FUNCTION, CATALYTIC ACTIVITY, INTERACTION WITH RBBP8, AND MUTAGENESIS OF\nRP
        \  ILE-26.\nRX   PubMed=16818604; DOI=10.1101/gad.1431006;\nRA   Yu X., Fu
        S., Lai M., Baer R., Chen J.;\nRT   \"BRCA1 ubiquitinates its phosphorylation-dependent
        binding partner CtIP.\";\nRL   Genes Dev. 20:1721-1726(2006).\nRN   [37]\nRP
        \  FUNCTION, AND INTERACTION WITH ACACA.\nRX   PubMed=16326698; DOI=10.1074/jbc.m504652200;\nRA
        \  Moreau K., Dizin E., Ray H., Luquain C., Lefai E., Foufelle F., Billaud
        M.,\nRA   Lenoir G.M., Venezia N.D.;\nRT   \"BRCA1 affects lipid synthesis
        through its interaction with acetyl-CoA\nRT   carboxylase.\";\nRL   J. Biol.
        Chem. 281:3172-3181(2006).\nRN   [38]\nRP   INTERACTION WITH ACACA.\nRX   PubMed=16698035;
        DOI=10.1016/j.jmb.2006.04.010;\nRA   Ray H., Moreau K., Dizin E., Callebaut
        I., Venezia N.D.;\nRT   \"ACCA phosphopeptide recognition by the BRCT repeats
        of BRCA1.\";\nRL   J. Mol. Biol. 359:973-982(2006).\nRN   [39]\nRP   FUNCTION,
        CATALYTIC ACTIVITY, PHOSPHORYLATION BY AURKA, AND ACTIVITY\nRP   REGULATION.\nRX
        \  PubMed=18056443; DOI=10.1158/0008-5472.can-07-2578;\nRA   Sankaran S.,
        Crone D.E., Palazzo R.E., Parvin J.D.;\nRT   \"Aurora-A kinase regulates breast
        cancer associated gene 1 inhibition of\nRT   centrosome-dependent microtubule
        nucleation.\";\nRL   Cancer Res. 67:11186-11194(2007).\nRN   [40]\nRP   INTERACTION
        WITH ABRAXAS1.\nRX   PubMed=17643122; DOI=10.1038/nsmb1277;\nRA   Kim H.,
        Huang J., Chen J.;\nRT   \"CCDC98 is a BRCA1-BRCT domain-binding protein involved
        in the DNA damage\nRT   response.\";\nRL   Nat. Struct. Mol. Biol. 14:710-715(2007).\nRN
        \  [41]\nRP   INTERACTION WITH ABRAXAS1.\nRX   PubMed=17643121; DOI=10.1038/nsmb1279;\nRA
        \  Liu Z., Wu J., Yu X.;\nRT   \"CCDC98 targets BRCA1 to DNA damage sites.\";\nRL
        \  Nat. Struct. Mol. Biol. 14:716-720(2007).\nRN   [42]\nRP   IDENTIFICATION
        BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\nRC   TISSUE=Embryonic kidney;\nRX
        \  PubMed=17525332; DOI=10.1126/science.1140321;\nRA   Matsuoka S., Ballif
        B.A., Smogorzewska A., McDonald E.R. III, Hurov K.E.,\nRA   Luo J., Bakalarski
        C.E., Zhao Z., Solimini N., Lerenthal Y., Shiloh Y.,\nRA   Gygi S.P., Elledge
        S.J.;\nRT   \"ATM and ATR substrate analysis reveals extensive protein networks\nRT
        \  responsive to DNA damage.\";\nRL   Science 316:1160-1166(2007).\nRN   [43]\nRP
        \  FUNCTION, SUBCELLULAR LOCATION, AND INTERACTION WITH ABRAXAS1.\nRX   PubMed=17525340;
        DOI=10.1126/science.1139476;\nRA   Wang B., Matsuoka S., Ballif B.A., Zhang
        D., Smogorzewska A., Giyi S.,\nRA   Elledge S.J.;\nRT   \"Abraxas and RAP80
        form a BRCA1 protein complex required for the DNA damage\nRT   response.\";\nRL
        \  Science 316:1194-1198(2007).\nRN   [44]\nRP   INVOLVEMENT IN PNCA4.\nRX
        \  PubMed=18762988; DOI=10.1007/s00439-008-0554-0;\nRA   Al-Sukhni W., Rothenmund
        H., Borgida A.E., Zogopoulos G., O'Shea A.M.,\nRA   Pollett A., Gallinger
        S.;\nRT   \"Germline BRCA1 mutations predispose to pancreatic adenocarcinoma.\";\nRL
        \  Hum. Genet. 124:271-278(2008).\nRN   [45]\nRP   PHOSPHORYLATION [LARGE
        SCALE ANALYSIS] AT SER-395; SER-398; SER-753;\nRP   SER-1211; SER-1217 AND
        SER-1218, AND IDENTIFICATION BY MASS SPECTROMETRY\nRP   [LARGE SCALE ANALYSIS].\nRC
        \  TISSUE=Cervix carcinoma;\nRX   PubMed=18669648; DOI=10.1073/pnas.0805139105;\nRA
        \  Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,\nRA
        \  Elledge S.J., Gygi S.P.;\nRT   \"A quantitative atlas of mitotic phosphorylation.\";\nRL
        \  Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).\nRN   [46]\nRP   FUNCTION,
        AND IDENTIFICATION IN THE BRCA1-A COMPLEX.\nRX   PubMed=19261748; DOI=10.1101/gad.1770609;\nRA
        \  Feng L., Huang J., Chen J.;\nRT   \"MERIT40 facilitates BRCA1 localization
        and DNA damage repair.\";\nRL   Genes Dev. 23:719-728(2009).\nRN   [47]\nRP
        \  IDENTIFICATION IN THE BRCA1-A COMPLEX.\nRX   PubMed=19261749; DOI=10.1101/gad.1770309;\nRA
        \  Wang B., Hurov K., Hofmann K., Elledge S.J.;\nRT   \"NBA1, a new player
        in the Brca1 A complex, is required for DNA damage\nRT   resistance and checkpoint
        control.\";\nRL   Genes Dev. 23:729-739(2009).\nRN   [48]\nRP   IDENTIFICATION
        IN THE BRCA1-A COMPLEX.\nRX   PubMed=19261746; DOI=10.1101/gad.1739609;\nRA
        \  Shao G., Patterson-Fortin J., Messick T.E., Feng D., Shanbhag N., Wang
        Y.,\nRA   Greenberg R.A.;\nRT   \"MERIT40 controls BRCA1-Rap80 complex integrity
        and recruitment to DNA\nRT   double-strand breaks.\";\nRL   Genes Dev. 23:740-754(2009).\nRN
        \  [49]\nRP   IDENTIFICATION BY MASS SPECTROMETRY, FUNCTION, INTERACTION WITH
        PALB2,\nRP   IDENTIFICATION IN A BRCA COMPLEX WITH BRCA1 AND PALB2, AND CHARACTERIZATION\nRP
        \  OF VARIANT OVARIAN CANCER 1411-THR.\nRX   PubMed=19369211; DOI=10.1073/pnas.0811159106;\nRA
        \  Sy S.M., Huen M.S., Chen J.;\nRT   \"PALB2 is an integral component of
        the BRCA complex required for homologous\nRT   recombination repair.\";\nRL
        \  Proc. Natl. Acad. Sci. U.S.A. 106:7155-7160(2009).\nRN   [50]\nRP   PHOSPHORYLATION
        [LARGE SCALE ANALYSIS] AT SER-395 AND SER-398, AND\nRP   IDENTIFICATION BY
        MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\nRC   TISSUE=Leukemic T-cell;\nRX
        \  PubMed=19690332; DOI=10.1126/scisignal.2000007;\nRA   Mayya V., Lundgren
        D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,\nRA   Rodionov V., Han D.K.;\nRT
        \  \"Quantitative phosphoproteomic analysis of T cell receptor signaling\nRT
        \  reveals system-wide modulation of protein-protein interactions.\";\nRL
        \  Sci. Signal. 2:RA46-RA46(2009).\nRN   [51]\nRP   FUNCTION, INTERACTION
        WITH CCAR2, AND SUBCELLULAR LOCATION.\nRX   PubMed=20160719; DOI=10.1038/sj.bjc.6605577;\nRA
        \  Hiraike H., Wada-Hiraike O., Nakagawa S., Koyama S., Miyamoto Y., Sone
        K.,\nRA   Tanikawa M., Tsuruga T., Nagasaka K., Matsumoto Y., Oda K., Shoji
        K.,\nRA   Fukuhara H., Saji S., Nakagawa K., Kato S., Yano T., Taketani Y.;\nRT
        \  \"Identification of DBC1 as a transcriptional repressor for BRCA1.\";\nRL
        \  Br. J. Cancer 102:1061-1067(2010).\nRN   [52]\nRP   FUNCTION, CATALYTIC
        ACTIVITY, INTERACTION WITH BARD1 AND UBXN1,\nRP   UBIQUITINATION, AND MUTAGENESIS
        OF ILE-26.\nRX   PubMed=20351172; DOI=10.1128/mcb.01056-09;\nRA   Wu-Baer
        F., Ludwig T., Baer R.;\nRT   \"The UBXN1 protein associates with autoubiquitinated
        forms of the BRCA1\nRT   tumor suppressor and inhibits its enzymatic function.\";\nRL
        \  Mol. Cell. Biol. 30:2787-2798(2010).\nRN   [53]\nRP   FUNCTION IN CHROMOSOMAL
        STABILITY, AND PHOSPHORYLATION AT SER-988 BY CHEK2.\nRX   PubMed=20364141;
        DOI=10.1038/ncb2051;\nRA   Stolz A., Ertych N., Kienitz A., Vogel C., Schneider
        V., Fritz B.,\nRA   Jacob R., Dittmar G., Weichert W., Petersen I., Bastians
        H.;\nRT   \"The CHK2-BRCA1 tumour suppressor pathway ensures chromosomal stability
        in\nRT   human somatic cells.\";\nRL   Nat. Cell Biol. 12:492-499(2010).\nRN
        \  [54]\nRP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-423;
        SER-694;\nRP   SER-1328; SER-1336 AND SER-1342, AND IDENTIFICATION BY MASS
        SPECTROMETRY\nRP   [LARGE SCALE ANALYSIS].\nRC   TISSUE=Cervix carcinoma;\nRX
        \  PubMed=20068231; DOI=10.1126/scisignal.2000475;\nRA   Olsen J.V., Vermeulen
        M., Santamaria A., Kumar C., Miller M.L.,\nRA   Jensen L.J., Gnad F., Cox
        J., Jensen T.S., Nigg E.A., Brunak S., Mann M.;\nRT   \"Quantitative phosphoproteomics
        reveals widespread full phosphorylation\nRT   site occupancy during mitosis.\";\nRL
        \  Sci. Signal. 3:RA3-RA3(2010).\nRN   [55]\nRP   PHOSPHORYLATION AT SER-1524,
        AND SUBCELLULAR LOCATION.\nRX   PubMed=21144835; DOI=10.1016/j.bbrc.2010.12.005;\nRA
        \  Kang Y., Cheong H.M., Lee J.H., Song P.I., Lee K.H., Kim S.Y., Jun J.Y.,\nRA
        \  You H.J.;\nRT   \"Protein phosphatase 5 is necessary for ATR-mediated DNA
        repair.\";\nRL   Biochem. Biophys. Res. Commun. 404:476-481(2011).\nRN   [56]\nRP
        \  INTERACTION WITH PCLAF.\nRX   PubMed=21673012; DOI=10.1158/1541-7786.mcr-10-0503;\nRA
        \  Kais Z., Barsky S.H., Mathsyaraja H., Zha A., Ransburgh D.J., He G.,\nRA
        \  Pilarski R.T., Shapiro C.L., Huang K., Parvin J.D.;\nRT   \"KIAA0101 interacts
        with BRCA1 and regulates centrosome number.\";\nRL   Mol. Cancer Res. 9:1091-1099(2011).\nRN
        \  [57]\nRP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-1218;
        SER-1336 AND\nRP   SER-1342, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
        SCALE ANALYSIS].\nRX   PubMed=21406692; DOI=10.1126/scisignal.2001570;\nRA
        \  Rigbolt K.T., Prokhorova T.A., Akimov V., Henningsen J., Johansen P.T.,\nRA
        \  Kratchmarova I., Kassem M., Mann M., Olsen J.V., Blagoev B.;\nRT   \"System-wide
        temporal characterization of the proteome and phosphoproteome\nRT   of human
        embryonic stem cell differentiation.\";\nRL   Sci. Signal. 4:RS3-RS3(2011).\nRN
        \  [58]\nRP   ACETYLATION [LARGE SCALE ANALYSIS] AT MET-1, AND IDENTIFICATION
        BY MASS\nRP   SPECTROMETRY [LARGE SCALE ANALYSIS].\nRX   PubMed=22814378;
        DOI=10.1073/pnas.1210303109;\nRA   Van Damme P., Lasa M., Polevoda B., Gazquez
        C., Elosegui-Artola A.,\nRA   Kim D.S., De Juan-Pardo E., Demeyer K., Hole
        K., Larrea E., Timmerman E.,\nRA   Prieto J., Arnesen T., Sherman F., Gevaert
        K., Aldabe R.;\nRT   \"N-terminal acetylome analyses and functional insights
        of the N-terminal\nRT   acetyltransferase NatB.\";\nRL   Proc. Natl. Acad.
        Sci. U.S.A. 109:12449-12454(2012).\nRN   [59]\nRP   INTERACTION WITH FBXO44,
        AND UBIQUITINATION.\nRX   PubMed=23086937; DOI=10.1074/jbc.m112.407106;\nRA
        \  Lu Y., Li J., Cheng D., Parameswaran B., Zhang S., Jiang Z., Yew P.R.,\nRA
        \  Peng J., Ye Q., Hu Y.;\nRT   \"The F-box protein FBXO44 mediates BRCA1
        ubiquitination and degradation.\";\nRL   J. Biol. Chem. 287:41014-41022(2012).\nRN
        \  [60]\nRP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-114; SER-434;
        SER-551;\nRP   SER-694; SER-708; SER-1009; SER-1189; SER-1191 AND SER-1542,
        AND\nRP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\nRC
        \  TISSUE=Cervix carcinoma, and Erythroleukemia;\nRX   PubMed=23186163; DOI=10.1021/pr300630k;\nRA
        \  Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,\nRA
        \  Mohammed S.;\nRT   \"Toward a comprehensive characterization of a human
        cancer cell\nRT   phosphoproteome.\";\nRL   J. Proteome Res. 12:260-271(2013).\nRN
        \  [61]\nRP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-459; LYS-583;
        LYS-654;\nRP   LYS-734 AND LYS-739, AND IDENTIFICATION BY MASS SPECTROMETRY
        [LARGE SCALE\nRP   ANALYSIS].\nRX   PubMed=25218447; DOI=10.1038/nsmb.2890;\nRA
        \  Hendriks I.A., D'Souza R.C., Yang B., Verlaan-de Vries M., Mann M.,\nRA
        \  Vertegaal A.C.;\nRT   \"Uncovering global SUMOylation signaling networks
        in a site-specific\nRT   manner.\";\nRL   Nat. Struct. Mol. Biol. 21:927-936(2014).\nRN
        \  [62]\nRP   SUMOYLATION [LARGE SCALE ANALYSIS] AT LYS-339; LYS-443 AND LYS-583,
        AND\nRP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].\nRX
        \  PubMed=25755297; DOI=10.1074/mcp.o114.044792;\nRA   Xiao Z., Chang J.G.,
        Hendriks I.A., Sigurdsson J.O., Olsen J.V.,\nRA   Vertegaal A.C.;\nRT   \"System-wide
        analysis of SUMOylation dynamics in response to replication\nRT   stress reveals
        novel small ubiquitin-like modified target proteins and\nRT   acceptor lysines
        relevant for genome stability.\";\nRL   Mol. Cell. Proteomics 14:1419-1434(2015).\nRN
        \  [63]\nRP   INTERACTION WITH EXD2.\nRX   PubMed=26807646; DOI=10.1038/ncb3303;\nRA
        \  Broderick R., Nieminuszczy J., Baddock H.T., Deshpande R.A., Gileadi O.,\nRA
        \  Paull T.T., McHugh P.J., Niedzwiedz W.;\nRT   \"EXD2 promotes homologous
        recombination by facilitating DNA end\nRT   resection.\";\nRL   Nat. Cell
        Biol. 18:271-280(2016).\nRN   [64]\nRP   SUMOYLATION [LARGE SCALE ANALYSIS]
        AT LYS-109; LYS-301; LYS-339; LYS-443;\nRP   LYS-459; LYS-519; LYS-583; LYS-918;
        LYS-987 AND LYS-1079, AND\nRP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE
        SCALE ANALYSIS].\nRX   PubMed=28112733; DOI=10.1038/nsmb.3366;\nRA   Hendriks
        I.A., Lyon D., Young C., Jensen L.J., Vertegaal A.C.,\nRA   Nielsen M.L.;\nRT
        \  \"Site-specific mapping of the human SUMO proteome reveals co-modification\nRT
        \  with phosphorylation.\";\nRL   Nat. Struct. Mol. Biol. 24:325-336(2017).\nRN
        \  [65]\nRP   INTERACTION WITH PALB2.\nRX   PubMed=28319063; DOI=10.1038/onc.2017.46;\nRA
        \  Foo T.K., Tischkowitz M., Simhadri S., Boshari T., Zayed N., Burke K.A.,\nRA
        \  Berman S.H., Blecua P., Riaz N., Huo Y., Ding Y.C., Neuhausen S.L.,\nRA
        \  Weigelt B., Reis-Filho J.S., Foulkes W.D., Xia B.;\nRT   \"Compromised
        BRCA1-PALB2 interaction is associated with breast cancer\nRT   risk.\";\nRL
        \  Oncogene 36:4161-4170(2017).\nRN   [66]\nRP   INTERACTION WITH ZGRF1.\nRX
        \  PubMed=34552057; DOI=10.1038/s41420-021-00633-7;\nRA   Yan S., Song M.,
        Ping J., Lai S.T., Cao X.Y., Bai C.J., Xie D.F., Guan H.,\nRA   Gao S.S.,
        Zhou P.K.;\nRT   \"ZGRF1 promotes end resection of DNA homologous recombination
        via forming\nRT   complex with BRCA1/EXO1.\";\nRL   Cell. Death. Discov. 7:260-260(2021).\nRN
        \  [67]\nRP   ERRATUM OF PUBMED:34552057.\nRX   PubMed=36400755; DOI=10.1038/s41420-022-01248-2;\nRA
        \  Yan S., Song M., Ping J., Lai S.T., Cao X.Y., Bai C.J., Xie D.F., Guan
        H.,\nRA   Gao S.S., Zhou P.K.;\nRL   Cell. Death. Discov. 8:460-460(2022).\nRN
        \  [68]\nRP   STRUCTURE BY NMR OF 1-110 IN COMPLEX WITH ZINC IONS AND BARD1,
        AND SUBUNIT.\nRX   PubMed=11573085; DOI=10.1038/nsb1001-833;\nRA   Brzovic
        P.S., Rajagopal P., Hoyt D.W., King M.C., Klevit R.E.;\nRT   \"Structure of
        a BRCA1-BARD1 heterodimeric RING-RING complex.\";\nRL   Nat. Struct. Biol.
        8:833-837(2001).\nRN   [69]\nRP   X-RAY CRYSTALLOGRAPHY (2.5 ANGSTROMS) OF
        1646-1859, PARTIAL PROTEIN\nRP   SEQUENCE, AND IDENTIFICATION BY MASS SPECTROMETRY.\nRX
        \  PubMed=11573086; DOI=10.1038/nsb1001-838;\nRA   Williams R.S., Green R.,
        Glover J.N.;\nRT   \"Crystal structure of the BRCT repeat region from the
        breast cancer-\nRT   associated protein BRCA1.\";\nRL   Nat. Struct. Biol.
        8:838-842(2001).\nRN   [70]\nRP   X-RAY CRYSTALLOGRAPHY (2.8 ANGSTROMS) OF
        1646-1859 OF VARIANT BC ARG-1775,\nRP   CHARACTERIZATION OF VARIANT BC ARG-1775,
        AND CIRCULAR DICHROISM.\nRX   PubMed=12427738; DOI=10.1074/jbc.m210019200;\nRA
        \  Williams R.S., Glover J.N.;\nRT   \"Structural consequences of a cancer-causing
        BRCA1-BRCT missense\nRT   mutation.\";\nRL   J. Biol. Chem. 278:2630-2635(2003).\nRN
        \  [71]\nRP   STRUCTURE BY NMR OF 1755-1863.\nRX   PubMed=15609993; DOI=10.1021/bi049550q;\nRA
        \  Gaiser O.J., Ball L.J., Schmieder P., Leitner D., Strauss H., Wahl M.,\nRA
        \  Kuhne R., Oschkinat H., Heinemann U.;\nRT   \"Solution structure, backbone
        dynamics, and association behavior of the C-\nRT   terminal BRCT domain from
        the breast cancer-associated protein BRCA1.\";\nRL   Biochemistry 43:15983-15995(2004).\nRN
        \  [72]\nRP   X-RAY CRYSTALLOGRAPHY (1.85 ANGSTROMS) OF 1649-1859 IN COMPLEX
        WITH\nRP   PHOSPHORYLATED BRIP1 PEPTIDE, MUTAGENESIS OF SER-1655; LYS-1702
        AND\nRP   GLY-1738, CHARACTERIZATION OF VARIANT OVARIAN CANCER ARG-1749,\nRP
        \  CHARACTERIZATION OF VARIANT BC ARG-1775, SUBCELLULAR LOCATION, AND\nRP
        \  INTERACTION WITH PHOSPHORYLATED BRIP1.\nRX   PubMed=15133502; DOI=10.1038/nsmb775;\nRA
        \  Clapperton J.A., Manke I.A., Lowery D.M., Ho T., Haire L.F., Yaffe M.B.,\nRA
        \  Smerdon S.J.;\nRT   \"Structure and mechanism of BRCA1 BRCT domain recognition
        of phosphorylated\nRT   BACH1 with implications for cancer.\";\nRL   Nat.
        Struct. Mol. Biol. 11:512-518(2004).\nRN   [73]\nRP   X-RAY CRYSTALLOGRAPHY
        (2.5 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH\nRP   PHOSPHORYLATED RBBP8 PEPTIDE,
        AND SUBUNIT.\nRX   PubMed=16101277; DOI=10.1021/bi0509651;\nRA   Varma A.K.,
        Brown R.S., Birrane G., Ladias J.A.;\nRT   \"Structural basis for cell cycle
        checkpoint control by the BRCA1-CtIP\nRT   complex.\";\nRL   Biochemistry
        44:10941-10946(2005).\nRN   [74]\nRP   X-RAY CRYSTALLOGRAPHY (3.21 ANGSTROMS)
        OF 1646-1859 IN COMPLEX WITH\nRP   PHOSPHORYLATED ACACA PEPTIDE, AND SUBUNIT.\nRX
        \  PubMed=18452305; DOI=10.1021/bi800314m;\nRA   Shen Y., Tong L.;\nRT   \"Structural
        evidence for direct interactions between the BRCT domains of\nRT   human BRCA1
        and a phospho-peptide from human ACC1.\";\nRL   Biochemistry 47:5767-5773(2008).\nRN
        \  [75]\nRP   X-RAY CRYSTALLOGRAPHY (3.6 ANGSTROMS) OF 1649-1859 OF VARIANT
        BC LYS-1775,\nRP   VARIANT BC LYS-1775, AND CHARACTERIZATION OF VARIANT BC
        LYS-1775.\nRX   PubMed=18285836; DOI=10.1038/ejhg.2008.13;\nRA   Tischkowitz
        M., Hamel N., Carvalho M.A., Birrane G., Soni A.,\nRA   van Beers E.H., Joosse
        S.A., Wong N., Novak D., Quenneville L.A.,\nRA   Grist S.A., Nederlof P.M.,
        Goldgar D.E., Tavtigian S.V., Monteiro A.N.,\nRA   Ladias J.A., Foulkes W.D.;\nRT
        \  \"Pathogenicity of the BRCA1 missense variant M1775K is determined by the\nRT
        \  disruption of the BRCT phosphopeptide-binding pocket: a multi-modal\nRT
        \  approach.\";\nRL   Eur. J. Hum. Genet. 16:820-832(2008).\nRN   [76]\nRP
        \  X-RAY CRYSTALLOGRAPHY (2.7 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH\nRP
        \  PHOSPHORYLATED PEPTIDES, AND DOMAIN.\nRX   PubMed=20159462; DOI=10.1016/j.str.2009.12.008;\nRA
        \  Campbell S.J., Edwards R.A., Glover J.N.;\nRT   \"Comparison of the structures
        and peptide binding specificities of the BRCT\nRT   domains of MDC1 and BRCA1.\";\nRL
        \  Structure 18:167-176(2010).\nRN   [77]\nRP   X-RAY CRYSTALLOGRAPHY (2.50
        ANGSTROMS) OF 1646-1859 IN COMPLEX WITH\nRP   PHOSPHORYLATED BRIP1 PEPTIDE,
        INTERACTION WITH BRIP1, MUTAGENESIS OF\nRP   GLY-1656; THR-1700; ARG-1835
        AND GLU-1836, AND CHARACTERIZATION OF VARIANTS\nRP   BC GLN-1699 AND TRP-1699.\nRX
        \  PubMed=21473589; DOI=10.1021/bi2003795;\nRA   Coquelle N., Green R., Glover
        J.N.;\nRT   \"Impact of BRCA1 BRCT domain missense substitutions on phosphopeptide\nRT
        \  recognition.\";\nRL   Biochemistry 50:4579-4589(2011).\nRN   [78]\nRP   X-RAY
        CRYSTALLOGRAPHY (3.50 ANGSTROMS) OF 1649-1859 IN COMPLEX WITH\nRP   ABRAXAS1,
        AND INTERACTION WITH ABRAXAS1.\nRX   PubMed=24316840; DOI=10.1107/s1744309113030649;\nRA
        \  Badgujar D.C., Sawant U., Vikrant X., Yadav L., Hosur M.V., Varma A.K.;\nRT
        \  \"Preliminary crystallographic studies of BRCA1 BRCT-ABRAXAS complex.\";\nRL
        \  Acta Crystallogr. F 69:1401-1404(2013).\nRN   [79]\nRP   X-RAY CRYSTALLOGRAPHY
        (2.50 ANGSTROMS) OF 1646-1859 IN COMPLEX WITH\nRP   ABRAXAS1, INTERACTION
        WITH ABRAXAS1, SUBUNIT, SUBCELLULAR LOCATION, AND\nRP   MUTAGENESIS OF PHE-1662;
        MET-1663; TYR-1666; ARG-1670 AND LYS-1671.\nRX   PubMed=26778126; DOI=10.1016/j.molcel.2015.12.017;\nRA
        \  Wu Q., Paul A., Su D., Mehmood S., Foo T.K., Ochi T., Bunting E.L., Xia
        B.,\nRA   Robinson C.V., Wang B., Blundell T.L.;\nRT   \"Structure of BRCA1-BRCT/Abraxas
        complex reveals phosphorylation-dependent\nRT   BRCT dimerization at DNA damage
        sites.\";\nRL   Mol. Cell 61:434-448(2016).\nRN   [80]\nRP   REVIEW ON VARIANTS.\nRX
        \  PubMed=8807330; DOI=10.1002/humu.1380080102;\nRA   Couch F.J., Weber B.L.;\nRT
        \  \"Mutations and polymorphisms in the familial early-onset breast cancer\nRT
        \  (BRCA1) gene.\";\nRL   Hum. Mutat. 8:8-18(1996).\nRN   [81]\nRP   VARIANT
        BC ARG-1775, AND VARIANTS LEU-1637 AND GLU-1708.\nRX   PubMed=7939630; DOI=10.1126/science.7939630;\nRA
        \  Futreal P.A., Liu Q., Shattuck-Eidens D., Cochran C., Harshman K.,\nRA
        \  Tavtigian S., Bennett L.M., Haugen-Strano A., Swensen J., Miki Y.,\nRA
        \  Eddington K., McClure M., Frye C., Weaver-Felhaus J., Ding W., Gholami
        Z.,\nRA   Soederkvist P., Terry L., Jhanwar S., Berchuk A., Iglehart J.D.,
        Marks J.,\nRA   Ballinger D.G., Barrett J.C., Skolnick M.H., Kamb A., Wiseman
        R.;\nRT   \"BRCA1 mutations in primary breast and ovarian carcinomas.\";\nRL
        \  Science 266:120-122(1994).\nRN   [82]\nRP   VARIANT BC GLY-64, AND VARIANTS
        ALA-772; ASN-1040 AND GLY-1443.\nRX   PubMed=7894491; DOI=10.1038/ng1294-387;\nRA
        \  Castilla L.H., Couch F.J., Erdos M.R., Hoskins K.F., Calzone K.,\nRA   Garber
        J.E., Boyd J., Lubin M.B., Deshano M.L., Brody L.C., Collins F.S.,\nRA   Weber
        B.L.;\nRT   \"Mutations in the BRCA1 gene in families with early-onset breast
        and\nRT   ovarian cancer.\";\nRL   Nat. Genet. 8:387-391(1994).\nRN   [83]\nRP
        \  VARIANT BC GLY-61, AND VARIANTS ARG-356; GLY-1038; ASN-1040; ARG-1183 AND\nRP
        \  GLY-1613.\nRX   PubMed=7894493; DOI=10.1038/ng1294-399;\nRA   Friedman
        L.S., Ostermeyer E.A., Szabo C.I., Dowd P., Lynch E.D.,\nRA   Rowell S.E.,
        King M.-C.;\nRT   \"Confirmation of BRCA1 by analysis of germline mutations
        linked to breast\nRT   and ovarian cancer in ten families.\";\nRL   Nat. Genet.
        8:399-404(1994).\nRN   [84]\nRP   VARIANT BC GLY-61.\nRX   PubMed=8554067;\nRA
        \  Serova O., Montagna M., Torchard D., Narod S.A., Tonin P., Sylla B.,\nRA
        \  Lynch H.T., Feunteun J., Lenoir G.M.;\nRT   \"A high incidence of BRCA1
        mutations in 20 breast-ovarian cancer\nRT   families.\";\nRL   Am. J. Hum.
        Genet. 58:42-51(1996).\nRN   [85]\nRP   VARIANT BROVCA1 TRP-841.\nRX   PubMed=8968716;\nRX
        \  DOI=10.1002/(sici)1098-2272(1996)13:6<595::aid-gepi5>3.0.co;2-#;\nRA   Barker
        D.F., Almeida E.F.A., Casey G., Fain P.R., Liao S.-Y., Masunaka I.,\nRA   Noble
        B., Kurosaki T., Anton-Culver H.;\nRT   \"BRCA1 R841W: a strong candidate
        for a common mutation with moderate\nRT   phenotype.\";\nRL   Genet. Epidemiol.
        13:595-604(1996).\nRN   [86]\nRP   VARIANTS BC AND BROVCA1.\nRX   PubMed=8776600;
        DOI=10.1093/hmg/5.6.835;\nRA   Durocher F., Shattuck-Eidens D., McClure M.,
        Labrie F., Skolnick M.H.,\nRA   Goldgar D.E., Simard J.;\nRT   \"Comparison
        of BRCA1 polymorphisms, rare sequence variants and/or missense\nRT   mutations
        in unaffected and breast/ovarian cancer populations.\";\nRL   Hum. Mol. Genet.
        5:835-842(1996).\nRN   [87]\nRP   VARIANTS BC MET-271 AND SER-1150.\nRX   PubMed=8723683;\nRX
        \  DOI=10.1002/(sici)1098-1004(1996)7:4<334::aid-humu7>3.0.co;2-8;\nRA   Katagiri
        T., Emi M., Ito I., Kobayashi K., Yoshimoto M., Iwase T.,\nRA   Kasumi F.,
        Miki Y., Skolnick M.H., Nakamura Y.;\nRT   \"Mutations in the BRCA1 gene in
        Japanese breast cancer patients.\";\nRL   Hum. Mutat. 7:334-339(1996).\nRN
        \  [88]\nRP   VARIANT BC GLY-61, AND VARIANTS ARG-239; TRP-841 AND ILE-1512.\nRX
        \  PubMed=9760198; DOI=10.1007/s004390050799;\nRA   Dong J., Chang-Claude
        J., Wu Y., Schumacher V., Debatin I., Tonin P.,\nRA   Royer-Pokora B.;\nRT
        \  \"A high proportion of mutations in the BRCA1 gene in German breast/ovarian\nRT
        \  cancer families with clustering of mutations in the 3' third of the gene.\";\nRL
        \  Hum. Genet. 103:154-161(1998).\nRN   [89]\nRP   VARIANT BC GLY-64, AND
        VARIANTS ALA-772; GLU-820; ASN-1040; GLY-1443;\nRP   ILE-1512; LEU-1637 AND
        ILE-1652.\nRX   PubMed=9482581;\nRX   DOI=10.1002/(sici)1098-1004(1998)11:2<166::aid-humu10>3.0.co;2-x;\nRA
        \  Andersen T.I., Eiken H.G., Couch F., Kaada G., Skrede M., Johnsen H.,\nRA
        \  Aloysius T.A., Tveit K.M., Tranebjaerg L., Doerum A., Moeller P.,\nRA   Weber
        B.L., Boerresen-Dale A.-L.;\nRT   \"Constant denaturant gel electrophoresis
        (CDGE) in BRCA1 mutation\nRT   screening.\";\nRL   Hum. Mutat. 11:166-174(1998).\nRN
        \  [90]\nRP   VARIANTS BC SER-22; LEU-461; ASP-465; VAL-552; SER-892; ASP-960;
        ILE-1025\nRP   AND ALA-1047.\nRX   PubMed=9609997; DOI=10.1007/s100380050035;\nRA
        \  Katagiri T., Kasumi F., Yoshimoto M., Nomizu T., Asaishi K., Abe R.,\nRA
        \  Tsuchiya A., Sugano M., Takai S., Yoneda M., Fukutomi T., Nanba K.,\nRA
        \  Makita M., Okazaki H., Hirata K., Okazaki M., Furutsuma Y., Morishita Y.,\nRA
        \  Iino Y., Karino T., Ayabe H., Hara S., Kajiwara T., Houga S., Shimizu T.,\nRA
        \  Toda M., Yamazaki Y., Uchida T., Kunitomo K., Sonoo H., Kurebayashi J.,\nRA
        \  Shimotsuma K., Nakamura Y., Miki Y.;\nRT   \"High proportion of missense
        mutations of the BRCA1 and BRCA2 genes in\nRT   Japanese breast cancer families.\";\nRL
        \  J. Hum. Genet. 43:42-48(1998).\nRN   [91]\nRP   VARIANT OVARIAN CANCER
        ARG-1749.\nRX   PubMed=10486320; DOI=10.1086/302583;\nRA   Gayther S.A., Russell
        P., Harrington P., Antoniou A.C., Easton D.F.,\nRA   Ponder B.A.J.;\nRT   \"The
        contribution of germline BRCA1 and BRCA2 mutations to familial ovarian\nRT
        \  cancer: no evidence for other ovarian cancer-susceptibility genes.\";\nRL
        \  Am. J. Hum. Genet. 65:1021-1029(1999).\nRN   [92]\nRP   VARIANT BC SER-346,
        AND VARIANTS LEU-871; GLY-1038; ARG-1183 AND GLY-1613.\nRX   PubMed=10323242;
        DOI=10.1007/s004390050936;\nRA   Li S.S.-L., Tseng H.-M., Yang T.-P., Liu
        C.-H., Teng S.-J., Huang H.-W.,\nRA   Chen L.-M., Kao H.-W., Chen J.H., Tseng
        J.-N., Chen A., Hou M.-F.,\nRA   Huang T.-J., Chang H.-T., Mok K.-T., Tsai
        J.-H.;\nRT   \"Molecular characterization of germline mutations in the BRCA1
        and BRCA2\nRT   genes from breast cancer families in Taiwan.\";\nRL   Hum.
        Genet. 104:201-204(1999).\nRN   [93]\nRP   VARIANT OVARIAN CANCER LYS-227;
        PRO-1641; ASN-1692; SER-1776 AND SER-1812.\nRX   PubMed=10196379; DOI=10.1093/hmg/8.5.889;\nRA
        \  Janezic S.A., Ziogas A., Krumroy L.M., Krasner M., Plummer S.J., Cohen
        P.,\nRA   Gildea M., Barker D., Haile R., Casey G., Anton-Culver H.;\nRT   \"Germline
        BRCA1 alterations in a population-based series of ovarian cancer\nRT   cases.\";\nRL
        \  Hum. Mol. Genet. 8:889-897(1999).\nRN   [94]\nRP   VARIANTS GLY-1347; ILE-1512
        AND ILE-1652.\nRX   PubMed=12215251; DOI=10.1089/10906570260199375;\nRA   Deffenbaugh
        A.M., Frank T.S., Hoffman M., Cannon-Albright L.,\nRA   Neuhausen S.L.;\nRT
        \  \"Characterization of common BRCA1 and BRCA2 variants.\";\nRL   Genet.
        Test. 6:119-121(2002).\nRN   [95]\nRP   VARIANTS ILE-656; LEU-871 AND GLY-1613.\nRX
        \  PubMed=12442274; DOI=10.1002/humu.9083;\nRA   Zhi X., Szabo C., Chopin
        S., Suter N., Wang Q.-S., Ostrander E.A.,\nRA   Sinilnikova O.M., Lenoir G.M.,
        Goldgar D., Shi Y.-R.;\nRT   \"BRCA1 and BRCA2 sequence variants in Chinese
        breast cancer families.\";\nRL   Hum. Mutat. 20:474-474(2002).\nRN   [96]\nRP
        \  VARIANT BC TYR-749.\nRX   PubMed=12442275; DOI=10.1002/humu.9084;\nRA   Ruiz-Flores
        P., Sinilnikova O.M., Badzioch M., Calderon-Garciduenas A.L.,\nRA   Chopin
        S., Fabrice O., Gonzalez-Guerrero J.F., Szabo C., Lenoir G.,\nRA   Goldgar
        D.E., Barrera-Saldana H.A.;\nRT   \"BRCA1 and BRCA2 mutation analysis of early-onset
        and familial breast\nRT   cancer cases in Mexico.\";\nRL   Hum. Mutat. 20:474-475(2002).\nRN
        \  [97]\nRP   VARIANTS BC GLY-61; LYS-71; GLN-866; TYR-888; ILE-1139; GLY-1210
        AND\nRP   PRO-1297, AND VARIANTS BROVCA1 TYR-835 AND PRO-1786.\nRX   PubMed=12938098;
        DOI=10.1002/humu.9174;\nRA   Meyer P., Voigtlaender T., Bartram C.R., Klaes
        R.;\nRT   \"Twenty-three novel BRCA1 and BRCA2 sequence alterations in breast
        and/or\nRT   ovarian cancer families in Southern Germany.\";\nRL   Hum. Mutat.
        22:259-259(2003).\nRN   [98]\nRP   VARIANTS ASN-693; ASN-1040; ALA-1060 AND
        MET-1665.\nRX   PubMed=15026808; DOI=10.1038/sj.bjc.6601656;\nRA   Claes K.,
        Poppe B., Coene I., De Paepe A., Messiaen L.;\nRT   \"BRCA1 and BRCA2 germline
        mutation spectrum and frequencies in Belgian\nRT   breast/ovarian cancer families.\";\nRL
        \  Br. J. Cancer 90:1244-1251(2004).\nRN   [99]\nRP   VARIANTS OC GLY-61;
        THR-1411; ARG-1697 AND TRP-1699.\nRX   PubMed=14746861; DOI=10.1016/j.ejca.2003.09.016;\nRA
        \  Malander S., Ridderheim M., Masbaeck A., Loman N., Kristoffersson U.,\nRA
        \  Olsson H., Nilbert M., Borg A.;\nRT   \"One in 10 ovarian cancer patients
        carry germ line BRCA1 or BRCA2\nRT   mutations: results of a prospective study
        in Southern Sweden.\";\nRL   Eur. J. Cancer 40:422-428(2004).\nRN   [100]\nRP
        \  VARIANTS BC/BROVCA1 LYS-10; LYS-23; ILE-1187; HIS-1200 AND TYR-1217,\nRP
        \  VARIANTS BC ILE-1204 AND ASN-1207, VARIANTS BROVCA1 LEU-1226 AND GLY-1243,\nRP
        \  AND VARIANT ARG-1183.\nRX   PubMed=14722926; DOI=10.1002/humu.9213;\nRA
        \  Valarmathi M.T., Sawhney M., Deo S.S.V., Shukla N.K., Das S.N.;\nRT   \"Novel
        germline mutations in the BRCA1 and BRCA2 genes in Indian breast and\nRT   breast-ovarian
        cancer families.\";\nRL   Hum. Mutat. 23:205-205(2004).\nRN   [101]\nRP   VARIANTS
        HIS-856; LEU-871; GLY-1038; ARG-1183; THR-1628; GLN-1690 AND\nRP   GLY-1713.\nRX
        \  PubMed=15365993; DOI=10.1002/humu.9275;\nRA   Seo J.H., Cho D.-Y., Ahn
        S.-H., Yoon K.-S., Kang C.-S., Cho H.M., Lee H.S.,\nRA   Choe J.J., Choi C.W.,
        Kim B.S., Shin S.W., Kim Y.H., Kim J.S., Son G.-S.,\nRA   Lee J.-B., Koo B.H.;\nRT
        \  \"BRCA1 and BRCA2 germline mutations in Korean patients with sporadic breast\nRT
        \  cancer.\";\nRL   Hum. Mutat. 24:350-350(2004).\nRN   [102]\nRP   VARIANTS
        [LARGE SCALE ANALYSIS] PHE-30; PHE-758 AND CYS-778.\nRX   PubMed=16959974;
        DOI=10.1126/science.1133427;\nRA   Sjoeblom T., Jones S., Wood L.D., Parsons
        D.W., Lin J., Barber T.D.,\nRA   Mandelker D., Leary R.J., Ptak J., Silliman
        N., Szabo S., Buckhaults P.,\nRA   Farrell C., Meeh P., Markowitz S.D., Willis
        J., Dawson D., Willson J.K.V.,\nRA   Gazdar A.F., Hartigan J., Wu L., Liu
        C., Parmigiani G., Park B.H.,\nRA   Bachman K.E., Papadopoulos N., Vogelstein
        B., Kinzler K.W.,\nRA   Velculescu V.E.;\nRT   \"The consensus coding sequences
        of human breast and colorectal cancers.\";\nRL   Science 314:268-274(2006).\nRN
        \  [103]\nRP   VARIANTS THR-18; MET-1495; ALA-1685; ARG-1689; TRP-1699; GLU-1706;\nRP
        \  GLU-1708; ARG-1715; ARG-1738; PRO-1764; SER-1766 AND VAL-1788, AND VARIANTS\nRP
        \  BROVCA1 GLY-1623 AND ILE-1685.\nRX   PubMed=17924331; DOI=10.1086/521032;\nRA
        \  Easton D.F., Deffenbaugh A.M., Pruss D., Frye C., Wenstrup R.J.,\nRA   Allen-Brady
        K., Tavtigian S.V., Monteiro A.N.A., Iversen E.S., Couch F.J.,\nRA   Goldgar
        D.E.;\nRT   \"A systematic genetic assessment of 1,433 sequence variants of
        unknown\nRT   clinical significance in the BRCA1 and BRCA2 breast cancer-predisposition\nRT
        \  genes.\";\nRL   Am. J. Hum. Genet. 81:873-883(2007).\nRN   [104]\nRP   CHARACTERIZATION
        OF VARIANT ILE-1685, AND CHARACTERIZATION OF VARIANT\nRP   BROVCA1 GLY-1623.\nRX
        \  PubMed=20513136; DOI=10.1002/humu.21267;\nRA   Walker L.C., Whiley P.J.,
        Couch F.J., Farrugia D.J., Healey S.,\nRA   Eccles D.M., Lin F., Butler S.A.,
        Goff S.A., Thompson B.A., Lakhani S.R.,\nRA   Da Silva L.M., Tavtigian S.V.,
        Goldgar D.E., Brown M.A., Spurdle A.B.;\nRT   \"Detection of splicing aberrations
        caused by BRCA1 and BRCA2 sequence\nRT   variants encoding missense substitutions:
        implications for prediction of\nRT   pathogenicity.\";\nRL   Hum. Mutat. 31:E1484-E1505(2010).\nRN
        \  [105]\nRP   VARIANT FANCS ALA-1736, CHARACTERIZATION OF VARIANT FANCS ALA-1736,\nRP
        \  SUBCELLULAR LOCATION, AND INTERACTION WITH UIMC1.\nRX   PubMed=23269703;
        DOI=10.1158/2159-8290.cd-12-0421;\nRA   Domchek S.M., Tang J., Stopfer J.,
        Lilli D.R., Hamel N., Tischkowitz M.,\nRA   Monteiro A.N., Messick T.E., Powers
        J., Yonker A., Couch F.J.,\nRA   Goldgar D.E., Davidson H.R., Nathanson K.L.,
        Foulkes W.D., Greenberg R.A.;\nRT   \"Biallelic deleterious BRCA1 mutations
        in a woman with early-onset ovarian\nRT   cancer.\";\nRL   Cancer Discov.
        3:399-405(2013).\nRN   [106]\nRP   CHARACTERIZATION OF VARIANTS BC PHE-4;
        THR-18; GLN-45; GLY-61; GLY-64;\nRP   TYR-67; LYS-132; HIS-142; PHE-147; PRO-165;
        TRP-170; TYR-186; ILE-191;\nRP   MET-231; VAL-245; VAL-246; LEU-271; PHE-668;
        ASN-695; LEU-798; TYR-810;\nRP   LYS-826; GLN-841; HIS-856; ASN-1101; ASN-1140;
        GLY-1140; LYS-1214;\nRP   LYS-1236; SER-1267; VAL-1282; SER-1297 DEL; ARG-1301;
        LYS-1346; ILE-1378;\nRP   VAL-1400; PRO-1407; THR-1411; GLY-1443; GLY-1448;
        CYS-1486; MET-1534;\nRP   PRO-1589; THR-1628; PRO-1651; PHE-1651; PHE-1655;
        ARG-1686; GLN-1686;\nRP   VAL-1688 DEL; ILE-1691; TRP-1699; GLN-1699; GLU-1706;
        ALA-1706; GLU-1708;\nRP   CYS-1718; ALA-1720; LYS-1735; ALA-1736; GLY-1739;
        VAL-1739; GLN-1746;\nRP   THR-1753; PRO-1764; SER-1767; VAL-1770; CYS-1782;
        THR-1789; ASP-1794;\nRP   ASP-1804; ARG-1812; ARG-1837 AND LEU-1862, AND VARIANTS
        CYS-105; CYS-866;\nRP   ALA-1060; LYS-1250 AND ILE-1652.\nRX   PubMed=23867111;
        DOI=10.1158/2159-8290.cd-13-0094;\nRA   Bouwman P., van der Gulden H., van
        der Heijden I., Drost R., Klijn C.N.,\nRA   Prasetyanti P., Pieterse M., Wientjens
        E., Seibler J., Hogervorst F.B.,\nRA   Jonkers J.;\nRT   \"A high-throughput
        functional complementation assay for classification of\nRT   BRCA1 missense
        variants.\";\nRL   Cancer Discov. 3:1142-1155(2013).\nRN   [107]\nRP   VARIANT
        FANCS TRP-1699, AND SUBCELLULAR LOCATION.\nRX   PubMed=25472942; DOI=10.1158/2159-8290.cd-14-1156;\nRG
        \  University of Washington Centre for Mendelian Genomics;\nRG   FORGE Canada
        Consortium;\nRA   Sawyer S.L., Tian L., Kaehkoenen M., Schwartzentruber J.,
        Kircher M.,\nRA   Majewski J., Dyment D.A., Innes A.M., Boycott K.M., Moreau
        L.A.,\nRA   Moilanen J.S., Greenberg R.A.;\nRT   \"Biallelic mutations in
        BRCA1 cause a new Fanconi anemia subtype.\";\nRL   Cancer Discov. 5:135-142(2015).\nRN
        \  [108]\nRP   VARIANT BC PRO-1780, VARIANT BROVCA1 PRO-1780, AND VARIANT
        OC PRO-1780.\nRX   PubMed=28364669; DOI=10.1016/j.breast.2017.03.006;\nRA
        \  Ryu J.M., Kang G., Nam S.J., Kim S.W., Yu J., Lee S.K., Bae S.Y., Park
        S.,\nRA   Paik H.J., Kim J.W., Park S.S., Lee J.E., Kim S.W.;\nRT   \"Suggestion
        of BRCA1 c.5339T>C (p.L1780P) variant confer from 'unknown\nRT   significance'
        to 'Likely pathogenic' based on clinical evidence in Korea.\";\nRL   Breast
        33:109-116(2017).\nRN   [109]\nRP   VARIANT FANCS 903-CYS--TYR-1863 DEL.\nRX
        \  PubMed=29133208; DOI=10.1016/j.ejmg.2017.11.003;\nRA   Freire B.L., Homma
        T.K., Funari M.F.A., Lerario A.M., Leal A.M.,\nRA   Velloso E.D.R.P., Malaquias
        A.C., Jorge A.A.L.;\nRT   \"Homozygous loss of function BRCA1 variant causing
        a Fanconi-anemia-like\nRT   phenotype, a clinical report and review of previous
        patients.\";\nRL   Eur. J. Med. Genet. 61:130-133(2018).\nCC   -!- FUNCTION:
        E3 ubiquitin-protein ligase that specifically mediates the\nCC       formation
        of 'Lys-6'-linked polyubiquitin chains and plays a central\nCC       role
        in DNA repair by facilitating cellular responses to DNA damage\nCC       (PubMed:10500182,
        PubMed:12887909, PubMed:12890688, PubMed:14976165,\nCC       PubMed:16818604,
        PubMed:17525340, PubMed:19261748). It is unclear\nCC       whether it also
        mediates the formation of other types of polyubiquitin\nCC       chains (PubMed:12890688).
        The BRCA1-BARD1 heterodimer coordinates a\nCC       diverse range of cellular
        pathways such as DNA damage repair,\nCC       ubiquitination and transcriptional
        regulation to maintain genomic\nCC       stability (PubMed:12890688, PubMed:14976165,
        PubMed:20351172).\nCC       Regulates centrosomal microtubule nucleation (PubMed:18056443).\nCC
        \      Required for appropriate cell cycle arrests after ionizing irradiation\nCC
        \      in both the S-phase and the G2 phase of the cell cycle\nCC       (PubMed:10724175,
        PubMed:11836499, PubMed:12183412, PubMed:19261748).\nCC       Required for
        FANCD2 targeting to sites of DNA damage (PubMed:12887909).\nCC       Inhibits
        lipid synthesis by binding to inactive phosphorylated ACACA\nCC       and
        preventing its dephosphorylation (PubMed:16326698). Contributes to\nCC       homologous
        recombination repair (HRR) via its direct interaction with\nCC       PALB2,
        fine-tunes recombinational repair partly through its modulatory\nCC       role
        in the PALB2-dependent loading of BRCA2-RAD51 repair machinery at\nCC       DNA
        breaks (PubMed:19369211). Component of the BRCA1-RBBP8 complex\nCC       which
        regulates CHEK1 activation and controls cell cycle G2/M\nCC       checkpoints
        on DNA damage via BRCA1-mediated ubiquitination of RBBP8\nCC       (PubMed:16818604).
        Acts as a transcriptional activator\nCC       (PubMed:20160719). {ECO:0000269|PubMed:10500182,\nCC
        \      ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:11836499,\nCC       ECO:0000269|PubMed:12183412,
        ECO:0000269|PubMed:12887909,\nCC       ECO:0000269|PubMed:12890688, ECO:0000269|PubMed:14976165,\nCC
        \      ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16818604,\nCC       ECO:0000269|PubMed:17525340,
        ECO:0000269|PubMed:18056443,\nCC       ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19369211,\nCC
        \      ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172}.\nCC   -!-
        CATALYTIC ACTIVITY:\nCC       Reaction=S-ubiquitinyl-[E2 ubiquitin-conjugating
        enzyme]-L-cysteine +\nCC         [acceptor protein]-L-lysine = [E2 ubiquitin-conjugating
        enzyme]-L-\nCC         cysteine + N(6)-ubiquitinyl-[acceptor protein]-L-lysine.;\nCC
        \        EC=2.3.2.27; Evidence={ECO:0000269|PubMed:10500182,\nCC         ECO:0000269|PubMed:12887909,
        ECO:0000269|PubMed:12890688,\nCC         ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:18056443,\nCC
        \        ECO:0000269|PubMed:20351172};\nCC   -!- ACTIVITY REGULATION: The
        E3 ubiquitin-protein ligase activity is\nCC       inhibited by phosphorylation
        by AURKA. Activity is increased by\nCC       phosphatase treatment. {ECO:0000269|PubMed:18056443}.\nCC
        \  -!- PATHWAY: Protein modification; protein ubiquitination.\nCC   -!- SUBUNIT:
        Heterodimer with BARD1 (PubMed:11573085, PubMed:12890688,\nCC       PubMed:14976165).
        Part of the BRCA1-associated genome surveillance\nCC       complex (BASC),
        which contains BRCA1, MSH2, MSH6, MLH1, ATM, BLM, PMS2\nCC       and the MRE11-RAD50-NBN
        protein (MRN) complex (PubMed:10783165). This\nCC       association could
        be a dynamic process changing throughout the cell\nCC       cycle and within
        subnuclear domains (PubMed:10783165). Component of the\nCC       BRCA1-A complex,
        at least composed of BRCA1, BARD1, UIMC1/RAP80,\nCC       ABRAXAS1, BRCC3/BRCC36,
        BABAM2 and BABAM1/NBA1 (PubMed:19261746,\nCC       PubMed:19261748, PubMed:19261749,
        PubMed:20351172). Interacts (via the\nCC       BRCT domains) with ABRAXAS1
        (phosphorylated form); this is important\nCC       for recruitment to sites
        of DNA damage (PubMed:17525340,\nCC       PubMed:17643121, PubMed:17643122,
        PubMed:23269703, PubMed:24316840,\nCC       PubMed:26778126). Can form a heterotetramer
        with two molecules of\nCC       ABRAXAS1 (phosphorylated form) (PubMed:26778126).
        Component of the\nCC       BRCA1-RBBP8 complex (PubMed:16101277). Interacts
        (via the BRCT domains)\nCC       with RBBP8 ('Ser-327' phosphorylated form);
        the interaction\nCC       ubiquitinates RBBP8, regulates CHEK1 activation,
        and involves RBBP8 in\nCC       BRCA1-dependent G2/M checkpoint control on
        DNA damage (PubMed:16818604,\nCC       PubMed:9811458). Associates with RNA
        polymerase II holoenzyme\nCC       (PubMed:9662397). Interacts with SMC1A,
        NELFB, DCLRE1C, CLSPN\nCC       (PubMed:11739404, PubMed:11877377, PubMed:15096610,
        PubMed:15456891).\nCC       Interacts with CHEK1, CHEK2, BAP1, BRCC3, UBXN1
        and PCLAF\nCC       (PubMed:10724175, PubMed:11836499, PubMed:14636569, PubMed:20351172,\nCC
        \      PubMed:21673012). Interacts (via BRCT domains) with BRIP1\nCC       (phosphorylated
        form) (PubMed:11301010, PubMed:15133502,\nCC       PubMed:21473589). Interacts
        with FANCD2 (ubiquitinated form)\nCC       (PubMed:11239454). Interacts with
        H2AX (phosphorylated on 'Ser-140')\nCC       (PubMed:12419185). Interacts
        (via the BRCT domains) with ACACA\nCC       (phosphorylated form); the interaction
        prevents dephosphorylation of\nCC       ACACA (PubMed:12360400, PubMed:16326698,
        PubMed:16698035,\nCC       PubMed:18452305). Part of a BRCA complex containing
        BRCA1, BRCA2 and\nCC       PALB2 (PubMed:19369211). Interacts directly with
        PALB2; the interaction\nCC       is essential for its function in HRR (PubMed:19369211,\nCC
        \      PubMed:28319063). Interacts directly with BRCA2; the interaction occurs\nCC
        \      only in the presence of PALB2 which serves as the bridging protein\nCC
        \      (PubMed:19369211). Interacts (via the BRCT domains) with LMO4; the\nCC
        \      interaction represses the transcriptional activity of BRCA1\nCC       (PubMed:11751867).
        Interacts (via the BRCT domains) with CCAR2 (via N-\nCC       terminus); the
        interaction represses the transcriptional activator\nCC       activity of
        BRCA1 (PubMed:20160719). Interacts with EXD2\nCC       (PubMed:26807646).
        Interacts (via C-terminus) with DHX9; this\nCC       interaction is direct
        and links BRCA1 to the RNA polymerase II\nCC       holoenzyme (PubMed:9662397).
        Interacts with DNA helicase ZGRF1; the\nCC       interaction is increased
        following DNA damage induction\nCC       (PubMed:34552057). Interacts with
        FBXO44; this interaction mediates\nCC       BRCA1 ubiquitination and subsequent
        degradation (PubMed:23086937).\nCC       {ECO:0000269|PubMed:10724175, ECO:0000269|PubMed:10783165,\nCC
        \      ECO:0000269|PubMed:11239454, ECO:0000269|PubMed:11301010,\nCC       ECO:0000269|PubMed:11573085,
        ECO:0000269|PubMed:11739404,\nCC       ECO:0000269|PubMed:11751867, ECO:0000269|PubMed:11836499,\nCC
        \      ECO:0000269|PubMed:11877377, ECO:0000269|PubMed:12360400,\nCC       ECO:0000269|PubMed:12419185,
        ECO:0000269|PubMed:12890688,\nCC       ECO:0000269|PubMed:14636569, ECO:0000269|PubMed:14976165,\nCC
        \      ECO:0000269|PubMed:15096610, ECO:0000269|PubMed:15133502,\nCC       ECO:0000269|PubMed:15456891,
        ECO:0000269|PubMed:16101277,\nCC       ECO:0000269|PubMed:16326698, ECO:0000269|PubMed:16698035,\nCC
        \      ECO:0000269|PubMed:16818604, ECO:0000269|PubMed:17525340,\nCC       ECO:0000269|PubMed:17643121,
        ECO:0000269|PubMed:17643122,\nCC       ECO:0000269|PubMed:18452305, ECO:0000269|PubMed:19261746,\nCC
        \      ECO:0000269|PubMed:19261748, ECO:0000269|PubMed:19261749,\nCC       ECO:0000269|PubMed:19369211,
        ECO:0000269|PubMed:20159462,\nCC       ECO:0000269|PubMed:20160719, ECO:0000269|PubMed:20351172,\nCC
        \      ECO:0000269|PubMed:21473589, ECO:0000269|PubMed:21673012,\nCC       ECO:0000269|PubMed:23086937,
        ECO:0000269|PubMed:23269703,\nCC       ECO:0000269|PubMed:24316840, ECO:0000269|PubMed:26778126,\nCC
        \      ECO:0000269|PubMed:26807646, ECO:0000269|PubMed:28319063,\nCC       ECO:0000269|PubMed:34552057,
        ECO:0000269|PubMed:9528852,\nCC       ECO:0000269|PubMed:9662397, ECO:0000269|PubMed:9811458}.\nCC
        \  -!- INTERACTION:\nCC       P38398; Q6UWZ7: ABRAXAS1; NbExp=16; IntAct=EBI-349905,
        EBI-1263451;\nCC       P38398; Q13085: ACACA; NbExp=2; IntAct=EBI-349905,
        EBI-717681;\nCC       P38398; Q92560: BAP1; NbExp=3; IntAct=EBI-349905, EBI-1791447;\nCC
        \      P38398; Q99728: BARD1; NbExp=20; IntAct=EBI-349905, EBI-473181;\nCC
        \      P38398; Q7Z569: BRAP; NbExp=3; IntAct=EBI-349905, EBI-349900;\nCC       P38398;
        Q6PJG6: BRAT1; NbExp=6; IntAct=EBI-349905, EBI-10826195;\nCC       P38398;
        P38398: BRCA1; NbExp=4; IntAct=EBI-349905, EBI-349905;\nCC       P38398; Q9BX63:
        BRIP1; NbExp=33; IntAct=EBI-349905, EBI-3509650;\nCC       P38398; P24385:
        CCND1; NbExp=3; IntAct=EBI-349905, EBI-375001;\nCC       P38398; P24864: CCNE1;
        NbExp=2; IntAct=EBI-349905, EBI-519526;\nCC       P38398; O14757: CHEK1; NbExp=3;
        IntAct=EBI-349905, EBI-974488;\nCC       P38398; P03372: ESR1; NbExp=16; IntAct=EBI-349905,
        EBI-78473;\nCC       P38398; Q92731: ESR2; NbExp=4; IntAct=EBI-349905, EBI-78505;\nCC
        \      P38398; O15360: FANCA; NbExp=5; IntAct=EBI-349905, EBI-81570;\nCC       P38398;
        Q9BXW9: FANCD2; NbExp=3; IntAct=EBI-349905, EBI-359343;\nCC       P38398;
        Q14192: FHL2; NbExp=6; IntAct=EBI-349905, EBI-701903;\nCC       P38398; P78347:
        GTF2I; NbExp=5; IntAct=EBI-349905, EBI-359622;\nCC       P38398; P16104: H2AX;
        NbExp=4; IntAct=EBI-349905, EBI-494830;\nCC       P38398; O75330: HMMR; NbExp=4;
        IntAct=EBI-349905, EBI-2556203;\nCC       P38398; P10809: HSPD1; NbExp=2;
        IntAct=EBI-349905, EBI-352528;\nCC       P38398; Q16666: IFI16; NbExp=9; IntAct=EBI-349905,
        EBI-2867186;\nCC       P38398; P52292: KPNA2; NbExp=3; IntAct=EBI-349905,
        EBI-349938;\nCC       P38398; Q14676: MDC1; NbExp=4; IntAct=EBI-349905, EBI-495644;\nCC
        \      P38398; Q8WX92: NELFB; NbExp=5; IntAct=EBI-349905, EBI-347721;\nCC
        \      P38398; Q86YC2: PALB2; NbExp=27; IntAct=EBI-349905, EBI-1222653;\nCC
        \      P38398; P62136: PPP1CA; NbExp=2; IntAct=EBI-349905, EBI-357253;\nCC
        \      P38398; P62140: PPP1CB; NbExp=3; IntAct=EBI-349905, EBI-352350;\nCC
        \      P38398; P36873: PPP1CC; NbExp=2; IntAct=EBI-349905, EBI-356283;\nCC
        \      P38398; Q96SB3: PPP1R9B; NbExp=4; IntAct=EBI-349905, EBI-351275;\nCC
        \      P38398; Q99708: RBBP8; NbExp=15; IntAct=EBI-349905, EBI-745715;\nCC
        \      P38398; P63165: SUMO1; NbExp=3; IntAct=EBI-349905, EBI-80140;\nCC       P38398;
        P61956: SUMO2; NbExp=2; IntAct=EBI-349905, EBI-473220;\nCC       P38398; P11388:
        TOP2A; NbExp=3; IntAct=EBI-349905, EBI-539628;\nCC       P38398; P04637: TP53;
        NbExp=2; IntAct=EBI-349905, EBI-366083;\nCC       P38398; Q12888: TP53BP1;
        NbExp=5; IntAct=EBI-349905, EBI-396540;\nCC       P38398; Q96RL1: UIMC1; NbExp=13;
        IntAct=EBI-349905, EBI-725300;\nCC       P38398; Q96RL1-1: UIMC1; NbExp=2;
        IntAct=EBI-349905, EBI-9640371;\nCC       P38398; Q6NZY4: ZCCHC8; NbExp=2;
        IntAct=EBI-349905, EBI-1263058;\nCC       P38398; Q86YA3: ZGRF1; NbExp=4;
        IntAct=EBI-349905, EBI-10962579;\nCC       P38398; Q9GZX5: ZNF350; NbExp=3;
        IntAct=EBI-349905, EBI-396421;\nCC       P38398; P03126: E6; Xeno; NbExp=7;
        IntAct=EBI-349905, EBI-1177242;\nCC       P38398; P03129: E7; Xeno; NbExp=5;
        IntAct=EBI-349905, EBI-866453;\nCC       P38398; Q61188: Ezh2; Xeno; NbExp=5;
        IntAct=EBI-349905, EBI-904311;\nCC       P38398-1; Q99728: BARD1; NbExp=3;
        IntAct=EBI-21498346, EBI-473181;\nCC       P38398-1; Q13526: PIN1; NbExp=4;
        IntAct=EBI-21498346, EBI-714158;\nCC       P38398-5; Q92560: BAP1; NbExp=2;
        IntAct=EBI-2015072, EBI-1791447;\nCC       P38398-6; Q14457: BECN1; NbExp=3;
        IntAct=EBI-25833510, EBI-949378;\nCC       P38398-6; P42858: HTT; NbExp=3;
        IntAct=EBI-25833510, EBI-466029;\nCC   -!- SUBCELLULAR LOCATION: Nucleus {ECO:0000269|PubMed:15133502,\nCC
        \      ECO:0000269|PubMed:17525340, ECO:0000269|PubMed:20160719,\nCC       ECO:0000269|PubMed:21144835,
        ECO:0000269|PubMed:26778126,\nCC       ECO:0000269|PubMed:9528852}. Chromosome
        {ECO:0000269|PubMed:23269703,\nCC       ECO:0000269|PubMed:25472942, ECO:0000269|PubMed:26778126}.
        Cytoplasm\nCC       {ECO:0000269|PubMed:20160719}. Note=Localizes at sites
        of DNA damage at\nCC       double-strand breaks (DSBs); recruitment to DNA
        damage sites is\nCC       mediated by ABRAXAS1 and the BRCA1-A complex (PubMed:26778126).\nCC
        \      Translocated to the cytoplasm during UV-induced apoptosis\nCC       (PubMed:20160719).
        {ECO:0000269|PubMed:20160719,\nCC       ECO:0000269|PubMed:26778126}.\nCC
        \  -!- SUBCELLULAR LOCATION: [Isoform 3]: Cytoplasm.\nCC   -!- SUBCELLULAR
        LOCATION: [Isoform 5]: Cytoplasm\nCC       {ECO:0000269|PubMed:8972225}.\nCC
        \  -!- ALTERNATIVE PRODUCTS:\nCC       Event=Alternative splicing, Alternative
        initiation; Named isoforms=8;\nCC       Name=1;\nCC         IsoId=P38398-1;
        Sequence=Displayed;\nCC       Name=2;\nCC         IsoId=P38398-2; Sequence=VSP_047891;\nCC
        \      Name=3; Synonyms=Delta11b;\nCC         IsoId=P38398-3; Sequence=VSP_035399,
        VSP_043797;\nCC       Name=4; Synonyms=DeltaBRCA1(17aa);\nCC         IsoId=P38398-4;
        Sequence=VSP_035396;\nCC       Name=5; Synonyms=Delta11, Delta772-3095;\nCC
        \        IsoId=P38398-5; Sequence=VSP_035398;\nCC       Name=6;\nCC         IsoId=P38398-6;
        Sequence=VSP_035399, VSP_043797, VSP_043798;\nCC       Name=7;\nCC         IsoId=P38398-7;
        Sequence=VSP_055404;\nCC       Name=8;\nCC         IsoId=P38398-8; Sequence=VSP_057569;\nCC
        \  -!- TISSUE SPECIFICITY: Isoform 1 and isoform 3 are widely expressed.\nCC
        \      Isoform 3 is reduced or absent in several breast and ovarian cancer\nCC
        \      cell lines.\nCC   -!- DOMAIN: The BRCT domains recognize and bind phosphorylated
        pSXXF motif\nCC       on proteins. The interaction with the phosphorylated
        pSXXF motif of\nCC       ABRAXAS1, recruits BRCA1 at DNA damage sites.\nCC
        \      {ECO:0000269|PubMed:20159462}.\nCC   -!- DOMAIN: The RING-type zinc
        finger domain interacts with BAP1.\nCC       {ECO:0000269|PubMed:20159462}.\nCC
        \  -!- PTM: Phosphorylated in response to IR, UV, and various stimuli that\nCC
        \      cause checkpoint activation, probably by ATM or ATR (PubMed:11114888,\nCC
        \      PubMed:12183412, PubMed:21144835). Phosphorylation at Ser-988 by CHEK2\nCC
        \      regulates mitotic spindle assembly (PubMed:10724175, PubMed:20364141).\nCC
        \      Phosphorylation by AURKA regulates centrosomal microtubule nucleation\nCC
        \      (PubMed:18056443). {ECO:0000269|PubMed:10724175,\nCC       ECO:0000269|PubMed:11114888,
        ECO:0000269|PubMed:12183412,\nCC       ECO:0000269|PubMed:18056443, ECO:0000269|PubMed:20364141,\nCC
        \      ECO:0000269|PubMed:21144835}.\nCC   -!- PTM: Autoubiquitinated, undergoes
        'Lys-6'-linked polyubiquitination.\nCC       'Lys-6'-linked polyubiquitination
        does not promote degradation.\nCC       Ubiquitinated in a FBXO44-dependent
        manner; leading to proteasomal\nCC       degradation (PubMed:23086937). {ECO:0000269|PubMed:12890688,\nCC
        \      ECO:0000269|PubMed:20351172, ECO:0000269|PubMed:23086937}.\nCC   -!-
        POLYMORPHISM: There is evidence that the presence of the rare form of\nCC
        \      Gln-356-Arg and Leu-871-Pro polymorphisms may be associated with an\nCC
        \      increased risk for developing ovarian cancer.\nCC   -!- DISEASE: Breast
        cancer (BC) [MIM:114480]: A common malignancy\nCC       originating from breast
        epithelial tissue. Breast neoplasms can be\nCC       distinguished by their
        histologic pattern. Invasive ductal carcinoma is\nCC       by far the most
        common type. Breast cancer is etiologically and\nCC       genetically heterogeneous.
        Important genetic factors have been\nCC       indicated by familial occurrence
        and bilateral involvement. Mutations\nCC       at more than one locus can
        be involved in different families or even in\nCC       the same case. {ECO:0000269|PubMed:10323242,\nCC
        \      ECO:0000269|PubMed:11114888, ECO:0000269|PubMed:11301010,\nCC       ECO:0000269|PubMed:12427738,
        ECO:0000269|PubMed:12442275,\nCC       ECO:0000269|PubMed:12938098, ECO:0000269|PubMed:14722926,\nCC
        \      ECO:0000269|PubMed:15133502, ECO:0000269|PubMed:18285836,\nCC       ECO:0000269|PubMed:21473589,
        ECO:0000269|PubMed:23867111,\nCC       ECO:0000269|PubMed:28364669, ECO:0000269|PubMed:7545954,\nCC
        \      ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:7894493,\nCC       ECO:0000269|PubMed:7939630,
        ECO:0000269|PubMed:8554067,\nCC       ECO:0000269|PubMed:8723683, ECO:0000269|PubMed:8776600,\nCC
        \      ECO:0000269|PubMed:9482581, ECO:0000269|PubMed:9609997,\nCC       ECO:0000269|PubMed:9760198}.
        Note=Disease susceptibility is associated\nCC       with variants affecting
        the gene represented in this entry. Mutations\nCC       in BRCA1 are thought
        to be responsible for 45% of inherited breast\nCC       cancer. Moreover,
        BRCA1 carriers have a 4-fold increased risk of colon\nCC       cancer, whereas
        male carriers face a 3-fold increased risk of prostate\nCC       cancer. Cells
        lacking BRCA1 show defects in DNA repair by homologous\nCC       recombination.\nCC
        \  -!- DISEASE: Breast-ovarian cancer, familial, 1 (BROVCA1) [MIM:604370]:
        A\nCC       condition associated with familial predisposition to cancer of
        the\nCC       breast and ovaries. Characteristic features in affected families
        are an\nCC       early age of onset of breast cancer (often before age 50),
        increased\nCC       chance of bilateral cancers (cancer that develop in both
        breasts, or\nCC       both ovaries, independently), frequent occurrence of
        breast cancer\nCC       among men, increased incidence of tumors of other
        specific organs, such\nCC       as the prostate. {ECO:0000269|PubMed:12938098,\nCC
        \      ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:17924331,\nCC       ECO:0000269|PubMed:20513136,
        ECO:0000269|PubMed:28364669,\nCC       ECO:0000269|PubMed:8968716}. Note=Disease
        susceptibility is associated\nCC       with variants affecting the gene represented
        in this entry. Mutations\nCC       in BRCA1 are thought to be responsible
        for more than 80% of inherited\nCC       breast-ovarian cancer.\nCC   -!-
        DISEASE: Ovarian cancer (OC) [MIM:167000]: The term ovarian cancer\nCC       defines
        malignancies originating from ovarian tissue. Although many\nCC       histologic
        types of ovarian tumors have been described, epithelial\nCC       ovarian
        carcinoma is the most common form. Ovarian cancers are often\nCC       asymptomatic
        and the recognized signs and symptoms, even of late-stage\nCC       disease,
        are vague. Consequently, most patients are diagnosed with\nCC       advanced
        disease. {ECO:0000269|PubMed:10196379,\nCC       ECO:0000269|PubMed:10486320,
        ECO:0000269|PubMed:14746861,\nCC       ECO:0000269|PubMed:28364669}. Note=Disease
        susceptibility is associated\nCC       with variants affecting the gene represented
        in this entry.\nCC   -!- DISEASE: Pancreatic cancer 4 (PNCA4) [MIM:614320]:
        A malignant neoplasm\nCC       of the pancreas. Tumors can arise from both
        the exocrine and endocrine\nCC       portions of the pancreas, but 95% of
        them develop from the exocrine\nCC       portion, including the ductal epithelium,
        acinar cells, connective\nCC       tissue, and lymphatic tissue. {ECO:0000269|PubMed:18762988}.\nCC
        \      Note=Disease susceptibility is associated with variants affecting the\nCC
        \      gene represented in this entry.\nCC   -!- DISEASE: Fanconi anemia,
        complementation group S (FANCS) [MIM:617883]:\nCC       A form of Fanconi
        anemia, a disorder affecting all bone marrow elements\nCC       and resulting
        in anemia, leukopenia and thrombopenia. It is associated\nCC       with cardiac,
        renal and limb malformations, dermal pigmentary changes,\nCC       and a predisposition
        to the development of malignancies. At the\nCC       cellular level it is
        associated with hypersensitivity to DNA-damaging\nCC       agents, chromosomal
        instability (increased chromosome breakage) and\nCC       defective DNA repair.
        {ECO:0000269|PubMed:23269703,\nCC       ECO:0000269|PubMed:25472942, ECO:0000269|PubMed:29133208}.
        Note=Disease\nCC       susceptibility is associated with variants affecting
        the gene\nCC       represented in this entry.\nCC   -!- MISCELLANEOUS: [Isoform
        2]: May be produced at very low levels due to a\nCC       premature stop codon
        in the mRNA, leading to nonsense-mediated mRNA\nCC       decay. {ECO:0000305}.\nCC
        \  -!- MISCELLANEOUS: [Isoform 4]: Produced by alternative initiation at Met-\nCC
        \      18 of isoform 1. {ECO:0000305}.\nCC   -!- MISCELLANEOUS: [Isoform 8]:
        The N-terminus is confirmed by several\nCC       cDNAs. {ECO:0000305}.\nCC
        \  -!- CAUTION: An article that concluded that AURKA-mediated phosphorylation\nCC
        \      of BRCA1 Ser-308 plays a role in the normal cell cycle G2/M transition\nCC
        \      was withdrawn due to data manipulation of flow cytometry data.\nCC
        \      {ECO:0000305|PubMed:14990569, ECO:0000305|PubMed:26341884}.\nCC   -!-
        SEQUENCE CAUTION:\nCC       Sequence=AAB61673.1; Type=Erroneous translation;
        Note=Wrong choice of CDS.; Evidence={ECO:0000305};\nCC       Sequence=AAI15038.1;
        Type=Erroneous initiation; Note=Truncated N-terminus.; Evidence={ECO:0000305};\nCC
        \      Sequence=AAI15038.1; Type=Erroneous termination; Note=Truncated C-terminus.;
        Evidence={ECO:0000305};\nCC   -!- WEB RESOURCE: Name=Atlas of Genetics and
        Cytogenetics in Oncology and\nCC       Haematology;\nCC       URL=\"https://atlasgeneticsoncology.org/gene/163/BRCA1\";\nCC
        \  -!- WEB RESOURCE: Name=Wikipedia; Note=BRCA1 entry;\nCC       URL=\"https://en.wikipedia.org/wiki/BRCA1\";\nCC
        \  ---------------------------------------------------------------------------\nCC
        \  Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms\nCC
        \  Distributed under the Creative Commons Attribution (CC BY 4.0) License\nCC
        \  ---------------------------------------------------------------------------\nDR
        \  EMBL; U14680; AAA73985.1; -; mRNA.\nDR   EMBL; L78833; AAC37594.1; -; Genomic_DNA.\nDR
        \  EMBL; U64805; AAC00049.1; -; mRNA.\nDR   EMBL; AF005068; AAB61673.1; ALT_SEQ;
        mRNA.\nDR   EMBL; DQ190450; ABA29208.1; -; Genomic_DNA.\nDR   EMBL; DQ190451;
        ABA29211.1; -; Genomic_DNA.\nDR   EMBL; DQ190452; ABA29214.1; -; Genomic_DNA.\nDR
        \  EMBL; DQ190453; ABA29217.1; -; Genomic_DNA.\nDR   EMBL; DQ190454; ABA29220.1;
        -; Genomic_DNA.\nDR   EMBL; DQ190455; ABA29223.1; -; Genomic_DNA.\nDR   EMBL;
        DQ190456; ABA29226.1; -; Genomic_DNA.\nDR   EMBL; AY273801; AAP12647.1; -;
        Genomic_DNA.\nDR   EMBL; AC060780; -; NOT_ANNOTATED_CDS; Genomic_DNA.\nDR
        \  EMBL; AC135721; -; NOT_ANNOTATED_CDS; Genomic_DNA.\nDR   EMBL; BC072418;
        AAH72418.1; -; mRNA.\nDR   EMBL; BC115037; AAI15038.1; ALT_SEQ; mRNA.\nDR
        \  CCDS; CCDS11453.1; -. [P38398-1]\nDR   CCDS; CCDS11454.2; -. [P38398-3]\nDR
        \  CCDS; CCDS11455.2; -. [P38398-6]\nDR   CCDS; CCDS11456.2; -. [P38398-7]\nDR
        \  CCDS; CCDS11459.2; -. [P38398-8]\nDR   PIR; A58881; A58881.\nDR   RefSeq;
        NP_001394512.1; NM_001407583.1. [P38398-7]\nDR   RefSeq; NP_001394514.1; NM_001407585.1.
        [P38398-7]\nDR   RefSeq; NP_001394522.1; NM_001407593.1. [P38398-1]\nDR   RefSeq;
        NP_001394523.1; NM_001407594.1. [P38398-1]\nDR   RefSeq; NP_001394525.1; NM_001407596.1.
        [P38398-1]\nDR   RefSeq; NP_001394526.1; NM_001407597.1. [P38398-1]\nDR   RefSeq;
        NP_001394527.1; NM_001407598.1. [P38398-1]\nDR   RefSeq; NP_001394531.1; NM_001407602.1.
        [P38398-1]\nDR   RefSeq; NP_001394532.1; NM_001407603.1. [P38398-1]\nDR   RefSeq;
        NP_001394534.1; NM_001407605.1. [P38398-1]\nDR   RefSeq; NP_001394621.1; NM_001407692.1.
        [P38398-8]\nDR   RefSeq; NP_001394623.1; NM_001407694.1. [P38398-8]\nDR   RefSeq;
        NP_001394624.1; NM_001407695.1. [P38398-8]\nDR   RefSeq; NP_001394625.1; NM_001407696.1.
        [P38398-8]\nDR   RefSeq; NP_001394626.1; NM_001407697.1. [P38398-8]\nDR   RefSeq;
        NP_001394627.1; NM_001407698.1. [P38398-8]\nDR   RefSeq; NP_001394653.1; NM_001407724.1.
        [P38398-8]\nDR   RefSeq; NP_001394654.1; NM_001407725.1. [P38398-8]\nDR   RefSeq;
        NP_001394655.1; NM_001407726.1. [P38398-8]\nDR   RefSeq; NP_001394656.1; NM_001407727.1.
        [P38398-8]\nDR   RefSeq; NP_001394657.1; NM_001407728.1. [P38398-8]\nDR   RefSeq;
        NP_001394658.1; NM_001407729.1. [P38398-8]\nDR   RefSeq; NP_001394659.1; NM_001407730.1.
        [P38398-8]\nDR   RefSeq; NP_001394660.1; NM_001407731.1. [P38398-8]\nDR   RefSeq;
        NP_001394922.1; NM_001407993.1. [P38398-3]\nDR   RefSeq; NP_001395347.1; NM_001408418.1.
        [P38398-5]\nDR   RefSeq; NP_001395348.1; NM_001408419.1. [P38398-5]\nDR   RefSeq;
        NP_001395349.1; NM_001408420.1. [P38398-5]\nDR   RefSeq; NP_009225.1; NM_007294.4.
        [P38398-1]\nDR   RefSeq; NP_009228.2; NM_007297.4. [P38398-8]\nDR   RefSeq;
        NP_009229.2; NM_007298.4. [P38398-3]\nDR   RefSeq; NP_009230.2; NM_007299.4.
        [P38398-6]\nDR   RefSeq; NP_009231.2; NM_007300.4. [P38398-7]\nDR   PDB; 1JM7;
        NMR; -; A=1-110.\nDR   PDB; 1JNX; X-ray; 2.50 A; X=1646-1859.\nDR   PDB; 1N5O;
        X-ray; 2.80 A; X=1646-1859.\nDR   PDB; 1OQA; NMR; -; A=1755-1863.\nDR   PDB;
        1T15; X-ray; 1.85 A; A=1646-1859.\nDR   PDB; 1T29; X-ray; 2.30 A; A=1646-1859.\nDR
        \  PDB; 1T2U; X-ray; 2.80 A; A=1646-1859.\nDR   PDB; 1T2V; X-ray; 3.30 A;
        A/B/C/D/E=1646-1859.\nDR   PDB; 1Y98; X-ray; 2.50 A; A=1646-1859.\nDR   PDB;
        2ING; X-ray; 3.60 A; X=1649-1859.\nDR   PDB; 3COJ; X-ray; 3.21 A; A/B/C/D/E/F/G/X=1646-1859.\nDR
        \  PDB; 3K0H; X-ray; 2.70 A; A=1646-1859.\nDR   PDB; 3K0K; X-ray; 2.70 A;
        A=1646-1859.\nDR   PDB; 3K15; X-ray; 2.80 A; A=1646-1859.\nDR   PDB; 3K16;
        X-ray; 3.00 A; A=1646-1859.\nDR   PDB; 3PXA; X-ray; 2.55 A; A=1646-1859.\nDR
        \  PDB; 3PXB; X-ray; 2.50 A; A=1646-1859.\nDR   PDB; 3PXC; X-ray; 2.80 A;
        X=1646-1859.\nDR   PDB; 3PXD; X-ray; 2.80 A; A=1646-1859.\nDR   PDB; 3PXE;
        X-ray; 2.85 A; A/B/C/D=1646-1859.\nDR   PDB; 4IFI; X-ray; 2.20 A; A=1646-1859.\nDR
        \  PDB; 4IGK; X-ray; 1.75 A; A/B=1646-1859.\nDR   PDB; 4JLU; X-ray; 3.50 A;
        A=1649-1859.\nDR   PDB; 4OFB; X-ray; 3.05 A; A=1646-1859.\nDR   PDB; 4U4A;
        X-ray; 3.51 A; A/B/C=1646-1859.\nDR   PDB; 4Y18; X-ray; 3.50 A; A/B/C/D/E/F/G/H=1646-1859.\nDR
        \  PDB; 4Y2G; X-ray; 2.50 A; A=1646-1859.\nDR   PDB; 6G2I; EM; 5.90 A; H/K/M/O/S/U/W/Y=1646-1859.\nDR
        \  PDB; 7JZV; EM; 3.90 A; A=2-104.\nDR   PDB; 7LYB; EM; 3.28 A; M=1-100.\nDR
        \  PDB; 8GRQ; EM; 3.87 A; K=6-97.\nDR   PDB; 8RS8; X-ray; 1.31 A; A/B/C/D=1646-1859.\nDR
        \  PDBsum; 1JM7; -.\nDR   PDBsum; 1JNX; -.\nDR   PDBsum; 1N5O; -.\nDR   PDBsum;
        1OQA; -.\nDR   PDBsum; 1T15; -.\nDR   PDBsum; 1T29; -.\nDR   PDBsum; 1T2U;
        -.\nDR   PDBsum; 1T2V; -.\nDR   PDBsum; 1Y98; -.\nDR   PDBsum; 2ING; -.\nDR
        \  PDBsum; 3COJ; -.\nDR   PDBsum; 3K0H; -.\nDR   PDBsum; 3K0K; -.\nDR   PDBsum;
        3K15; -.\nDR   PDBsum; 3K16; -.\nDR   PDBsum; 3PXA; -.\nDR   PDBsum; 3PXB;
        -.\nDR   PDBsum; 3PXC; -.\nDR   PDBsum; 3PXD; -.\nDR   PDBsum; 3PXE; -.\nDR
        \  PDBsum; 4IFI; -.\nDR   PDBsum; 4IGK; -.\nDR   PDBsum; 4JLU; -.\nDR   PDBsum;
        4OFB; -.\nDR   PDBsum; 4U4A; -.\nDR   PDBsum; 4Y18; -.\nDR   PDBsum; 4Y2G;
        -.\nDR   PDBsum; 6G2I; -.\nDR   PDBsum; 7JZV; -.\nDR   PDBsum; 7LYB; -.\nDR
        \  PDBsum; 8GRQ; -.\nDR   PDBsum; 8RS8; -.\nDR   AlphaFoldDB; P38398; -.\nDR
        \  BMRB; P38398; -.\nDR   EMDB; EMD-23591; -.\nDR   EMDB; EMD-34212; -.\nDR
        \  EMDB; EMD-4344; -.\nDR   EMDB; EMD-6340; -.\nDR   EMDB; EMD-6400; -.\nDR
        \  SMR; P38398; -.\nDR   BioGRID; 107140; 1289.\nDR   ComplexPortal; CPX-715;
        BRCA1-BARD1 complex.\nDR   ComplexPortal; CPX-845; BRCA1-PALB2-BRCA2 homologous
        recombination DNA repair complex.\nDR   ComplexPortal; CPX-955; BRCC E3 ubiquitin
        ligase complex.\nDR   CORUM; P38398; -.\nDR   DIP; DIP-5971N; -.\nDR   FunCoup;
        P38398; 1566.\nDR   IntAct; P38398; 265.\nDR   MINT; P38398; -.\nDR   STRING;
        9606.ENSP00000418960; -.\nDR   BindingDB; P38398; -.\nDR   ChEMBL; CHEMBL5990;
        -.\nDR   MoonProt; P38398; -.\nDR   GlyConnect; 2024; 1 N-Linked glycan (1
        site).\nDR   GlyCosmos; P38398; 1 site, 2 glycans.\nDR   GlyGen; P38398; 3
        sites, 3 N-linked glycans (2 sites), 1 O-linked glycan (1 site).\nDR   iPTMnet;
        P38398; -.\nDR   PhosphoSitePlus; P38398; -.\nDR   BioMuta; BRCA1; -.\nDR
        \  DMDM; 728984; -.\nDR   CPTAC; CPTAC-2610; -.\nDR   CPTAC; CPTAC-2611; -.\nDR
        \  CPTAC; CPTAC-3218; -.\nDR   CPTAC; CPTAC-3219; -.\nDR   CPTAC; CPTAC-916;
        -.\nDR   jPOST; P38398; -.\nDR   MassIVE; P38398; -.\nDR   PaxDb; 9606-ENSP00000418960;
        -.\nDR   PeptideAtlas; P38398; -.\nDR   ProteomicsDB; 20208; -.\nDR   ProteomicsDB;
        55287; -. [P38398-1]\nDR   ProteomicsDB; 55288; -. [P38398-2]\nDR   ProteomicsDB;
        55289; -. [P38398-3]\nDR   ProteomicsDB; 55290; -. [P38398-4]\nDR   ProteomicsDB;
        55291; -. [P38398-5]\nDR   ProteomicsDB; 55292; -. [P38398-6]\nDR   Pumba;
        P38398; -.\nDR   Antibodypedia; 4527; 2267 antibodies from 47 providers.\nDR
        \  CPTC; P38398; 4 antibodies.\nDR   DNASU; 672; -.\nDR   Ensembl; ENST00000352993.7;
        ENSP00000312236.5; ENSG00000012048.27. [P38398-5]\nDR   Ensembl; ENST00000357654.9;
        ENSP00000350283.3; ENSG00000012048.27. [P38398-1]\nDR   Ensembl; ENST00000461221.5;
        ENSP00000418548.1; ENSG00000012048.27. [P38398-2]\nDR   Ensembl; ENST00000461798.5;
        ENSP00000417988.1; ENSG00000012048.27. [P38398-2]\nDR   Ensembl; ENST00000468300.5;
        ENSP00000417148.1; ENSG00000012048.27. [P38398-6]\nDR   Ensembl; ENST00000470026.6;
        ENSP00000419274.2; ENSG00000012048.27. [P38398-1]\nDR   Ensembl; ENST00000471181.7;
        ENSP00000418960.2; ENSG00000012048.27. [P38398-7]\nDR   Ensembl; ENST00000491747.6;
        ENSP00000420705.2; ENSG00000012048.27. [P38398-3]\nDR   Ensembl; ENST00000493795.5;
        ENSP00000418775.1; ENSG00000012048.27. [P38398-8]\nDR   Ensembl; ENST00000494123.6;
        ENSP00000419103.2; ENSG00000012048.27. [P38398-1]\nDR   Ensembl; ENST00000618469.2;
        ENSP00000478114.2; ENSG00000012048.27. [P38398-1]\nDR   Ensembl; ENST00000652672.2;
        ENSP00000498906.2; ENSG00000012048.27. [P38398-8]\nDR   Ensembl; ENST00000713676.1;
        ENSP00000518978.1; ENSG00000012048.27. [P38398-1]\nDR   GeneID; 672; -.\nDR
        \  KEGG; hsa:672; -.\nDR   MANE-Select; ENST00000357654.9; ENSP00000350283.3;
        NM_007294.4; NP_009225.1.\nDR   UCSC; uc002icq.4; human. [P38398-1]\nDR   UCSC;
        uc010cyx.4; human.\nDR   AGR; HGNC:1100; -.\nDR   CIViC; 672; 90 evidence
        items across 70 molecular profiles.\nDR   ClinPGx; PA25411; -.\nDR   CTD;
        672; -.\nDR   DisGeNET; 672; -.\nDR   GeneCards; BRCA1; -.\nDR   GeneReviews;
        BRCA1; -.\nDR   HGNC; HGNC:1100; BRCA1.\nDR   HPA; ENSG00000012048; Low tissue
        specificity.\nDR   MalaCards; BRCA1; -.\nDR   MIM; 113705; gene.\nDR   MIM;
        114480; phenotype.\nDR   MIM; 167000; phenotype.\nDR   MIM; 604370; phenotype.\nDR
        \  MIM; 614320; phenotype.\nDR   MIM; 617883; phenotype.\nDR   OpenTargets;
        ENSG00000012048; -.\nDR   Orphanet; 667662; Breast implant-associated anaplastic
        large cell lymphoma.\nDR   Orphanet; 70567; Cholangiocarcinoma.\nDR   Orphanet;
        1333; Familial pancreatic carcinoma.\nDR   Orphanet; 1331; Familial prostate
        cancer.\nDR   Orphanet; 84; Fanconi anemia.\nDR   Orphanet; 145; Hereditary
        breast and/or ovarian cancer syndrome.\nDR   Orphanet; 227535; Hereditary
        breast cancer.\nDR   Orphanet; 694963; Inflammatory breast cancer.\nDR   Orphanet;
        168829; Primary peritoneal carcinoma.\nDR   VEuPathDB; HostDB:ENSG00000012048;
        -.\nDR   eggNOG; KOG4362; Eukaryota.\nDR   GeneTree; ENSGT00440000034289;
        -.\nDR   HOGENOM; CLU_002290_0_0_1; -.\nDR   InParanoid; P38398; -.\nDR   OMA;
        ATCQQSP; -.\nDR   OrthoDB; 6105938at2759; -.\nDR   PAN-GO; P38398; 11 GO annotations
        based on evolutionary models.\nDR   PhylomeDB; P38398; -.\nDR   BRENDA; 2.3.2.27;
        2681.\nDR   PathwayCommons; P38398; -.\nDR   Reactome; R-HSA-1221632; Meiotic
        synapsis.\nDR   Reactome; R-HSA-3108214; SUMOylation of DNA damage response
        and repair proteins.\nDR   Reactome; R-HSA-5685938; HDR through Single Strand
        Annealing (SSA).\nDR   Reactome; R-HSA-5685942; HDR through Homologous Recombination
        (HRR).\nDR   Reactome; R-HSA-5689901; Metalloprotease DUBs.\nDR   Reactome;
        R-HSA-5693554; Resolution of D-loop Structures through Synthesis-Dependent
        Strand Annealing (SDSA).\nDR   Reactome; R-HSA-5693565; Recruitment and ATM-mediated
        phosphorylation of repair and signaling proteins at DNA double strand breaks.\nDR
        \  Reactome; R-HSA-5693568; Resolution of D-loop Structures through Holliday
        Junction Intermediates.\nDR   Reactome; R-HSA-5693571; Nonhomologous End-Joining
        (NHEJ).\nDR   Reactome; R-HSA-5693579; Homologous DNA Pairing and Strand Exchange.\nDR
        \  Reactome; R-HSA-5693607; Processing of DNA double-strand break ends.\nDR
        \  Reactome; R-HSA-5693616; Presynaptic phase of homologous DNA pairing and
        strand exchange.\nDR   Reactome; R-HSA-6796648; TP53 Regulates Transcription
        of DNA Repair Genes.\nDR   Reactome; R-HSA-6804756; Regulation of TP53 Activity
        through Phosphorylation.\nDR   Reactome; R-HSA-69473; G2/M DNA damage checkpoint.\nDR
        \  Reactome; R-HSA-8951664; Neddylation.\nDR   Reactome; R-HSA-8953750; Transcriptional
        Regulation by E2F6.\nDR   Reactome; R-HSA-912446; Meiotic recombination.\nDR
        \  Reactome; R-HSA-9663199; Defective DNA double strand break response due
        to BRCA1 loss of function.\nDR   Reactome; R-HSA-9699150; Defective DNA double
        strand break response due to BARD1 loss of function.\nDR   Reactome; R-HSA-9701192;
        Defective homologous recombination repair (HRR) due to BRCA1 loss of function.\nDR
        \  Reactome; R-HSA-9704331; Defective HDR through Homologous Recombination
        Repair (HRR) due to PALB2 loss of BRCA1 binding function.\nDR   Reactome;
        R-HSA-9704646; Defective HDR through Homologous Recombination Repair (HRR)
        due to PALB2 loss of BRCA2/RAD51/RAD51C binding function.\nDR   Reactome;
        R-HSA-9709570; Impaired BRCA2 binding to RAD51.\nDR   Reactome; R-HSA-9709603;
        Impaired BRCA2 binding to PALB2.\nDR   Reactome; R-HSA-9755511; KEAP1-NFE2L2
        pathway.\nDR   Reactome; R-HSA-9825895; Regulation of MITF-M-dependent genes
        involved in DNA replication, damage repair and senescence.\nDR   SignaLink;
        P38398; -.\nDR   SIGNOR; P38398; -.\nDR   UniPathway; UPA00143; -.\nDR   Agora;
        ENSG00000012048; -.\nDR   BioGRID-ORCS; 672; 412 hits in 1226 CRISPR screens.\nDR
        \  ChiTaRS; BRCA1; human.\nDR   EvolutionaryTrace; P38398; -.\nDR   GeneWiki;
        BRCA1; -.\nDR   GenomeRNAi; 672; -.\nDR   Pharos; P38398; Tchem.\nDR   PRO;
        PR:P38398; -.\nDR   Proteomes; UP000005640; Chromosome 17.\nDR   RNAct; P38398;
        protein.\nDR   Bgee; ENSG00000012048; Expressed in ventricular zone and 135
        other cell types or tissues.\nDR   ExpressionAtlas; P38398; baseline and differential.\nDR
        \  GO; GO:0070531; C:BRCA1-A complex; IDA:UniProtKB.\nDR   GO; GO:0070532;
        C:BRCA1-B complex; IPI:ComplexPortal.\nDR   GO; GO:0031436; C:BRCA1-BARD1
        complex; IDA:UniProtKB.\nDR   GO; GO:0070533; C:BRCA1-C complex; IPI:ComplexPortal.\nDR
        \  GO; GO:0005694; C:chromosome; ISS:UniProtKB.\nDR   GO; GO:0005737; C:cytoplasm;
        IDA:UniProtKB.\nDR   GO; GO:1990391; C:DNA repair complex; IPI:ComplexPortal.\nDR
        \  GO; GO:0000931; C:gamma-tubulin ring complex; NAS:UniProtKB.\nDR   GO;
        GO:0000800; C:lateral element; IDA:MGI.\nDR   GO; GO:0001673; C:male germ
        cell nucleus; IEA:Ensembl.\nDR   GO; GO:0016604; C:nuclear body; IDA:HPA.\nDR
        \  GO; GO:0000152; C:nuclear ubiquitin ligase complex; IDA:ComplexPortal.\nDR
        \  GO; GO:0005654; C:nucleoplasm; IDA:HPA.\nDR   GO; GO:0005634; C:nucleus;
        IDA:UniProtKB.\nDR   GO; GO:0005886; C:plasma membrane; IDA:BHF-UCL.\nDR   GO;
        GO:0032991; C:protein-containing complex; IDA:UniProtKB.\nDR   GO; GO:1990904;
        C:ribonucleoprotein complex; IDA:MGI.\nDR   GO; GO:0000151; C:ubiquitin ligase
        complex; NAS:UniProtKB.\nDR   GO; GO:0001741; C:XY body; IEA:Ensembl.\nDR
        \  GO; GO:0003684; F:damaged DNA binding; IEA:Ensembl.\nDR   GO; GO:0003677;
        F:DNA binding; TAS:ProtInc.\nDR   GO; GO:0019899; F:enzyme binding; IPI:UniProtKB.\nDR
        \  GO; GO:0140863; F:histone H2AK127 ubiquitin ligase activity; TAS:ARUK-UCL.\nDR
        \  GO; GO:0140864; F:histone H2AK129 ubiquitin ligase activity; TAS:ARUK-UCL.\nDR
        \  GO; GO:0042802; F:identical protein binding; IPI:IntAct.\nDR   GO; GO:0002039;
        F:p53 binding; IDA:DisProt.\nDR   GO; GO:0003723; F:RNA binding; IDA:MGI.\nDR
        \  GO; GO:0070063; F:RNA polymerase binding; IDA:UniProtKB.\nDR   GO; GO:0000976;
        F:transcription cis-regulatory region binding; IDA:BHF-UCL.\nDR   GO; GO:0003713;
        F:transcription coactivator activity; IDA:BHF-UCL.\nDR   GO; GO:0015631; F:tubulin
        binding; NAS:UniProtKB.\nDR   GO; GO:0031625; F:ubiquitin protein ligase binding;
        IPI:UniProtKB.\nDR   GO; GO:0061649; F:ubiquitin-modified histone reader activity;
        TAS:ARUK-UCL.\nDR   GO; GO:0004842; F:ubiquitin-protein transferase activity;
        IDA:UniProtKB.\nDR   GO; GO:0008270; F:zinc ion binding; TAS:ProtInc.\nDR
        \  GO; GO:0071681; P:cellular response to indole-3-methanol; IDA:UniProtKB.\nDR
        \  GO; GO:0071479; P:cellular response to ionizing radiation; IMP:ComplexPortal.\nDR
        \  GO; GO:0071356; P:cellular response to tumor necrosis factor; IMP:BHF-UCL.\nDR
        \  GO; GO:0007098; P:centrosome cycle; IEA:Ensembl.\nDR   GO; GO:0043009;
        P:chordate embryonic development; IBA:GO_Central.\nDR   GO; GO:0006338; P:chromatin
        remodeling; TAS:ARUK-UCL.\nDR   GO; GO:0007059; P:chromosome segregation;
        IMP:UniProtKB.\nDR   GO; GO:0006974; P:DNA damage response; TAS:UniProt.\nDR
        \  GO; GO:0006301; P:DNA damage tolerance; IDA:HGNC-UCL.\nDR   GO; GO:0006281;
        P:DNA repair; NAS:ComplexPortal.\nDR   GO; GO:0110025; P:DNA strand resection
        involved in replication fork processing; NAS:ComplexPortal.\nDR   GO; GO:0006302;
        P:double-strand break repair; IDA:CACAO.\nDR   GO; GO:0000724; P:double-strand
        break repair via homologous recombination; IDA:HGNC-UCL.\nDR   GO; GO:0006633;
        P:fatty acid biosynthetic process; IEA:UniProtKB-KW.\nDR   GO; GO:0035825;
        P:homologous recombination; NAS:ComplexPortal.\nDR   GO; GO:0008630; P:intrinsic
        apoptotic signaling pathway in response to DNA damage; IDA:MGI.\nDR   GO;
        GO:0007095; P:mitotic G2 DNA damage checkpoint signaling; IMP:UniProtKB.\nDR
        \  GO; GO:0044818; P:mitotic G2/M transition checkpoint; NAS:ComplexPortal.\nDR
        \  GO; GO:0045786; P:negative regulation of cell cycle; NAS:ComplexPortal.\nDR
        \  GO; GO:0030308; P:negative regulation of cell growth; IMP:DisProt.\nDR
        \  GO; GO:0046600; P:negative regulation of centriole replication; NAS:UniProtKB.\nDR
        \  GO; GO:0045892; P:negative regulation of DNA-templated transcription; IDA:UniProtKB.\nDR
        \  GO; GO:1902042; P:negative regulation of extrinsic apoptotic signaling
        pathway via death domain receptors; IMP:BHF-UCL.\nDR   GO; GO:0045717; P:negative
        regulation of fatty acid biosynthetic process; IMP:UniProtKB.\nDR   GO; GO:0044027;
        P:negative regulation of gene expression via chromosomal CpG island methylation;
        IMP:BHF-UCL.\nDR   GO; GO:0033147; P:negative regulation of intracellular
        estrogen receptor signaling pathway; IMP:CACAO.\nDR   GO; GO:2000378; P:negative
        regulation of reactive oxygen species metabolic process; IMP:BHF-UCL.\nDR
        \  GO; GO:0045766; P:positive regulation of angiogenesis; IMP:BHF-UCL.\nDR
        \  GO; GO:0045739; P:positive regulation of DNA repair; IMP:UniProtKB.\nDR
        \  GO; GO:0045893; P:positive regulation of DNA-templated transcription; IDA:UniProtKB.\nDR
        \  GO; GO:0010628; P:positive regulation of gene expression; IMP:BHF-UCL.\nDR
        \  GO; GO:0045944; P:positive regulation of transcription by RNA polymerase
        II; IDA:UniProtKB.\nDR   GO; GO:0010575; P:positive regulation of vascular
        endothelial growth factor production; IMP:BHF-UCL.\nDR   GO; GO:0051865; P:protein
        autoubiquitination; IDA:UniProtKB.\nDR   GO; GO:0085020; P:protein K6-linked
        ubiquitination; IDA:UniProtKB.\nDR   GO; GO:0016567; P:protein ubiquitination;
        IDA:HGNC-UCL.\nDR   GO; GO:0060816; P:random inactivation of X chromosome;
        IEA:Ensembl.\nDR   GO; GO:0051726; P:regulation of cell cycle; IDA:BHF-UCL.\nDR
        \  GO; GO:2000001; P:regulation of DNA damage checkpoint; NAS:ComplexPortal.\nDR
        \  GO; GO:0006282; P:regulation of DNA repair; NAS:ComplexPortal.\nDR   GO;
        GO:0006357; P:regulation of transcription by RNA polymerase II; IMP:UniProtKB.\nDR
        \  GO; GO:0010212; P:response to ionizing radiation; IMP:UniProtKB.\nDR   CDD;
        cd17735; BRCT_BRCA1_rpt1; 1.\nDR   CDD; cd17721; BRCT_BRCA1_rpt2; 1.\nDR   CDD;
        cd16498; RING-HC_BRCA1; 1.\nDR   DisProt; DP00238; -.\nDR   FunFam; 3.30.40.10:FF:000213;
        Breast cancer type 1 susceptibility protein homolog; 1.\nDR   FunFam; 3.40.50.10190:FF:000006;
        Breast cancer type 1 susceptibility protein homolog; 1.\nDR   FunFam; 3.40.50.10190:FF:000025;
        Breast cancer type 1 susceptibility protein homolog; 1.\nDR   Gene3D; 3.40.50.10190;
        BRCT domain; 2.\nDR   Gene3D; 3.30.40.10; Zinc/RING finger domain, C3HC4 (zinc
        finger); 1.\nDR   IDEAL; IID00042; -.\nDR   InterPro; IPR011364; BRCA1.\nDR
        \  InterPro; IPR031099; BRCA1-associated.\nDR   InterPro; IPR025994; BRCA1_serine_dom.\nDR
        \  InterPro; IPR001357; BRCT_dom.\nDR   InterPro; IPR036420; BRCT_dom_sf.\nDR
        \  InterPro; IPR018957; Znf_C3HC4_RING-type.\nDR   InterPro; IPR001841; Znf_RING.\nDR
        \  InterPro; IPR013083; Znf_RING/FYVE/PHD.\nDR   InterPro; IPR017907; Znf_RING_CS.\nDR
        \  PANTHER; PTHR13763:SF0; BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN; 1.\nDR
        \  PANTHER; PTHR13763; BREAST CANCER TYPE 1 SUSCEPTIBILITY PROTEIN BRCA1;
        1.\nDR   Pfam; PF00533; BRCT; 2.\nDR   Pfam; PF12820; BRCT_assoc; 1.\nDR   Pfam;
        PF00097; zf-C3HC4; 1.\nDR   PIRSF; PIRSF001734; BRCA1; 1.\nDR   PRINTS; PR00493;
        BRSTCANCERI.\nDR   SMART; SM00292; BRCT; 2.\nDR   SMART; SM00184; RING; 1.\nDR
        \  SUPFAM; SSF52113; BRCT domain; 2.\nDR   SUPFAM; SSF57850; RING/U-box; 1.\nDR
        \  PROSITE; PS50172; BRCT; 2.\nDR   PROSITE; PS00518; ZF_RING_1; 1.\nDR   PROSITE;
        PS50089; ZF_RING_2; 1.\nPE   1: Evidence at protein level;\nKW   3D-structure;
        Acetylation; Activator; Alternative initiation;\nKW   Alternative splicing;
        Cell cycle; Chromosome; Cytoplasm;\nKW   Direct protein sequencing; Disease
        variant; DNA damage; DNA recombination;\nKW   DNA repair; DNA-binding; Fanconi
        anemia; Fatty acid biosynthesis;\nKW   Fatty acid metabolism; Isopeptide bond;
        Lipid biosynthesis;\nKW   Lipid metabolism; Metal-binding; Nucleus; Phosphoprotein;\nKW
        \  Proteomics identification; Reference proteome; Repeat; Transcription;\nKW
        \  Transcription regulation; Transferase; Tumor suppressor; Ubl conjugation;\nKW
        \  Ubl conjugation pathway; Zinc; Zinc-finger.\nFT   CHAIN           1..1863\nFT
        \                  /note=\"Breast cancer type 1 susceptibility protein\"\nFT
        \                  /id=\"PRO_0000055830\"\nFT   DOMAIN          1642..1736\nFT
        \                  /note=\"BRCT 1\"\nFT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00033\"\nFT
        \  DOMAIN          1756..1855\nFT                   /note=\"BRCT 2\"\nFT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00033\"\nFT
        \  ZN_FING         24..65\nFT                   /note=\"RING-type\"\nFT                   /evidence=\"ECO:0000255|PROSITE-ProRule:PRU00175\"\nFT
        \  REGION          230..270\nFT                   /note=\"Disordered\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   REGION
        \         306..338\nFT                   /note=\"Disordered\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  REGION          534..570\nFT                   /note=\"Disordered\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   REGION
        \         654..709\nFT                   /note=\"Disordered\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  REGION          1181..1216\nFT                   /note=\"Disordered\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   REGION
        \         1322..1387\nFT                   /note=\"Disordered\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  REGION          1397..1424\nFT                   /note=\"Interaction with
        PALB2\"\nFT                   /evidence=\"ECO:0000269|PubMed:19369211\"\nFT
        \  REGION          1440..1505\nFT                   /note=\"Disordered\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   REGION
        \         1565..1596\nFT                   /note=\"Disordered\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  COMPBIAS        248..260\nFT                   /note=\"Basic and acidic
        residues\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  COMPBIAS        327..338\nFT                   /note=\"Basic and acidic
        residues\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  COMPBIAS        534..544\nFT                   /note=\"Low complexity\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   COMPBIAS
        \       1373..1387\nFT                   /note=\"Polar residues\"\nFT                   /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT
        \  COMPBIAS        1445..1470\nFT                   /note=\"Polar residues\"\nFT
        \                  /evidence=\"ECO:0000256|SAM:MobiDB-lite\"\nFT   MOD_RES
        \        1\nFT                   /note=\"N-acetylmethionine\"\nFT                   /evidence=\"ECO:0007744|PubMed:22814378\"\nFT
        \  MOD_RES         114\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:20068231,\nFT
        \                  ECO:0007744|PubMed:21406692, ECO:0007744|PubMed:23186163\"\nFT
        \  MOD_RES         395\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:18669648,\nFT
        \                  ECO:0007744|PubMed:19690332\"\nFT   MOD_RES         398\nFT
        \                  /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:18669648,\nFT
        \                  ECO:0007744|PubMed:19690332\"\nFT   MOD_RES         423\nFT
        \                  /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:20068231\"\nFT
        \  MOD_RES         434\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:23186163\"\nFT
        \  MOD_RES         551\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:23186163\"\nFT
        \  MOD_RES         694\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:20068231,\nFT
        \                  ECO:0007744|PubMed:23186163\"\nFT   MOD_RES         708\nFT
        \                  /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:23186163\"\nFT
        \  MOD_RES         725\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0000250|UniProtKB:P48754\"\nFT
        \  MOD_RES         753\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:18669648\"\nFT
        \  MOD_RES         840\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0000250|UniProtKB:P48754\"\nFT
        \  MOD_RES         988\nFT                   /note=\"Phosphoserine; by CHEK2\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10724175,\nFT                   ECO:0000269|PubMed:20364141\"\nFT
        \  MOD_RES         1009\nFT                   /note=\"Phosphoserine\"\nFT
        \                  /evidence=\"ECO:0007744|PubMed:23186163\"\nFT   MOD_RES
        \        1143\nFT                   /note=\"Phosphoserine; by ATR; in vitro\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:11114888\"\nFT   MOD_RES
        \        1189\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:23186163\"\nFT
        \  MOD_RES         1191\nFT                   /note=\"Phosphoserine\"\nFT
        \                  /evidence=\"ECO:0007744|PubMed:23186163\"\nFT   MOD_RES
        \        1211\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:18669648\"\nFT
        \  MOD_RES         1217\nFT                   /note=\"Phosphoserine\"\nFT
        \                  /evidence=\"ECO:0007744|PubMed:18669648\"\nFT   MOD_RES
        \        1218\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:18669648,\nFT
        \                  ECO:0007744|PubMed:21406692\"\nFT   MOD_RES         1280\nFT
        \                  /note=\"Phosphoserine; by ATR; in vitro\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MOD_RES         1328\nFT                   /note=\"Phosphoserine\"\nFT
        \                  /evidence=\"ECO:0007744|PubMed:20068231\"\nFT   MOD_RES
        \        1336\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:17081983,\nFT
        \                  ECO:0007744|PubMed:20068231, ECO:0007744|PubMed:21406692\"\nFT
        \  MOD_RES         1342\nFT                   /note=\"Phosphoserine\"\nFT
        \                  /evidence=\"ECO:0007744|PubMed:20068231,\nFT                   ECO:0007744|PubMed:21406692\"\nFT
        \  MOD_RES         1387\nFT                   /note=\"Phosphoserine; by ATM
        and ATR\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MOD_RES         1394\nFT                   /note=\"Phosphothreonine; by
        ATR; in vitro\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MOD_RES         1423\nFT                   /note=\"Phosphoserine; by ATM
        and ATR\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MOD_RES         1457\nFT                   /note=\"Phosphoserine; by ATR;
        in vitro\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MOD_RES         1524\nFT                   /note=\"Phosphoserine; by ATM\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:21144835\"\nFT   MOD_RES
        \        1542\nFT                   /note=\"Phosphoserine\"\nFT                   /evidence=\"ECO:0007744|PubMed:23186163\"\nFT
        \  CROSSLNK        109\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        301\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        339\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447,\nFT
        \                  ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        443\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25755297,\nFT
        \                  ECO:0007744|PubMed:28112733\"\nFT   CROSSLNK        459\nFT
        \                  /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain
        with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447,\nFT
        \                  ECO:0007744|PubMed:28112733\"\nFT   CROSSLNK        519\nFT
        \                  /note=\"Glycyl lysine isopeptide (Lys-Gly) (interchain
        with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        583\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447,\nFT
        \                  ECO:0007744|PubMed:25755297, ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        654\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447\"\nFT
        \  CROSSLNK        734\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447\"\nFT
        \  CROSSLNK        739\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:25218447\"\nFT
        \  CROSSLNK        918\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        987\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  CROSSLNK        1079\nFT                   /note=\"Glycyl lysine isopeptide
        (Lys-Gly) (interchain with\nFT                   G-Cter in SUMO2)\"\nFT                   /evidence=\"ECO:0007744|PubMed:28112733\"\nFT
        \  VAR_SEQ         1..47\nFT                   /note=\"Missing (in isoform
        8)\"\nFT                   /id=\"VSP_057569\"\nFT   VAR_SEQ         1..17\nFT
        \                  /note=\"Missing (in isoform 4)\"\nFT                   /evidence=\"ECO:0000305\"\nFT
        \                  /id=\"VSP_035396\"\nFT   VAR_SEQ         64..1863\nFT                   /note=\"Missing
        (in isoform 2)\"\nFT                   /evidence=\"ECO:0000303|Ref.4\"\nFT
        \                  /id=\"VSP_047891\"\nFT   VAR_SEQ         224..1365\nFT
        \                  /note=\"Missing (in isoform 5)\"\nFT                   /evidence=\"ECO:0000305\"\nFT
        \                  /id=\"VSP_035398\"\nFT   VAR_SEQ         264..1366\nFT
        \                  /note=\"Missing (in isoform 3 and isoform 6)\"\nFT                   /evidence=\"ECO:0000303|PubMed:15489334,\nFT
        \                  ECO:0000303|PubMed:9010228\"\nFT                   /id=\"VSP_035399\"\nFT
        \  VAR_SEQ         1453\nFT                   /note=\"Missing (in isoform
        3 and isoform 6)\"\nFT                   /evidence=\"ECO:0000303|PubMed:15489334,\nFT
        \                  ECO:0000303|PubMed:9010228\"\nFT                   /id=\"VSP_043797\"\nFT
        \  VAR_SEQ         1453\nFT                   /note=\"A -> DSHIHGQRNNSMFSKRPREHIS
        (in isoform 7)\"\nFT                   /evidence=\"ECO:0000303|PubMed:15489334\"\nFT
        \                  /id=\"VSP_055404\"\nFT   VAR_SEQ         1778..1863\nFT
        \                  /note=\"DQLEWMVQLCGASVVKELSSFTLGTGVHPIVVVQPDAWTEDNGFHAIGQMCE\nFT
        \                  APVVTREWVLDSVALYQCQELDTYLIPQIPHSHY -> GCPPNCGCAARCLDRGQWLPC\nFT
        \                  NWADV (in isoform 6)\"\nFT                   /evidence=\"ECO:0000303|PubMed:15489334\"\nFT
        \                  /id=\"VSP_043798\"\nFT   VARIANT         4\nFT                   /note=\"S
        -> F (in BC; uncertain significance;\nFT                   dbSNP:rs786203152)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070458\"\nFT
        \  VARIANT         10\nFT                   /note=\"E -> K (in BC and BROVCA1)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:14722926\"\nFT                   /id=\"VAR_020679\"\nFT
        \  VARIANT         11\nFT                   /note=\"V -> A (found in breast-ovarian
        cancer patients;\nFT                   uncertain significance; dbSNP:rs80357017)\"\nFT
        \                  /id=\"VAR_007754\"\nFT   VARIANT         18\nFT                   /note=\"M
        -> T (in BC; pathogenic; dbSNP:rs80356929)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_063899\"\nFT
        \  VARIANT         21\nFT                   /note=\"I -> V (found in breast-ovarian
        cancer patients;\nFT                   uncertain significance; dbSNP:rs80357406)\"\nFT
        \                  /id=\"VAR_007755\"\nFT   VARIANT         22\nFT                   /note=\"L
        -> S (in BC; dbSNP:rs80357438)\"\nFT                   /evidence=\"ECO:0000269|PubMed:9609997\"\nFT
        \                  /id=\"VAR_007756\"\nFT   VARIANT         23\nFT                   /note=\"E
        -> K (in BC and BROVCA1)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020680\"\nFT   VARIANT         30\nFT                   /note=\"L
        -> F (in a breast cancer sample; somatic\nFT                   mutation)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:16959974\"\nFT                   /id=\"VAR_035947\"\nFT
        \  VARIANT         45\nFT                   /note=\"K -> Q (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs769650474)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070459\"\nFT
        \  VARIANT         61\nFT                   /note=\"C -> G (in BC and OC;
        pathogenic; no interaction\nFT                   with BAP1; dbSNP:rs28897672)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12938098,\nFT                   ECO:0000269|PubMed:14746861,
        ECO:0000269|PubMed:23867111,\nFT                   ECO:0000269|PubMed:7894493,
        ECO:0000269|PubMed:8554067,\nFT                   ECO:0000269|PubMed:9528852,
        ECO:0000269|PubMed:9760198\"\nFT                   /id=\"VAR_007757\"\nFT
        \  VARIANT         64\nFT                   /note=\"C -> G (in BC; no interaction
        with BAP1;\nFT                   dbSNP:rs80357064)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111,\nFT
        \                  ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:9482581,\nFT
        \                  ECO:0000269|PubMed:9528852\"\nFT                   /id=\"VAR_007758\"\nFT
        \  VARIANT         64\nFT                   /note=\"C -> Y (in BC; pathogenic;
        dbSNP:rs55851803)\"\nFT                   /id=\"VAR_007759\"\nFT   VARIANT
        \        67\nFT                   /note=\"D -> Y (in BC; benign; functionally
        neutral in\nFT                   vitro; dbSNP:rs80357102)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070460\"\nFT   VARIANT         71\nFT                   /note=\"R
        -> K (in BC; uncertain significance;\nFT                   dbSNP:rs80356913)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12938098\"\nFT                   /id=\"VAR_020681\"\nFT
        \  VARIANT         105\nFT                   /note=\"Y -> C (in dbSNP:rs28897673)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070461\"\nFT
        \  VARIANT         132\nFT                   /note=\"N -> K (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs80357413)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070462\"\nFT
        \  VARIANT         142\nFT                   /note=\"P -> H (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs55971303)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070463\"\nFT
        \  VARIANT         147\nFT                   /note=\"L -> F (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs748876625)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070464\"\nFT
        \  VARIANT         153\nFT                   /note=\"S -> R (in dbSNP:rs28897674)\"\nFT
        \                  /id=\"VAR_052077\"\nFT   VARIANT         165\nFT                   /note=\"L
        -> P (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070465\"\nFT   VARIANT         170\nFT                   /note=\"R
        -> W (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs80357325)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070466\"\nFT   VARIANT         186\nFT                   /note=\"S
        -> Y (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs55688530)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070467\"\nFT   VARIANT         191\nFT                   /note=\"V
        -> I (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs80357090)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070468\"\nFT   VARIANT         227\nFT                   /note=\"E
        -> K (in ovarian cancer; uncertain significance)\"\nFT                   /evidence=\"ECO:0000269|PubMed:10196379\"\nFT
        \                  /id=\"VAR_008759\"\nFT   VARIANT         231\nFT                   /note=\"T
        -> M (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs80357001)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070469\"\nFT   VARIANT         239\nFT                   /note=\"H
        -> R (in dbSNP:rs80357396)\"\nFT                   /evidence=\"ECO:0000269|PubMed:9010228,\nFT
        \                  ECO:0000269|PubMed:9760198\"\nFT                   /id=\"VAR_007760\"\nFT
        \  VARIANT         245\nFT                   /note=\"D -> V (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs80356865)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070470\"\nFT
        \  VARIANT         246\nFT                   /note=\"L -> V (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs28897675)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070471\"\nFT
        \  VARIANT         271\nFT                   /note=\"V -> L (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs80357244)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070472\"\nFT
        \  VARIANT         271\nFT                   /note=\"V -> M (in BC; dbSNP:rs80357244)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:8723683\"\nFT                   /id=\"VAR_007761\"\nFT
        \  VARIANT         275\nFT                   /note=\"G -> S (in dbSNP:rs8176153)\"\nFT
        \                  /evidence=\"ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_019944\"\nFT
        \  VARIANT         346\nFT                   /note=\"P -> S (in BC; benign;
        dbSNP:rs80357015)\"\nFT                   /evidence=\"ECO:0000269|PubMed:10323242\"\nFT
        \                  /id=\"VAR_008760\"\nFT   VARIANT         356\nFT                   /note=\"Q
        -> R (in dbSNP:rs1799950)\"\nFT                   /evidence=\"ECO:0000269|PubMed:7894493,
        ECO:0000269|Ref.5,\nFT                   ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007762\"\nFT
        \  VARIANT         369\nFT                   /note=\"Missing (in BC; dbSNP:rs80358325)\"\nFT
        \                  /id=\"VAR_007763\"\nFT   VARIANT         379\nFT                   /note=\"I
        -> M (in dbSNP:rs56128296)\"\nFT                   /id=\"VAR_007764\"\nFT
        \  VARIANT         461\nFT                   /note=\"F -> L (in BC; benign;
        dbSNP:rs56046357)\"\nFT                   /evidence=\"ECO:0000269|PubMed:9609997\"\nFT
        \                  /id=\"VAR_007765\"\nFT   VARIANT         465\nFT                   /note=\"Y
        -> D (in BC; dbSNP:rs397508869)\"\nFT                   /evidence=\"ECO:0000269|PubMed:9609997\"\nFT
        \                  /id=\"VAR_007766\"\nFT   VARIANT         507\nFT                   /note=\"R
        -> I (found in breast-ovarian cancer patients;\nFT                   uncertain
        significance; dbSNP:rs80357224)\"\nFT                   /id=\"VAR_007767\"\nFT
        \  VARIANT         552\nFT                   /note=\"G -> V (in BC; dbSNP:rs397508893)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9609997\"\nFT                   /id=\"VAR_007768\"\nFT
        \  VARIANT         656\nFT                   /note=\"N -> I\"\nFT                   /evidence=\"ECO:0000269|PubMed:12442274\"\nFT
        \                  /id=\"VAR_020682\"\nFT   VARIANT         668\nFT                   /note=\"L
        -> F (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs80357250)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070473\"\nFT   VARIANT         693\nFT                   /note=\"D
        -> N (in dbSNP:rs4986850)\"\nFT                   /evidence=\"ECO:0000269|PubMed:15026808,
        ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007769\"\nFT   VARIANT
        \        695\nFT                   /note=\"D -> N (in BC; uncertain significance;
        functionally\nFT                   neutral in vitro; dbSNP:rs28897681)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070474\"\nFT
        \  VARIANT         723\nFT                   /note=\"N -> D (in dbSNP:rs4986845)\"\nFT
        \                  /id=\"VAR_020110\"\nFT   VARIANT         749\nFT                   /note=\"D
        -> Y (in BC; dbSNP:rs80357114)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12442275\"\nFT
        \                  /id=\"VAR_020683\"\nFT   VARIANT         758\nFT                   /note=\"L
        -> F (in a breast cancer sample; somatic\nFT                   mutation)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:16959974\"\nFT                   /id=\"VAR_035948\"\nFT
        \  VARIANT         772\nFT                   /note=\"V -> A (in dbSNP:rs80357467)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:7894491,\nFT                   ECO:0000269|PubMed:9482581\"\nFT
        \                  /id=\"VAR_007770\"\nFT   VARIANT         778\nFT                   /note=\"G
        -> C (in a breast cancer sample; somatic\nFT                   mutation)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:16959974\"\nFT                   /id=\"VAR_035949\"\nFT
        \  VARIANT         798\nFT                   /note=\"P -> L (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs876660005)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070475\"\nFT
        \  VARIANT         810\nFT                   /note=\"N -> Y (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs28897682)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070476\"\nFT
        \  VARIANT         820\nFT                   /note=\"K -> E (in dbSNP:rs56082113)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9482581\"\nFT                   /id=\"VAR_007771\"\nFT
        \  VARIANT         826\nFT                   /note=\"T -> K (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs28897683)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_007772\"\nFT
        \  VARIANT         835\nFT                   /note=\"H -> Y (in BROVCA1; uncertain
        significance;\nFT                   dbSNP:rs751656678)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12938098\"\nFT
        \                  /id=\"VAR_020684\"\nFT   VARIANT         841\nFT                   /note=\"R
        -> Q (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs80357337)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070477\"\nFT   VARIANT         841\nFT                   /note=\"R
        -> W (in BROVCA1; benign; dbSNP:rs1800709)\"\nFT                   /evidence=\"ECO:0000269|PubMed:8968716,\nFT
        \                  ECO:0000269|PubMed:9760198\"\nFT                   /id=\"VAR_007773\"\nFT
        \  VARIANT         856\nFT                   /note=\"Y -> H (in BC; benign;
        dbSNP:rs80356892)\"\nFT                   /evidence=\"ECO:0000269|PubMed:15365993,\nFT
        \                  ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_020685\"\nFT
        \  VARIANT         866\nFT                   /note=\"R -> C (in dbSNP:rs41286300)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070478\"\nFT
        \  VARIANT         866\nFT                   /note=\"R -> Q (in BC; uncertain
        significance)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12938098\"\nFT
        \                  /id=\"VAR_020686\"\nFT   VARIANT         871\nFT                   /note=\"P
        -> L (in dbSNP:rs799917)\"\nFT                   /evidence=\"ECO:0000269|PubMed:10323242,\nFT
        \                  ECO:0000269|PubMed:12442274, ECO:0000269|PubMed:15365993,\nFT
        \                  ECO:0000269|PubMed:15489334, ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007774\"\nFT
        \  VARIANT         888\nFT                   /note=\"H -> Y (in BC; uncertain
        significance;\nFT                   dbSNP:rs80357480)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12938098\"\nFT
        \                  /id=\"VAR_020687\"\nFT   VARIANT         892\nFT                   /note=\"L
        -> S (in BC; dbSNP:rs397508994)\"\nFT                   /evidence=\"ECO:0000269|PubMed:9609997\"\nFT
        \                  /id=\"VAR_007775\"\nFT   VARIANT         903..1863\nFT
        \                  /note=\"Missing (in FANCS)\"\nFT                   /evidence=\"ECO:0000269|PubMed:29133208\"\nFT
        \                  /id=\"VAR_080693\"\nFT   VARIANT         925\nFT                   /note=\"I
        -> L (in dbSNP:rs4986847)\"\nFT                   /id=\"VAR_021913\"\nFT   VARIANT
        \        960\nFT                   /note=\"G -> D (in BC; dbSNP:rs397509022)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9609997\"\nFT                   /id=\"VAR_007776\"\nFT
        \  VARIANT         989\nFT                   /note=\"F -> S (in dbSNP:rs4986848)\"\nFT
        \                  /id=\"VAR_020111\"\nFT   VARIANT         1008\nFT                   /note=\"M
        -> I (in dbSNP:rs1800704)\"\nFT                   /id=\"VAR_007777\"\nFT   VARIANT
        \        1025\nFT                   /note=\"T -> I (in BC; dbSNP:rs397509034)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9609997\"\nFT                   /id=\"VAR_007778\"\nFT
        \  VARIANT         1038\nFT                   /note=\"E -> G (in dbSNP:rs16941)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10323242,\nFT                   ECO:0000269|PubMed:15365993,
        ECO:0000269|PubMed:15489334,\nFT                   ECO:0000269|PubMed:7894493,
        ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007779\"\nFT   VARIANT
        \        1040\nFT                   /note=\"S -> N (in dbSNP:rs4986852)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:15026808,\nFT                   ECO:0000269|PubMed:7894491,
        ECO:0000269|PubMed:7894493,\nFT                   ECO:0000269|PubMed:9482581,
        ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007780\"\nFT   VARIANT
        \        1047\nFT                   /note=\"V -> A (in BC; dbSNP:rs397509037)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9609997\"\nFT                   /id=\"VAR_007781\"\nFT
        \  VARIANT         1060\nFT                   /note=\"E -> A (in dbSNP:rs80357184)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:15026808,\nFT                   ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_020688\"\nFT   VARIANT         1101\nFT                   /note=\"S
        -> N (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs41293447)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070479\"\nFT   VARIANT         1139\nFT                   /note=\"S
        -> I (in BC; benign; dbSNP:rs80357228)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12938098\"\nFT
        \                  /id=\"VAR_020689\"\nFT   VARIANT         1140\nFT                   /note=\"S
        -> G (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs2227945)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111,
        ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_019945\"\nFT   VARIANT
        \        1140\nFT                   /note=\"S -> N (in BC; uncertain significance;
        functionally\nFT                   neutral in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070480\"\nFT   VARIANT         1150\nFT                   /note=\"P
        -> S (in BC; benign; dbSNP:rs80357272)\"\nFT                   /evidence=\"ECO:0000269|PubMed:8723683\"\nFT
        \                  /id=\"VAR_007782\"\nFT   VARIANT         1183\nFT                   /note=\"K
        -> R (in dbSNP:rs16942)\"\nFT                   /evidence=\"ECO:0000269|PubMed:10323242,\nFT
        \                  ECO:0000269|PubMed:14722926, ECO:0000269|PubMed:15365993,\nFT
        \                  ECO:0000269|PubMed:15489334, ECO:0000269|PubMed:7894493,\nFT
        \                  ECO:0000269|Ref.6\"\nFT                   /id=\"VAR_007783\"\nFT
        \  VARIANT         1187\nFT                   /note=\"S -> I (in BC and BROVCA1)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:14722926\"\nFT                   /id=\"VAR_020690\"\nFT
        \  VARIANT         1200\nFT                   /note=\"Q -> H (in BC and BROVCA1;
        benign;\nFT                   dbSNP:rs56214134)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020691\"\nFT   VARIANT         1204\nFT                   /note=\"R
        -> I (in BC)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020692\"\nFT   VARIANT         1207\nFT                   /note=\"K
        -> N (in BC)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020693\"\nFT   VARIANT         1210\nFT                   /note=\"E
        -> G (in BC; uncertain significance;\nFT                   dbSNP:rs1060502347)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12938098\"\nFT                   /id=\"VAR_020694\"\nFT
        \  VARIANT         1214\nFT                   /note=\"E -> K (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs80356923)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070481\"\nFT
        \  VARIANT         1217\nFT                   /note=\"S -> Y (in BC and BROVCA1)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:14722926\"\nFT                   /id=\"VAR_020695\"\nFT
        \  VARIANT         1219\nFT                   /note=\"E -> D (in dbSNP:rs80356876)\"\nFT
        \                  /id=\"VAR_007784\"\nFT   VARIANT         1226\nFT                   /note=\"F
        -> L (in BROVCA1)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020696\"\nFT   VARIANT         1236\nFT                   /note=\"N
        -> K (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs28897687)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_052078\"\nFT   VARIANT         1243\nFT                   /note=\"R
        -> G (in BROVCA1)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14722926\"\nFT
        \                  /id=\"VAR_020697\"\nFT   VARIANT         1250\nFT                   /note=\"E
        -> K (in dbSNP:rs28897686)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_052079\"\nFT   VARIANT         1267\nFT                   /note=\"L
        -> S (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs587782190)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070482\"\nFT   VARIANT         1282\nFT                   /note=\"E
        -> V (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs80357217)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070483\"\nFT   VARIANT         1297\nFT                   /note=\"S
        -> P (in BC; uncertain significance;\nFT                   dbSNP:rs1450793674)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12938098\"\nFT                   /id=\"VAR_020698\"\nFT
        \  VARIANT         1297\nFT                   /note=\"Missing (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070484\"\nFT   VARIANT         1301\nFT                   /note=\"S
        -> R (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs273900719)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070485\"\nFT   VARIANT         1346\nFT                   /note=\"E
        -> K (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs80357407)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070486\"\nFT   VARIANT         1347\nFT                   /note=\"R
        -> G (in dbSNP:rs28897689)\"\nFT                   /evidence=\"ECO:0000269|PubMed:12215251\"\nFT
        \                  /id=\"VAR_007785\"\nFT   VARIANT         1378\nFT                   /note=\"V
        -> I (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs28897690)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070487\"\nFT   VARIANT         1400\nFT                   /note=\"M
        -> V (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs80357306)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070488\"\nFT   VARIANT         1406\nFT                   /note=\"K
        -> N (in dbSNP:rs1800707)\"\nFT                   /id=\"VAR_008761\"\nFT   VARIANT
        \        1407\nFT                   /note=\"L -> P (in BC; uncertain significance;
        functionally\nFT                   neutral in vitro; dbSNP:rs80357492)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070489\"\nFT
        \  VARIANT         1411\nFT                   /note=\"M -> T (in BC and OC;
        uncertain significance;\nFT                   decreased interaction with PALB2;
        dbSNP:rs273900729)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14746861,\nFT
        \                  ECO:0000269|PubMed:19369211, ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_020699\"\nFT   VARIANT         1431\nFT                   /note=\"S
        -> P\"\nFT                   /id=\"VAR_007786\"\nFT   VARIANT         1443\nFT
        \                  /note=\"R -> G (in BC; benign; functionally neutral in\nFT
        \                  vitro; dbSNP:rs41293455)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111,\nFT
        \                  ECO:0000269|PubMed:7894491, ECO:0000269|PubMed:9482581\"\nFT
        \                  /id=\"VAR_007787\"\nFT   VARIANT         1443\nFT                   /note=\"R
        -> Q (in dbSNP:rs4986849)\"\nFT                   /id=\"VAR_020112\"\nFT   VARIANT
        \        1448\nFT                   /note=\"S -> G (in BC; uncertain significance;
        functionally\nFT                   neutral in vitro; dbSNP:rs80357486)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070490\"\nFT
        \  VARIANT         1486\nFT                   /note=\"S -> C (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs397507232)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070491\"\nFT
        \  VARIANT         1495\nFT                   /note=\"R -> M (in BC; dbSNP:rs80357389)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:17924331\"\nFT                   /id=\"VAR_063900\"\nFT
        \  VARIANT         1512\nFT                   /note=\"S -> I (in dbSNP:rs1800744)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12215251,\nFT                   ECO:0000269|PubMed:9482581,
        ECO:0000269|PubMed:9760198\"\nFT                   /id=\"VAR_007788\"\nFT
        \  VARIANT         1534\nFT                   /note=\"V -> M (in BC; benign;
        functionally neutral in\nFT                   vitro; dbSNP:rs55815649)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070492\"\nFT
        \  VARIANT         1561\nFT                   /note=\"T -> I (found in breast
        cancer; uncertain\nFT                   significance; dbSNP:rs56158747)\"\nFT
        \                  /id=\"VAR_007789\"\nFT   VARIANT         1589\nFT                   /note=\"R
        -> P (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070493\"\nFT   VARIANT         1606\nFT                   /note=\"K
        -> E (in dbSNP:rs80356943)\"\nFT                   /id=\"VAR_007790\"\nFT
        \  VARIANT         1613\nFT                   /note=\"S -> G (in dbSNP:rs1799966)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10323242,\nFT                   ECO:0000269|PubMed:12442274,
        ECO:0000269|PubMed:15489334,\nFT                   ECO:0000269|PubMed:7894493,
        ECO:0000269|PubMed:9010228,\nFT                   ECO:0000269|Ref.6\"\nFT
        \                  /id=\"VAR_007791\"\nFT   VARIANT         1620\nFT                   /note=\"T
        -> A (in dbSNP:rs8176219)\"\nFT                   /evidence=\"ECO:0000269|Ref.6\"\nFT
        \                  /id=\"VAR_019946\"\nFT   VARIANT         1623\nFT                   /note=\"A
        -> G (in BROVCA1; major splicing aberration\nFT                   identified
        with this mutant; dbSNP:rs80356862)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:20513136\"\nFT                   /id=\"VAR_063901\"\nFT
        \  VARIANT         1628\nFT                   /note=\"M -> T (in dbSNP:rs4986854)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:15365993,\nFT                   ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_007793\"\nFT   VARIANT         1628\nFT                   /note=\"M
        -> V (found in breast and ovarian cancer patients;\nFT                   uncertain
        significance; dbSNP:rs80357465)\"\nFT                   /id=\"VAR_007792\"\nFT
        \  VARIANT         1637\nFT                   /note=\"P -> L (in dbSNP:rs80357048)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:7939630,\nFT                   ECO:0000269|PubMed:9482581\"\nFT
        \                  /id=\"VAR_007794\"\nFT   VARIANT         1641\nFT                   /note=\"A
        -> P (in ovarian cancer; uncertain significance;\nFT                   dbSNP:rs1800726)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10196379\"\nFT                   /id=\"VAR_008762\"\nFT
        \  VARIANT         1651\nFT                   /note=\"S -> F (in BC; uncertain
        significance;\nFT                   dbSNP:rs80356938)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070494\"\nFT   VARIANT         1651\nFT                   /note=\"S
        -> P (in BC; uncertain significance;\nFT                   dbSNP:rs879254042)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070495\"\nFT
        \  VARIANT         1652\nFT                   /note=\"M -> I (in dbSNP:rs1799967)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12215251,\nFT                   ECO:0000269|PubMed:15489334,
        ECO:0000269|PubMed:23867111,\nFT                   ECO:0000269|PubMed:9482581\"\nFT
        \                  /id=\"VAR_007795\"\nFT   VARIANT         1655\nFT                   /note=\"S
        -> F (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357390)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070496\"\nFT   VARIANT         1662\nFT                   /note=\"F
        -> C (in dbSNP:rs28897695)\"\nFT                   /id=\"VAR_052080\"\nFT
        \  VARIANT         1665\nFT                   /note=\"V -> M (in dbSNP:rs80357169)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:15026808\"\nFT                   /id=\"VAR_020700\"\nFT
        \  VARIANT         1685\nFT                   /note=\"T -> A (in BC; pathogenic;
        dbSNP:rs80356890)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063902\"\nFT   VARIANT         1685\nFT                   /note=\"T
        -> I (in BROVCA1; pathogenic)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:20513136\"\nFT                   /id=\"VAR_063903\"\nFT
        \  VARIANT         1686\nFT                   /note=\"H -> Q (in BC; uncertain
        significance; functionally\nFT                   impaired in vitro; dbSNP:rs397509218)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070497\"\nFT
        \  VARIANT         1686\nFT                   /note=\"H -> R (in BC; uncertain
        significance; functionally\nFT                   impaired in vitro; dbSNP:rs730882166)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070498\"\nFT
        \  VARIANT         1688\nFT                   /note=\"Missing (in BC; uncertain
        significance; functionally\nFT                   impaired in vitro; dbSNP:rs80358344)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070499\"\nFT
        \  VARIANT         1689\nFT                   /note=\"M -> R (in BC; uncertain
        significance;\nFT                   dbSNP:rs80357061)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063904\"\nFT   VARIANT         1690\nFT                   /note=\"K
        -> Q (in some patients with sporadic breast\nFT                   cancer;
        uncertain significance; dbSNP:rs397507239)\"\nFT                   /evidence=\"ECO:0000269|PubMed:15365993\"\nFT
        \                  /id=\"VAR_020701\"\nFT   VARIANT         1691\nFT                   /note=\"T
        -> I (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357034)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070500\"\nFT   VARIANT         1692\nFT                   /note=\"D
        -> N (in ovarian cancer; uncertain significance;\nFT                   dbSNP:rs80187739)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10196379\"\nFT                   /id=\"VAR_008763\"\nFT
        \  VARIANT         1697\nFT                   /note=\"C -> R (in OC; pathogenic;
        dbSNP:rs80356993)\"\nFT                   /evidence=\"ECO:0000269|PubMed:14746861\"\nFT
        \                  /id=\"VAR_020702\"\nFT   VARIANT         1699\nFT                   /note=\"R
        -> Q (in BC; pathogenic; strongly reduces affinity\nFT                   for
        a BRIP1 phosphopeptide; functionally impaired in vitro;\nFT                   dbSNP:rs41293459)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:21473589,\nFT                   ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070501\"\nFT   VARIANT         1699\nFT                   /note=\"R
        -> W (in BC, OC and FANCS; impairs protein\nFT                   stability;
        functionally impaired in vitro;\nFT                   dbSNP:rs55770810)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:14746861,\nFT                   ECO:0000269|PubMed:17924331,
        ECO:0000269|PubMed:21473589,\nFT                   ECO:0000269|PubMed:23867111,
        ECO:0000269|PubMed:25472942\"\nFT                   /id=\"VAR_075666\"\nFT
        \  VARIANT         1706\nFT                   /note=\"G -> A (in BC; benign;
        dbSNP:rs80356860)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070502\"\nFT   VARIANT         1706\nFT                   /note=\"G
        -> E (in BC; pathogenic; dbSNP:rs80356860)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_063905\"\nFT
        \  VARIANT         1708\nFT                   /note=\"A -> E (in BC; abolishes
        ACACA binding;\nFT                   dbSNP:rs28897696)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:23867111, ECO:0000269|PubMed:7939630\"\nFT
        \                  /id=\"VAR_007796\"\nFT   VARIANT         1713\nFT                   /note=\"V
        -> G\"\nFT                   /evidence=\"ECO:0000269|PubMed:15365993\"\nFT
        \                  /id=\"VAR_007797\"\nFT   VARIANT         1715\nFT                   /note=\"S
        -> R (in BC; pathogenic; dbSNP:rs80357094)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063906\"\nFT   VARIANT         1718\nFT                   /note=\"W
        -> C (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357239)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070503\"\nFT   VARIANT         1720\nFT                   /note=\"T
        -> A (in BC; benign; functionally neutral in\nFT                   vitro;
        no effect on in vitro phosphorylation by ATR;\nFT                   dbSNP:rs56195342)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:11114888,\nFT                   ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070504\"\nFT   VARIANT         1735\nFT                   /note=\"E
        -> K (in BC; uncertain significance;\nFT                   dbSNP:rs397509238)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070505\"\nFT
        \  VARIANT         1736\nFT                   /note=\"V -> A (in BC and FANCS;
        pathogenic; decreased\nFT                   localization to DNA damage sites
        and reduced interaction\nFT                   with UIMC1/RAP80; dbSNP:rs45553935)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23269703,\nFT                   ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070506\"\nFT   VARIANT         1738\nFT                   /note=\"G
        -> R (in BC; pathogenic; dbSNP:rs80356937)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063907\"\nFT   VARIANT         1739\nFT                   /note=\"D
        -> G (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357227)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070507\"\nFT   VARIANT         1739\nFT                   /note=\"D
        -> V (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357227)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070508\"\nFT   VARIANT         1746\nFT                   /note=\"H
        -> Q (in BC; uncertain significance;\nFT                   dbSNP:rs786202389)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070509\"\nFT
        \  VARIANT         1749\nFT                   /note=\"P -> R (in ovarian cancer;
        uncertain significance;\nFT                   abolishes ACACA binding and
        strongly reduces BRIP1 binding;\nFT                   dbSNP:rs80357462)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10486320,\nFT                   ECO:0000269|PubMed:11301010,
        ECO:0000269|PubMed:15133502\"\nFT                   /id=\"VAR_007798\"\nFT
        \  VARIANT         1753\nFT                   /note=\"R -> T (in BC; uncertain
        significance;\nFT                   dbSNP:rs397509246)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070510\"\nFT   VARIANT         1764\nFT                   /note=\"L
        -> P (in BC; pathogenic; functionally impaired in\nFT                   vitro;
        dbSNP:rs80357281)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331,\nFT
        \                  ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_063908\"\nFT
        \  VARIANT         1766\nFT                   /note=\"I -> S (in BC; pathogenic;
        dbSNP:rs80357463)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063909\"\nFT   VARIANT         1767\nFT                   /note=\"C
        -> S (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs1597804426)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070511\"\nFT   VARIANT         1770\nFT                   /note=\"G
        -> V (in BC; pathogenic; functionally impaired in\nFT                   vitro;
        dbSNP:rs863224765)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070512\"\nFT   VARIANT         1775\nFT                   /note=\"M
        -> K (in BC; pathogenic; strongly reduced\nFT                   transcription
        transactivation; abolishes interaction with\nFT                   BRIP1 and
        RBBP8; dbSNP:rs41293463)\"\nFT                   /evidence=\"ECO:0000269|PubMed:18285836\"\nFT
        \                  /id=\"VAR_063212\"\nFT   VARIANT         1775\nFT                   /note=\"M
        -> R (in BC; pathogenic; alters protein stability\nFT                   and
        abolishes ACACA and BRIP1 binding; dbSNP:rs41293463)\"\nFT                   /evidence=\"ECO:0000269|PubMed:11301010,\nFT
        \                  ECO:0000269|PubMed:12427738, ECO:0000269|PubMed:15133502,\nFT
        \                  ECO:0000269|PubMed:7545954, ECO:0000269|PubMed:7939630\"\nFT
        \                  /id=\"VAR_007799\"\nFT   VARIANT         1776\nFT                   /note=\"P
        -> S (in ovarian cancer; uncertain significance;\nFT                   dbSNP:rs1800757)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10196379\"\nFT                   /id=\"VAR_008764\"\nFT
        \  VARIANT         1780\nFT                   /note=\"L -> P (in BC, BROVCA1
        and OC; uncertain\nFT                   significance; dbSNP:rs80357474)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:28364669\"\nFT                   /id=\"VAR_079607\"\nFT
        \  VARIANT         1782\nFT                   /note=\"W -> C (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070513\"\nFT   VARIANT         1786\nFT                   /note=\"L
        -> P (in BROVCA1; uncertain significance;\nFT                   dbSNP:rs398122697)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:12938098\"\nFT                   /id=\"VAR_020704\"\nFT
        \  VARIANT         1788\nFT                   /note=\"G -> V (in BC; pathogenic;
        dbSNP:rs80357069)\"\nFT                   /evidence=\"ECO:0000269|PubMed:17924331\"\nFT
        \                  /id=\"VAR_063910\"\nFT   VARIANT         1789\nFT                   /note=\"A
        -> T (in BC; uncertain significance; functionally\nFT                   impaired
        in vitro; dbSNP:rs80357078)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070514\"\nFT   VARIANT         1794\nFT                   /note=\"E
        -> D (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro; dbSNP:rs397509275)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070515\"\nFT   VARIANT         1804\nFT                   /note=\"V
        -> D (in BC; benign; functionally neutral in\nFT                   vitro;
        dbSNP:rs80356920)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070516\"\nFT   VARIANT         1812\nFT                   /note=\"P
        -> R (in BC; uncertain significance; functionally\nFT                   neutral
        in vitro)\"\nFT                   /evidence=\"ECO:0000269|PubMed:23867111\"\nFT
        \                  /id=\"VAR_070517\"\nFT   VARIANT         1812\nFT                   /note=\"P
        -> S (in ovarian cancer; uncertain significance;\nFT                   dbSNP:rs1800751)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:10196379\"\nFT                   /id=\"VAR_008765\"\nFT
        \  VARIANT         1837\nFT                   /note=\"W -> R (in BC; pathogenic;
        functionally impaired in\nFT                   vitro; dbSNP:rs80356959)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070518\"\nFT
        \  VARIANT         1862\nFT                   /note=\"H -> L (in BC; uncertain
        significance; functionally\nFT                   neutral in vitro; dbSNP:rs80357183)\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:23867111\"\nFT                   /id=\"VAR_070519\"\nFT
        \  MUTAGEN         26\nFT                   /note=\"I->A: Disrupts the interaction
        with E2 enzymes,\nFT                   thereby abolishing the E3 ubiquitin-protein
        ligase\nFT                   activity.\"\nFT                   /evidence=\"ECO:0000269|PubMed:16818604,\nFT
        \                  ECO:0000269|PubMed:20351172\"\nFT   MUTAGEN         26\nFT
        \                  /note=\"I->E: No ubiquitination of RBBP8. No restoration\nFT
        \                  RBBP8-mediated focus formation or G2/M checkpoint control\nFT
        \                  upon DNA damage.\"\nFT                   /evidence=\"ECO:0000269|PubMed:16818604,\nFT
        \                  ECO:0000269|PubMed:20351172\"\nFT   MUTAGEN         71\nFT
        \                  /note=\"R->G: No effect on interaction with BAP1.\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:9528852\"\nFT   MUTAGEN
        \        1143\nFT                   /note=\"S->A: Reduces in vitro phosphorylation
        by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1239\nFT                   /note=\"S->A: No effect on in
        vitro phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1280\nFT                   /note=\"S->A: Reduces in vitro
        phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1298\nFT                   /note=\"S->A: No effect on in
        vitro phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1330\nFT                   /note=\"S->A: No effect on in
        vitro phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1387\nFT                   /note=\"S->A: Loss of IR-induced
        S-phase checkpoint. Reduces\nFT                   in vitro phosphorylation
        by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888,\nFT
        \                  ECO:0000269|PubMed:12183412\"\nFT   MUTAGEN         1394\nFT
        \                  /note=\"T->A: Reduces in vitro phosphorylation by ATR.\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:11114888\"\nFT   MUTAGEN
        \        1423\nFT                   /note=\"S->A: Inhibition of the infrared-induced
        G2 arrest.\nFT                   Reduces phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888,\nFT
        \                  ECO:0000269|PubMed:12183412\"\nFT   MUTAGEN         1457\nFT
        \                  /note=\"S->A: Reduces in vitro phosphorylation by ATR.\"\nFT
        \                  /evidence=\"ECO:0000269|PubMed:11114888\"\nFT   MUTAGEN
        \        1466\nFT                   /note=\"S->A: No effect on in vitro phosphorylation
        by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1524\nFT                   /note=\"S->A: No change in infrared
        S-phase delay; when\nFT                   associated with A-1387. No effect
        on in vitro\nFT                   phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888,\nFT
        \                  ECO:0000269|PubMed:12183412\"\nFT   MUTAGEN         1655\nFT
        \                  /note=\"S->A: Abolishes interaction with BRIP1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:15133502\"\nFT
        \  MUTAGEN         1656\nFT                   /note=\"G->D: No effect on affinity
        for a BRIP1\nFT                   phosphopeptide.\"\nFT                   /evidence=\"ECO:0000269|PubMed:21473589\"\nFT
        \  MUTAGEN         1662\nFT                   /note=\"F->S: Does not abolish
        ABRAXAS1 binding, but\nFT                   abolishes formation of a heterotetramer
        with ABRAXAS1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:26778126\"\nFT
        \  MUTAGEN         1663\nFT                   /note=\"M->K: Does not abolish
        ABRAXAS1 binding, but\nFT                   abolishes formation of a heterotetramer
        with ABRAXAS1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:26778126\"\nFT
        \  MUTAGEN         1666\nFT                   /note=\"Y->A: Does not abolish
        ABRAXAS1 binding, but impairs\nFT                   formation of a heterotetramer
        with ABRAXAS1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:26778126\"\nFT
        \  MUTAGEN         1670\nFT                   /note=\"R->E: Impairs formation
        of a heterotetramer with\nFT                   ABRAXAS1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:26778126\"\nFT
        \  MUTAGEN         1671\nFT                   /note=\"K->E: Impairs formation
        of a heterotetramer with\nFT                   ABRAXAS1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:26778126\"\nFT
        \  MUTAGEN         1700\nFT                   /note=\"T->A: Strongly reduces
        affinity for a BRIP1\nFT                   phosphopeptide.\"\nFT                   /evidence=\"ECO:0000269|PubMed:21473589\"\nFT
        \  MUTAGEN         1702\nFT                   /note=\"K->M: Abolishes interaction
        with BRIP1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:15133502\"\nFT
        \  MUTAGEN         1738\nFT                   /note=\"G->E: Abolishes interaction
        with BRIP1.\"\nFT                   /evidence=\"ECO:0000269|PubMed:15133502\"\nFT
        \  MUTAGEN         1755\nFT                   /note=\"S->A: No effect on in
        vitro phosphorylation by ATR.\"\nFT                   /evidence=\"ECO:0000269|PubMed:11114888\"\nFT
        \  MUTAGEN         1835\nFT                   /note=\"R->P: Mildly reduces
        affinity for a BRIP1\nFT                   phosphopeptide.\"\nFT                   /evidence=\"ECO:0000269|PubMed:21473589\"\nFT
        \  MUTAGEN         1836\nFT                   /note=\"E->K: Slightly reduces
        affinity for a BRIP1\nFT                   phosphopeptide.\"\nFT                   /evidence=\"ECO:0000269|PubMed:21473589\"\nFT
        \  CONFLICT        89\nFT                   /note=\"I -> T (in Ref. 4; AAB61673)\"\nFT
        \                  /evidence=\"ECO:0000305\"\nFT   CONFLICT        148\nFT
        \                  /note=\"Missing (in Ref. 4; AAB61673)\"\nFT                   /evidence=\"ECO:0000305\"\nFT
        \  CONFLICT        253\nFT                   /note=\"A -> V (in Ref. 3; AAC00049)\"\nFT
        \                  /evidence=\"ECO:0000305\"\nFT   CONFLICT        713\nFT
        \                  /note=\"S -> P (in Ref. 8; AAI15038)\"\nFT                   /evidence=\"ECO:0000305\"\nFT
        \  CONFLICT        1077\nFT                   /note=\"G -> R (in Ref. 4; AAB61673)\"\nFT
        \                  /evidence=\"ECO:0000305\"\nFT   CONFLICT        1426\nFT
        \                  /note=\"S -> P (in Ref. 3; AAC00049)\"\nFT                   /evidence=\"ECO:0000305\"\nFT
        \  CONFLICT        1527\nFT                   /note=\"E -> G (in Ref. 8; AAI15038)\"\nFT
        \                  /evidence=\"ECO:0000305\"\nFT   TURN            5..7\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   HELIX           8..21\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   STRAND          25..27\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   HELIX           49..52\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   STRAND          54..58\nFT
        \                  /evidence=\"ECO:0007829|PDB:1JM7\"\nFT   STRAND          62..64\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   STRAND          66..68\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   TURN            70..72\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   HELIX           80..96\nFT
        \                  /evidence=\"ECO:0007829|PDB:7LYB\"\nFT   STRAND          1651..1656\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1659..1671\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1675..1679\nFT
        \                  /evidence=\"ECO:0007829|PDB:1T29\"\nFT   STRAND          1686..1689\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1695..1697\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1701..1708\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1712..1715\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1717..1725\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1731..1734\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   TURN            1740..1742\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1743..1745\nFT
        \                  /evidence=\"ECO:0007829|PDB:1T29\"\nFT   HELIX           1748..1754\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   TURN            1755..1757\nFT
        \                  /evidence=\"ECO:0007829|PDB:1T29\"\nFT   TURN            1760..1763\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1765..1768\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1770..1772\nFT
        \                  /evidence=\"ECO:0007829|PDB:1T2V\"\nFT   STRAND          1773..1775\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1777..1786\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1790..1794\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1795..1797\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1801..1803\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1806..1810\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1812..1814\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1817..1819\nFT
        \                  /evidence=\"ECO:0007829|PDB:1OQA\"\nFT   HELIX           1820..1822\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1824..1827\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   STRAND          1828..1830\nFT
        \                  /evidence=\"ECO:0007829|PDB:3PXE\"\nFT   STRAND          1832..1834\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1835..1844\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   HELIX           1851..1853\nFT
        \                  /evidence=\"ECO:0007829|PDB:4IGK\"\nFT   CONFLICT        P38398-7:1461\nFT
        \                  /note=\"N -> D (in Ref. 8; AAI15038)\"\nFT                   /evidence=\"ECO:0000305\"\nSQ
        \  SEQUENCE   1863 AA;  207721 MW;  89C6D83FF56312AF CRC64;\n     MDLSALRVEE
        VQNVINAMQK ILECPICLEL IKEPVSTKCD HIFCKFCMLK LLNQKKGPSQ\n     CPLCKNDITK RSLQESTRFS
        QLVEELLKII CAFQLDTGLE YANSYNFAKK ENNSPEHLKD\n     EVSIIQSMGY RNRAKRLLQS EPENPSLQET
        SLSVQLSNLG TVRTLRTKQR IQPQKTSVYI\n     ELGSDSSEDT VNKATYCSVG DQELLQITPQ GTRDEISLDS
        AKKAACEFSE TDVTNTEHHQ\n     PSNNDLNTTE KRAAERHPEK YQGSSVSNLH VEPCGTNTHA SSLQHENSSL
        LLTKDRMNVE\n     KAEFCNKSKQ PGLARSQHNR WAGSKETCND RRTPSTEKKV DLNADPLCER KEWNKQKLPC\n
        \    SENPRDTEDV PWITLNSSIQ KVNEWFSRSD ELLGSDDSHD GESESNAKVA DVLDVLNEVD\n     EYSGSSEKID
        LLASDPHEAL ICKSERVHSK SVESNIEDKI FGKTYRKKAS LPNLSHVTEN\n     LIIGAFVTEP QIIQERPLTN
        KLKRKRRPTS GLHPEDFIKK ADLAVQKTPE MINQGTNQTE\n     QNGQVMNITN SGHENKTKGD SIQNEKNPNP
        IESLEKESAF KTKAEPISSS ISNMELELNI\n     HNSKAPKKNR LRRKSSTRHI HALELVVSRN LSPPNCTELQ
        IDSCSSSEEI KKKKYNQMPV\n     RHSRNLQLME GKEPATGAKK SNKPNEQTSK RHDSDTFPEL KLTNAPGSFT
        KCSNTSELKE\n     FVNPSLPREE KEEKLETVKV SNNAEDPKDL MLSGERVLQT ERSVESSSIS LVPGTDYGTQ\n
        \    ESISLLEVST LGKAKTEPNK CVSQCAAFEN PKGLIHGCSK DNRNDTEGFK YPLGHEVNHS\n     RETSIEMEES
        ELDAQYLQNT FKVSKRQSFA PFSNPGNAEE ECATFSAHSG SLKKQSPKVT\n     FECEQKEENQ GKNESNIKPV
        QTVNITAGFP VVGQKDKPVD NAKCSIKGGS RFCLSSQFRG\n     NETGLITPNK HGLLQNPYRI PPLFPIKSFV
        KTKCKKNLLE ENFEEHSMSP EREMGNENIP\n     STVSTISRNN IRENVFKEAS SSNINEVGSS TNEVGSSINE
        IGSSDENIQA ELGRNRGPKL\n     NAMLRLGVLQ PEVYKQSLPG SNCKHPEIKK QEYEEVVQTV NTDFSPYLIS
        DNLEQPMGSS\n     HASQVCSETP DDLLDDGEIK EDTSFAENDI KESSAVFSKS VQKGELSRSP SPFTHTHLAQ\n
        \    GYRRGAKKLE SSEENLSSED EELPCFQHLL FGKVNNIPSQ STRHSTVATE CLSKNTEENL\n     LSLKNSLNDC
        SNQVILAKAS QEHHLSEETK CSASLFSSQC SELEDLTANT NTQDPFLIGS\n     SKQMRHQSES QGVGLSDKEL
        VSDDEERGTG LEENNQEEQS MDSNLGEAAS GCESETSVSE\n     DCSGLSSQSD ILTTQQRDTM QHNLIKLQQE
        MAELEAVLEQ HGSQPSNSYP SIISDSSALE\n     DLRNPEQSTS EKAVLTSQKS SEYPISQNPE GLSADKFEVS
        ADSSTSKNKE PGVERSSPSK\n     CPSLDDRWYM HSCSGSLQNR NYPSQEELIK VVDVEEQQLE ESGPHDLTET
        SYLPRQDLEG\n     TPYLESGISL FSDDPESDPS EDRAPESARV GNIPSSTSAL KVPQLKVAES AQSPAAAHTT\n
        \    DTAGYNAMEE SVSREKPELT ASTERVNKRM SMVVSGLTPE EFMLVYKFAR KHHITLTNLI\n     TEETTHVVMK
        TDAEFVCERT LKYFLGIAGG KWVVSYFWVT QSIKERKMLN EHDFEVRGDV\n     VNGRNHQGPK RARESQDRKI
        FRGLEICCYG PFTNMPTDQL EWMVQLCGAS VVKELSSFTL\n     GTGVHPIVVV QPDAWTEDNG FHAIGQMCEA
        PVVTREWVLD SVALYQCQEL DTYLIPQIPH\n     SHY\n//\n"
    headers:
      Access-Control-Allow-Credentials:
      - 'true'
      Access-Control-Allow-Headers:
      - DNT,Keep-Alive,User-Agent,X-Requested-With,If-Modified-Since,Cache-Control,Content-Type,Range,Authorization
      Access-Control-Allow-Methods:
      - GET, PUT, POST, DELETE, PATCH, OPTIONS
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - Link, X-Total-Results, X-UniProt-Release, X-UniProt-Release-Date, X-API-Deployment-Date
      Access-Control-Max-Age:
      - '1728000'
      Cache-Control:
      - public, max-age=43200
      Connection:
      - keep-alive
      Content-Type:
      - text/plain;format=flatfile
      Date:
      - Mon, 09 Feb 2026 22:41:30 GMT
      Strict-Transport-Security:
      - max-age=31536000; includeSubDomains
      Transfer-Encoding:
      - chunked
      Vary:
      - accept,accept-encoding,x-uniprot-release,x-api-deployment-date, User-Agent,
        Accept-Encoding
      X-API-Deployment-Date:
      - 09-February-2026
      X-UniProt-Release:
      - '2026_01'
      X-UniProt-Release-Date:
      - 28-January-2026
      content-length:
      - '151385'
      x-cache:
      - miss cached
    status:
      code: 200
      message: OK
- request:
    body: null
    headers:
      Accept:
      - application/json
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://www.ebi.ac.uk/QuickGO/services/annotation/search?geneProductId=P38398&includeFields=goName&includeFields=taxonName&includeFields=name&limit=200
  response:
    body:
      string: '{"numberOfHits":314,"results":[{"id":"UniProtKB:P38398!488408304","geneProductId":"UniProtKB:P38398","qualifier":"acts_upstream_of","goId":"GO:0051726","goName":"regulation
        of cell cycle","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:21102443","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20210812","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408305","geneProductId":"UniProtKB:P38398","qualifier":"acts_upstream_of_or_within","goId":"GO:0008630","goName":"intrinsic
        apoptotic signaling pathway in response to DNA damage","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:14654789","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"MGI","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20040514","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408306","geneProductId":"UniProtKB:P38398","qualifier":"acts_upstream_of_positive_effect","goId":"GO:0044027","goName":"negative
        regulation of gene expression via chromosomal CpG island methylation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:20820192","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230719","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408307","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0000976","goName":"transcription
        cis-regulatory region binding","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408308","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0000976","goName":"transcription
        cis-regulatory region binding","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:20820192","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20110418","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408309","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0002039","goName":"p53
        binding","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:15571721","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"DisProt","extensions":[{"connectedXrefs":[{"db":"UniProtKB","id":"P04637","relation":"has_input"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408310","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003677","goName":"DNA
        binding","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR011364"}]},{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0238"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408311","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003677","goName":"DNA
        binding","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"PMID:9662397","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"PINC","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20030904","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408312","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003684","goName":"damaged
        DNA binding","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408313","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003713","goName":"transcription
        coactivator activity","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408314","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003713","goName":"transcription
        coactivator activity","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:20820192","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"UniProtKB","id":"P26358","relation":"has_input"},{"db":"GO","id":"0044027","relation":"causally_upstream_of"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240924","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408315","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003713","goName":"transcription
        coactivator activity","goEvidence":"IMP","goAspect":"molecular_function","evidenceCode":"ECO:0000315","reference":"PMID:9662397","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170706","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408316","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0003723","goName":"RNA
        binding","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:12419249","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"MGI","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20091111","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408317","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000256","reference":"GO_REF:0000002","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR011364"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"InterPro","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408318","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IBA","goAspect":"molecular_function","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349139"}]},{"connectedXrefs":[{"db":"TAIR","id":"locus:2133109"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408319","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:12890688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408320","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:17349954","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HGNC-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230614","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408321","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:19117993","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100510","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408322","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:20351172","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408323","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0004842","goName":"ubiquitin-protein
        transferase activity","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9701000","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240514","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408324","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:10477523","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408325","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:10518542","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P06400"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"DisProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408326","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:10855792","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P55072"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20060109","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408327","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11090615","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9GZX5"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0017053","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408328","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11239454","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BXW9"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408329","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11244506","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P03372"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408330","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11301010","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050708","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408331","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11573085","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408332","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11739404","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q8WX92"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0000790","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408333","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11739404","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408334","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11751867","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P61969"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20120708","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408335","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11836499","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O14757"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408336","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:11877377","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14683"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050707","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408337","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12242698","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P51587"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408338","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12242698","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q06609"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20040727","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408339","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12354784","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O15360"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"DisProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408340","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12354784","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O15360"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408341","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12419185","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P16104"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408342","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:12607005","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14676"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408343","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:14550570","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14192"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408344","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:14576432","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408345","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:14576433","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050708","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408346","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:14654789","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q16666"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005730","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0005654","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408347","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15107825","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9UHK0"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408348","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15125843","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408349","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15133502","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408350","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15265711","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050603","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408351","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15674350","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P03372"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408352","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15965487","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P11388"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408353","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15983032","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P03126"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408354","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15983032","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P03129"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408355","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:16101277","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230717","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408356","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:16326698","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q13085"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20061003","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408357","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:16326698","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q13085"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408358","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:16452482","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6PJG6"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100510","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408359","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:16452482","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6PJG6"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408360","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17334399","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P24385"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0005737","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408361","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17511879","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P36873"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408362","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17511879","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P62136"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408363","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17511879","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P62140"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408364","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525332","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P24864"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408365","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525332","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q12888"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0000790","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0016604","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408366","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525332","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14676"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408367","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525332","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6NZY4"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408368","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408369","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408370","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q96RL1"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408371","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408372","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17525340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408373","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17581638","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408374","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17643121","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408375","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17643121","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408376","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17643121","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q96RL1-1"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408377","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17873885","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408378","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18001824","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P16104"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408379","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18001824","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q12888"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0000790","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0016604","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408380","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18001825","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P16104"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408381","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18285836","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408382","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18285836","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408383","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:18716619","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100806","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408384","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19117993","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q92560"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100510","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408385","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19261748","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408386","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19369211","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YC2"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20101007","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408387","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19369211","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YC2"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408388","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19369211","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408389","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19369211","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408390","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:19369211","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408391","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:20016594","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P61956"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408392","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:20016594","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P63165"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408393","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:20016603","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P61956"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408394","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:20160719","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q8N163"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20150509","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408395","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:20351172","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q04323"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408396","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21240188","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O15360"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408397","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21240188","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408398","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21407215","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P78347"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408399","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21673012","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q15004"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20121022","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408400","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21951318","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q92731"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408401","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21988832","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P10809"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408402","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:21988832","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14192"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408403","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22110403","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O75330"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408404","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22110403","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408405","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22193777","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P16104"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408406","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22193777","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YC2"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408407","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22792074","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408408","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:22884692","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q12888"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0000790","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0016604","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408409","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:23624935","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q61188"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408410","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:23680151","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408411","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:24981860","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408412","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:26807646","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P49959"},{"db":"UniProtKB","id":"Q99708"},{"db":"UniProtKB","id":"Q9NVH0"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20160321","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408413","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:26833090","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P28715"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20210120","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408414","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:28319063","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YC2"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408415","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"O15360"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408416","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q12888"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0000790","relation":"occurs_in"}]},{"connectedXrefs":[{"db":"GO","id":"0016604","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408417","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q14676"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408418","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408419","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YC2"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408420","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q96RL1"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408421","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408422","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408423","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408424","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BXW9"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408425","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29899443","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q13085"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20190927","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408426","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:31527615","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P03372"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408427","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:33961781","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408428","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34552057","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YA3"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230727","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408429","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34552057","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q86YA3"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408430","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q6UWZ7"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408431","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q96RL1"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408432","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q96SB3"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408433","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408434","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408435","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q9BX63"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0035861","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408436","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:8944023","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99728"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408437","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9497340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P52292"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408438","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9497340","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q7Z569"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408439","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9528852","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q92560"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":[{"connectedXrefs":[{"db":"GO","id":"0005634","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408440","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9662397","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q08211"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170706","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408441","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9774970","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P51587"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070809","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408442","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9811458","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"Q99708"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408443","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0005515","goName":"protein
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:9926942","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P04637"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408444","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0008270","goName":"zinc
        ion binding","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR011364"}]},{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0863"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408445","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0008270","goName":"zinc
        ion binding","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"PMID:8944023","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"PINC","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20030904","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408446","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0015631","goName":"tubulin
        binding","goEvidence":"NAS","goAspect":"molecular_function","evidenceCode":"ECO:0000303","reference":"PMID:12214252","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20021023","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408447","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0016740","goName":"transferase
        activity","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0007322","reference":"GO_REF:0000043","withFrom":[{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0808"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408448","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0019899","goName":"enzyme
        binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:15965487","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P11388"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20060822","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408449","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0031625","goName":"ubiquitin
        protein ligase binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:17873885","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P61086"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100628","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408450","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0042802","goName":"identical
        protein binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:29656893","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408451","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0042802","goName":"identical
        protein binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:34591612","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408452","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0042802","goName":"identical
        protein binding","goEvidence":"IPI","goAspect":"molecular_function","evidenceCode":"ECO:0000353","reference":"PMID:8944023","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"IntAct","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260103","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408453","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0046872","goName":"metal
        ion binding","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR018957"}]},{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0479"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408454","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0061630","goName":"ubiquitin
        protein ligase activity","goEvidence":"IEA","goAspect":"molecular_function","evidenceCode":"ECO:0000501","reference":"GO_REF:0000003","withFrom":[{"connectedXrefs":[{"db":"EC","id":"2.3.2.27"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408455","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0061649","goName":"ubiquitin-modified
        histone reader activity","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"PMID:35351360","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ARUK-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240924","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408456","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0070063","goName":"RNA
        polymerase binding","goEvidence":"IDA","goAspect":"molecular_function","evidenceCode":"ECO:0000314","reference":"PMID:9662397","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170706","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408457","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0140863","goName":"histone
        H2AK127 ubiquitin ligase activity","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"PMID:35351360","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ARUK-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240924","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408458","geneProductId":"UniProtKB:P38398","qualifier":"enables","goId":"GO:0140864","goName":"histone
        H2AK129 ubiquitin ligase activity","goEvidence":"TAS","goAspect":"molecular_function","evidenceCode":"ECO:0000304","reference":"PMID:35351360","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ARUK-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240924","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408459","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0000724","goName":"double-strand
        break repair via homologous recombination","goEvidence":"IBA","goAspect":"biological_process","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349139"}]},{"connectedXrefs":[{"db":"TAIR","id":"locus:2133109"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"F4I443"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250903","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408460","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0000724","goName":"double-strand
        break repair via homologous recombination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:17349954","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HGNC-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070426","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408461","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0000724","goName":"double-strand
        break repair via homologous recombination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:28398198","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250415","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408462","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006281","goName":"DNA
        repair","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR011364"}]},{"connectedXrefs":[{"db":"InterPro","id":"IPR031099"}]},{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0234"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408463","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006281","goName":"DNA
        repair","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:22369660","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408464","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006282","goName":"regulation
        of DNA repair","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:20656689","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408465","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006301","goName":"DNA
        damage tolerance","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:17349954","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HGNC-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070426","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408466","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408467","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408468","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17643121","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408469","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:19261748","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408470","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:22186889","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"CACAO","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20120308","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408471","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006302","goName":"double-strand
        break repair","goEvidence":"TAS","goAspect":"biological_process","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693606","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250827","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408472","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006310","goName":"DNA
        recombination","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0007322","reference":"GO_REF:0000043","withFrom":[{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0233"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408473","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006338","goName":"chromatin
        remodeling","goEvidence":"TAS","goAspect":"biological_process","evidenceCode":"ECO:0000304","reference":"PMID:35351360","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ARUK-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240924","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408474","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006357","goName":"regulation
        of transcription by RNA polymerase II","goEvidence":"TAS","goAspect":"biological_process","evidenceCode":"ECO:0000304","reference":"PMID:10910365","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"PINC","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20030904","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408475","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006357","goName":"regulation
        of transcription by RNA polymerase II","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:9662397","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170706","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408476","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006629","goName":"lipid
        metabolic process","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0007322","reference":"GO_REF:0000043","withFrom":[{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0443"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408477","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006631","goName":"fatty
        acid metabolic process","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0007322","reference":"GO_REF:0000043","withFrom":[{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0276"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408478","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006633","goName":"fatty
        acid biosynthetic process","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0007322","reference":"GO_REF:0000043","withFrom":[{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0275"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408479","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006974","goName":"DNA
        damage response","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"InterPro","id":"IPR031099"}]},{"connectedXrefs":[{"db":"UniProtKB-KW","id":"KW-0227"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408480","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006974","goName":"DNA
        damage response","goEvidence":"TAS","goAspect":"biological_process","evidenceCode":"ECO:0000304","reference":"PMID:10910365","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"PINC","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20030904","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408481","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0006974","goName":"DNA
        damage response","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:16651405","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250320","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408482","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0007059","goName":"chromosome
        segregation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:15965487","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20060822","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408483","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0007095","goName":"mitotic
        G2 DNA damage checkpoint signaling","goEvidence":"IBA","goAspect":"biological_process","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349142"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230918","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408484","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0007095","goName":"mitotic
        G2 DNA damage checkpoint signaling","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20171116","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408485","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0007095","goName":"mitotic
        G2 DNA damage checkpoint signaling","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17643121","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20171116","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408486","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0007095","goName":"mitotic
        G2 DNA damage checkpoint signaling","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:19261748","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20171116","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408487","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0010212","goName":"response
        to ionizing radiation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408488","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0010212","goName":"response
        to ionizing radiation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17643121","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408489","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0010212","goName":"response
        to ionizing radiation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:19261748","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408490","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0010575","goName":"positive
        regulation of vascular endothelial growth factor production","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"},{"db":"UniProtKB","id":"P15692","relation":"has_input"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408491","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0010628","goName":"positive
        regulation of gene expression","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"},{"db":"UniProtKB","id":"P29474","relation":"has_input"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408492","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0016567","goName":"protein
        ubiquitination","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0007322","reference":"GO_REF:0000041","withFrom":[{"connectedXrefs":[{"db":"UniPathway","id":"UPA00143"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20240129","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408493","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0016567","goName":"protein
        ubiquitination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:17349954","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HGNC-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070426","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408494","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0030308","goName":"negative
        regulation of cell growth","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:10518542","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"DisProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408495","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0033147","goName":"negative
        regulation of intracellular estrogen receptor signaling pathway","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17505062","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"CACAO","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140131","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408496","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0035825","goName":"homologous
        recombination","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:22369660","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408497","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0035825","goName":"homologous
        recombination","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:30657944","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408498","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0043009","goName":"chordate
        embryonic development","goEvidence":"IBA","goAspect":"biological_process","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"MGI","id":"MGI:104537"}]},{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349142"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408499","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0044818","goName":"mitotic
        G2/M transition checkpoint","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:22369660","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408500","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045717","goName":"negative
        regulation of fatty acid biosynthetic process","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:16326698","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20061219","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408501","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045739","goName":"positive
        regulation of DNA repair","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408502","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045739","goName":"positive
        regulation of DNA repair","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:19261748","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408503","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045766","goName":"positive
        regulation of angiogenesis","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"}],"pageInfo":{"resultsPerPage":200,"current":1,"total":2}}'
    headers:
      Access-Control-Allow-Headers:
      - Content-Type
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - Keep-Alive
      Content-Type:
      - application/json
      Date:
      - Mon, 09 Feb 2026 22:39:38 GMT
      Keep-Alive:
      - timeout=60
      Strict-Transport-Security:
      - max-age=0
      Transfer-Encoding:
      - chunked
    status:
      code: 200
      message: ''
- request:
    body: null
    headers:
      Accept:
      - application/json
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://www.ebi.ac.uk/QuickGO/services/annotation/search?geneProductId=P38398&includeFields=goName&includeFields=taxonName&includeFields=name&limit=200&page=2
  response:
    body:
      string: '{"numberOfHits":314,"results":[{"id":"UniProtKB:P38398!488408504","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045786","goName":"negative
        regulation of cell cycle","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:15159397","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250320","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408505","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045892","goName":"negative
        regulation of DNA-templated transcription","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:16288014","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20060602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408506","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045893","goName":"positive
        regulation of DNA-templated transcription","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:12080089","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"DisProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408507","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045893","goName":"positive
        regulation of DNA-templated transcription","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:20160719","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20150509","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408508","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045944","goName":"positive
        regulation of transcription by RNA polymerase II","goEvidence":"IBA","goAspect":"biological_process","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"MGI","id":"MGI:104537"}]},{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349139"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408509","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045944","goName":"positive
        regulation of transcription by RNA polymerase II","goEvidence":"IEA","goAspect":"biological_process","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408510","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045944","goName":"positive
        regulation of transcription by RNA polymerase II","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:16331276","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100517","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408511","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0045944","goName":"positive
        regulation of transcription by RNA polymerase II","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:20820192","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"GO","id":"0044027","relation":"causally_upstream_of"},{"db":"UniProtKB","id":"P26358","relation":"has_input"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230719","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408512","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0046600","goName":"negative
        regulation of centriole replication","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0000303","reference":"PMID:12214252","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20021023","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408513","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0051865","goName":"protein
        autoubiquitination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:12890688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408514","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0051865","goName":"protein
        autoubiquitination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:20351172","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408515","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0071356","goName":"cellular
        response to tumor necrosis factor","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408516","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0071479","goName":"cellular
        response to ionizing radiation","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:14636569","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250623","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408517","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0071681","goName":"cellular
        response to indole-3-methanol","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:10868478","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100506","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408518","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0085020","goName":"protein
        K6-linked ubiquitination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:12890688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100604","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408519","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0085020","goName":"protein
        K6-linked ubiquitination","goEvidence":"IDA","goAspect":"biological_process","evidenceCode":"ECO:0000314","reference":"PMID:20351172","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100604","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408520","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:0110025","goName":"DNA
        strand resection involved in replication fork processing","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:29709199","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408521","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:1902042","goName":"negative
        regulation of extrinsic apoptotic signaling pathway via death domain receptors","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408522","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:2000001","goName":"regulation
        of DNA damage checkpoint","goEvidence":"NAS","goAspect":"biological_process","evidenceCode":"ECO:0005547","reference":"PMID:14636569","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250623","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408523","geneProductId":"UniProtKB:P38398","qualifier":"involved_in","goId":"GO:2000378","goName":"negative
        regulation of reactive oxygen species metabolic process","goEvidence":"IMP","goAspect":"biological_process","evidenceCode":"ECO:0000315","reference":"PMID:23415688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":[{"connectedXrefs":[{"db":"CL","id":"0002618","relation":"occurs_in"}]}],"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20140818","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408524","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0000793","goName":"condensed
        chromosome","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408525","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0000794","goName":"condensed
        nuclear chromosome","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408526","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0000800","goName":"lateral
        element","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:9774970","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"MGI","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20160830","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408527","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0001741","goName":"XY
        body","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000265","reference":"GO_REF:0000107","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Ensembl","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251226","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408528","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]},{"connectedXrefs":[{"db":"InterPro","id":"IPR011364"}]},{"connectedXrefs":[{"db":"UniProtKB-SubCell","id":"SL-0191"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408529","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:14636569","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250623","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408530","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408531","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:17643121","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408532","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0005547","reference":"PMID:18171670","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408533","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0005547","reference":"PMID:19369211","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250415","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408534","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:20160719","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20150509","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408535","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0005547","reference":"PMID:20656689","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408536","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0005547","reference":"PMID:22369660","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250807","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408537","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:26833090","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20210120","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408538","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:9342365","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"ComplexPortal","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20250320","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408539","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"GO_REF:0000052","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HPA","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251115","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408540","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000256","reference":"GO_REF:0000117","withFrom":[{"connectedXrefs":[{"db":"ARBA","id":"ARBA00026290"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408541","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-2997616","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220118","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408542","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-2997709","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20220119","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408543","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5659781","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408544","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5683385","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200923","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408545","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5683735","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408546","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5683801","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408547","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684052","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408548","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684071","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408549","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684108","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408550","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684875","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408551","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684882","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408552","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5684887","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408553","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685011","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408554","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685156","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408555","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685341","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408556","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685838","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408557","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685985","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408558","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5685994","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408559","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686410","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408560","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686440","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408561","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686469","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408562","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686483","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408563","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686642","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408564","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686657","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408565","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5686685","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408566","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5691411","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200923","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408567","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693539","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408568","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693542","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408569","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693551","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408570","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693561","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408571","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693564","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408572","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693580","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408573","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693584","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408574","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693589","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408575","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693593","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408576","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693608","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408577","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-5693620","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408578","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-6797712","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408579","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-6799332","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408580","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-69891","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408581","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9007605","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408582","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9663194","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200921","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408583","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9699163","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408584","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9700998","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408585","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9701000","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200923","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408586","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9701003","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408587","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9701199","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200929","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408588","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9704330","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408589","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9704408","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408590","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9707051","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20200923","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408591","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9709571","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408592","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9709601","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408593","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9853389","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20230123","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408594","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005654","goName":"nucleoplasm","goEvidence":"TAS","goAspect":"cellular_component","evidenceCode":"ECO:0000304","reference":"Reactome:R-HSA-9926521","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"Reactome","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130213","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408595","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005694","goName":"chromosome","goEvidence":"ISS","goAspect":"cellular_component","evidenceCode":"ECO:0000250","reference":"GO_REF:0000024","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20121024","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408596","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005694","goName":"chromosome","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]},{"connectedXrefs":[{"db":"UniProtKB-SubCell","id":"SL-0468"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408597","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005737","goName":"cytoplasm","goEvidence":"IEA","goAspect":"cellular_component","evidenceCode":"ECO:0000501","reference":"GO_REF:0000120","withFrom":[{"connectedXrefs":[{"db":"ARBA","id":"ARBA00026971"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P48754"}]},{"connectedXrefs":[{"db":"ensembl","id":"ENSMUSP00000017290"}]},{"connectedXrefs":[{"db":"UniProtKB-SubCell","id":"SL-0086"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20260105","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408598","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005737","goName":"cytoplasm","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:20160719","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20150509","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408599","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0005886","goName":"plasma
        membrane","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:21282464","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"BHF-UCL","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20110331","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408600","geneProductId":"UniProtKB:P38398","qualifier":"located_in","goId":"GO:0016604","goName":"nuclear
        body","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"GO_REF:0000052","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"HPA","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20251115","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408601","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0000151","goName":"ubiquitin
        ligase complex","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0000303","reference":"PMID:14976165","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050603","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408602","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0000931","goName":"gamma-tubulin
        ring complex","goEvidence":"NAS","goAspect":"cellular_component","evidenceCode":"ECO:0000303","reference":"PMID:12214252","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20021023","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408603","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0005634","goName":"nucleus","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:23855721","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"CACAO","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20130910","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408604","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0031436","goName":"BRCA1-BARD1
        complex","goEvidence":"IBA","goAspect":"cellular_component","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349139"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408605","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0031436","goName":"BRCA1-BARD1
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:12890688","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408606","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0031436","goName":"BRCA1-BARD1
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:15265711","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20050623","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408607","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0031436","goName":"BRCA1-BARD1
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:19117993","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100510","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408608","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0031436","goName":"BRCA1-BARD1
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:20351172","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20100602","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408609","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0032991","goName":"protein-containing
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:9774970","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20070809","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408610","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0032991","goName":"protein-containing
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:9774970","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"MGI","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20180219","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408611","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IBA","goAspect":"cellular_component","evidenceCode":"ECO:0000318","reference":"GO_REF:0000033","withFrom":[{"connectedXrefs":[{"db":"PANTHER","id":"PTN000349139"}]},{"connectedXrefs":[{"db":"UniProtKB","id":"P38398"}]}],"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"GO_Central","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20170228","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408612","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:17525340","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408613","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:17525341","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408614","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:17525342","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408615","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:19261748","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408616","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:0070531","goName":"BRCA1-A
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:19261749","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"UniProt","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20090422","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"},{"id":"UniProtKB:P38398!488408617","geneProductId":"UniProtKB:P38398","qualifier":"part_of","goId":"GO:1990904","goName":"ribonucleoprotein
        complex","goEvidence":"IDA","goAspect":"cellular_component","evidenceCode":"ECO:0000314","reference":"PMID:18809582","withFrom":null,"taxonId":9606,"taxonName":"Homo
        sapiens","assignedBy":"MGI","extensions":null,"targetSets":["BHF-UCL"],"symbol":"BRCA1","date":"20180313","synonyms":null,"name":"Breast
        cancer type 1 susceptibility protein"}],"pageInfo":{"resultsPerPage":200,"current":2,"total":2}}'
    headers:
      Access-Control-Allow-Headers:
      - Content-Type
      Access-Control-Allow-Origin:
      - '*'
      Connection:
      - Keep-Alive
      Content-Type:
      - application/json
      Date:
      - Mon, 09 Feb 2026 22:39:40 GMT
      Keep-Alive:
      - timeout=60
      Strict-Transport-Security:
      - max-age=0
      Transfer-Encoding:
      - chunked
    status:
      code: 200
      message: ''
- request:
    body: null
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://raw.githubusercontent.com/geneontology/go-site/refs/heads/master/metadata/gorefs.yaml
  response:
    body:
      string: "- id: GO_REF:0000001\n  title: OBSOLETE GO Consortium unpublished data\n
        \ description: No abstract available.\n  authors: GO Curators\n  is_obsolete:
        true\n  year: 1998\n- id: GO_REF:0000002\n  title: Gene Ontology annotation
        through association of InterPro records with GO\n    terms\n  description:
        |-\n    InterPro (http://www.ebi.ac.uk/interpro/) is an integrated resource
        from the EBI of protein families, domains and sites which are combined from
        a number \n    of different protein signature databases, including CATH-Gene3D,
        CDD, HAMAP, NCBIfam, Panther, Pfam, PIRSF, PRINTS, ProSite, SMART, and SUPERFAMILY.
        Signatures describing the same protein \n    family or domain are grouped
        into unique InterPro entries. When appropriate, the InterPro team maps InterPro
        entries to  GO terms (Molecular Function, Biological Process and/or Cellular
        Component). \n    InterPro runs InterProScan on the entire set of UniProt
        proteins. InterPro hits are assigned the corresponding GO annotations by the
        GOA pipeline. The mapping file is available at http://current.geneontology.org/ontology/external2go/interpro2go.\n
        \ comments:\n    - Note that some groups filter GO annotations based on InterPro-to-GO
        transitive assignment, e.g. to remove annotations redundant with manual curation.\n
        \ alt_id:\n    - GO_REF:0000007\n    - GO_REF:0000014\n    - GO_REF:0000016\n
        \   - GO_REF:0000017\n  authors: GO Central Curators, 2024\n  external_accession:\n
        \   - MGI:2152098\n    - J:72247\n    - ZFIN:ZDB-PUB-020724-1\n    - FB:FBrf0174215\n
        \   - dictyBase_REF:10157\n    - SGD_REF:S000124036\n  is_obsolete: false\n
        \ year: 2001\n- id: GO_REF:0000003\n  title: Gene Ontology annotation based
        on Enzyme Commission mapping\n  description: |-\n    In UniProt, proteins
        with enzymatic activities have traditionally been annotated using reference
        vocabularies such as the hierarchical enzyme classification of the Enzyme
        Nomenclature Committee of the IUBMB \n    (often referred to as Enzyme Commission
        or EC numbers; https://enzyme.expasy.org/). EC numbers are manually curated
        in Swiss-Prot ('UniProt Reviewed') entries and added automatically to \n    TrEMBL
        ('UniProt Uneviewed') entries. A mapping between EC numbers and GO Molecular
        Function terms is maintainted by GO editors. UniProt entries assigned with
        an EC number\n    with a GO mapping are automatically annotated with the correponding
        GO term, as described in PMID:30395331. GO annotations using this method receive
        the evidence code \n    Inferred from Electronic Annotation (IEA). This method
        has been evaluated at up to 100% accurate (Camon et. al. 2005). The EC2GO
        mapping file is available at\n    http://current.geneontology.org/ontology/external2go/ec2go.\n
        \ alt_id:\n    - GO_REF:0000005\n  authors: GO Central Curators, 2024\n  external_accession:\n
        \   - ZFIN:ZDB-PUB-031118-3\n    - SGD_REF:S000124037\n  citation: PMID:31688925\n
        \ is_obsolete: false\n  year: 2001\n- id: GO_REF:0000004\n  title: Gene Ontology
        annotation based on UniProtKB keyword mapping\n  description: |-\n    Transitive
        assignments using UniProtKB keywords. The UniProtKB keyword\n    controlled
        vocabulary has been created and used by the UniProt Knowledgebase\n    (UniProtKB)
        to supply 10 different categories of information to UniProtKB entries.\n    Further
        information on the UniProtKB keyword resource can be found at\n    http://www.uniprot.org/docs/keywlist.\n\n
        \   Further information on the UniProt annotation methods is available at\n
        \   https://www.uniprot.org/help/manual_curation and\n    https://www.uniprot.org/help/automatic_annotation.\n\n
        \   When a UniProtKB keyword describes a concept that is within the scope
        of the Gene\n    Ontology, it is investigated to determine whether it is appropriate
        to map the\n    keyword to an equivalent term in GO. The mapping between UniProtKB
        keywords and\n    GO terms is carried out manually. Definitions and hierarchies
        of the terms in the\n    two resources are compared and the mapping generated
        will reflect the most correct\n    correspondence. The translation table between
        GO terms and UniProtKB keywords is\n    maintained by the UniProt-GOA team
        and available at\n    http://www.geneontology.org/external2go/uniprotkb_kw2go.\n
        \ comments:\n    - Formerly GOA:spkw.\n  alt_id:\n    - GO_REF:0000009\n    -
        GO_REF:0000013\n  authors: GOA Curators\n  external_accession:\n    - MGI:1354194\n
        \   - J:60000\n    - ZFIN:ZDB-PUB-020723-1\n    - SGD_REF:S000124038\n  is_obsolete:
        false\n  year: 2000\n- id: GO_REF:0000006\n  title: OBSOLETE Gene Ontology
        annotation by the MGI curatorial staff, Mouse Locus\n    Catalog\n  description:
        |-\n    For annotations documented via this citation, curators used the information
        in\n    the Mouse Locus Catalog in MGI to assign GO terms. The GO terms were
        assigned\n    based on MLC textual descriptions of genes that could not be
        traced to the primary\n    literature. Details of this strategy can be found
        in Hill et al, Genomics (2001)\n    74:121-128.\n  authors: Mouse Genome Informatics
        Scientific Curators\n  citation: PMID:11374909\n  external_accession:\n    -
        MGI:2152097\n    - J:72246\n  is_obsolete: true\n  year: 2001\n- id: GO_REF:0000008\n
        \ title: Gene Ontology annotation by the MGI curatorial staff, curated orthology\n
        \ description: |-\n    The sequence conservation that permits the establishment
        of orthology between\n    mouse and rat or mouse and human genes is a strong
        predictor of the conservation\n    of function for the gene product across
        these species. Therefore, in instances\n    where a mouse gene product has
        not been functionally characterized, but its human\n    or rat orthologs have,
        Mouse Genome Informatics (MGI) curators append the GO terms\n    associated
        with the orthologous gene(s) to the mouse gene. Only those GO terms\n    assigned
        by experimental determination to the ortholog of the mouse gene will\n    be
        adopted by MGI. GO terms that are assigned to the ortholog of the mouse gene\n
        \   computationally (i.e. IEA), will not be transferred to the mouse ortholog.
        The\n    evidence code represented by this citation is Inferred by Sequence
        Orthology (ISO).\n  authors: Mouse Genome Informatics Scientific Curators\n
        \ external_accession:\n    - MGI:2154458\n    - J:73065\n  is_obsolete: false\n
        \ year: 2001\n- id: GO_REF:0000010\n  title: OBSOLETE Gene Ontology annotation
        by the MGI curatorial staff, mouse gene\n    nomenclature\n  description:
        |-\n    For annotations documented via this citation, curators designed queries
        based\n    on their knowledge of mouse gene nomenclature to group genes that
        shared common\n    molecular functions, biological processes or cellular components.
        GO annotations\n    were assigned to these genes in groups. Details of this
        strategy can be found\n    in Hill et al., Genomics (2001) 74:121-128.\n  authors:
        Mouse Genome Informatics Scientific Curators\n  citation: PMID:11374909\n
        \ external_accession:\n    - MGI:1347124\n    - J:56000\n  is_obsolete: true\n
        \ year: 1999\n- id: GO_REF:0000011\n  title: Hidden Markov Models (TIGR)\n
        \ description: |-\n    A Hidden Markov Model (HMM) is a statistical representation
        of patterns found\n    in a data set. When using HMMs with proteins, the HMM
        is a statistical model of\n    the patterns of the amino acids found in a
        multiple alignment of a set of proteins\n    called the \"seed\". Seed proteins
        are chosen based on sequence similarity to each\n    other. Seed members can
        be chosen with different levels of relationship to each\n    other. They can
        be members of a superfamily (ex. ABC transporter, ATP-binding\n    proteins),
        they can all share the same exact specific function (ex. biotin synthase)\n
        \   or they could share another type of relationship of intermediate specificity
        (ex.\n    subfamily, domain). New proteins can be scored against the model
        generated from\n    the seed according to how closely the patterns of amino
        acids in the new proteins\n    match those in the seed. There are two scores
        assigned to the HMM which allow\n    annotators to judge how well any new
        protein scores to the model. Proteins scoring\n    above the \"trusted cutoff\"
        score can be assumed to be part of the group defined\n    by the seed. Proteins
        scoring below the \"noise cutoff\" score can be assumed to\n    NOT be a part
        of the group. Proteins scoring between the trusted and noise cutoffs\n    may
        be part of the group but may not. One of the important features of HMMs is\n
        \   that they are built from a multiple alignment of protein sequences, not
        a pairwise\n    alignment. This is significant, since shared similarity between
        many proteins\n    is much more likely to indicate shared functional relationship
        than sequence similarity\n    between just two proteins. The usefulness of
        an HMM is directly related to the\n    amount of care that is taken in chosing
        the seed members, building a good multiple\n    alignment of the seed members,
        assessing the level of specificity of the model,\n    and choosing the cutoff
        scores correctly. In order to properly assess what functional\n    relevance
        an above-trusted scoring HMM match has to a query, one must carefully\n    determine
        what the functional scope of the HMM is. If the HMM models proteins\n    that
        all share the same function then it is likely possible to assign a specific\n
        \   function to high-scoring match proteins based on the HMM. If the HMM models
        proteins\n    that have a wide variety of functions, then it will not be possible
        to assign\n    a specific function to the query based on the HMM match, however,
        depending on\n    the nature of the HMM in question, it may be possible to
        assign a more general\n    (family or subfamily level) function. In order
        to determine the functional scope\n    of an HMM, one must carefully read
        the documentation associated with the HMM.\n    The annotator must also consider
        whether the function attributed to the proteins\n    in the HMM makes sense
        for the query based on what is known about the organism\n    in which the
        query protein resides and in light of any other information that\n    might
        be available about the query protein. After carefully considering all of\n
        \   these issues the annotator makes an annotation.\n  authors: Michelle Gwinn,
        TIGR Curators\n  is_obsolete: false\n  year: 2003\n- id: GO_REF:0000012\n
        \ title: Pairwise alignment (TIGR)\n  description: |-\n    Pairwise alignments
        are generated by taking two sequences and aligning them so\n    that the maximum
        number of amino acids in each protein match, or are similar to,\n    each
        other. Tools such as BLAST work by comparing a protein-of-interest individually\n
        \   with every protein in a database of known protein sequences and retaining
        only\n    those matches with a high probability of being significant. Basic
        BLAST generates\n    local alignments between proteins for regions of high
        similarity. Other pairwise\n    alignment tools attempt to generate global
        (full-length) protein alignments. A\n    tool called Blast_Extend_repraze
        (BER, http://ber.sourceforge.net) has some benefits\n    over basic BLAST.
        Input into the BER tool includes the underlying DNA sequence\n    for each
        protein as well as 300 nucleotides upstream and downstream of the predicted\n
        \   boundaries of the protein coding sequence. This allows annotators to see
        the DNA\n    sequence that underlies the query protein as part of the alignment.
        In addition,\n    the BER tool is able to look for continuation of regions
        of similarity through\n    frameshifts and in-frame stop codons.  If such
        regions are found the alignment\n    is continued. BER searches are done in
        a two-step process: step one is a BLAST\n    search against a non-redundant
        protein database, significant BLAST hits are stored\n    in a mini-database
        for each query protein; step two is a modified Smith-Waterman\n    alignment
        between the query and the proteins in its mini-database. In order to\n    assess
        whether a given BER alignment is good enough to assert that the query shares\n
        \   the function of the match protein, one must look at a several factors.
        First of\n    all, the match protein must itself be experimentally characterized
        in order to\n    avoid transitive annotation errors. In addition, any residues
        or secondary structures\n    known to be important for function in the match
        protein must be conserved in the\n    query. The alignment should be visually
        inspected to look for any areas of lesser\n    quality that might indicate
        the two proteins do not share the same function. Although\n    it is impossible
        to set cutoff values for percent identity and length of match\n    that will
        apply for every alignment, there are some guidelines. In general at\n    least
        40% identity that extends over the full lengths of both proteins is required\n
        \   in order to even consider functional equivalence. However, this percentage
        is\n    highly dependent on the length and complexity of the proteins. 40%
        identity between\n    two proteins 500 amino acids long is much more significant
        that 40% identity between\n    two proteins that are only 100 amino acids
        long. Therefore, the annotator's experience\n    and knowledge of what is
        considered significant for the organism and protein family\n    in question
        is very important. Some sets of proteins are much more highly conserved\n
        \   than others and therefore tolerances for percent identity may have to
        be adjusted.\n    Finally, the alignment must be considered in the context
        of what else is known\n    about the query protein and the organism as a whole.\n
        \ authors: Michelle Gwinn, TIGR Curators\n  is_obsolete: false\n  year: 2003\n-
        id: GO_REF:0000015\n  title: Use of the ND evidence code for Gene Ontology
        (GO) terms\n  description: |-\n    Direct annotations to any of the three
        root terms 'molecular function; GO:0003674',\n    'biological process; GO:0008150'
        or 'cellular component; GO:0005575' indicate\n    that curators have found
        no data supporting an annotation to a more specific term,\n    either in the
        literature and/or by sequence similarity for this gene or protein\n    as
        of the date of the annotation.\n  authors: GO Curators\n  external_accession:\n
        \   - ECO:0000307\n    - AspGD_REF:ASPL0000111607\n    - CGD_REF:CAL0125086\n
        \   - dictyBase_REF:2\n    - dictyBase_REF:9851\n    - FB:FBrf0159398\n    -
        MGI:MGI:2156816\n    - RGD:1598407\n    - SGD_REF:S000069584\n    - TAIR:Communication:1345790\n
        \   - ZFIN:ZDB-PUB-031118-1\n    - GO_REF:nd\n  is_obsolete: false\n  year:
        2002\n- id: GO_REF:0000018\n  title: OBSOLETE dictyBase 'Inferred from Electronic
        Annotation (BLAST method)'\n  description: |-\n    Gene Ontology (GO) annotations
        with the evidence code 'Inferred from Electronic\n    Annotation' (IEA) are
        assigned automatically to gene products in dictyBase. All\n    Dictyostelium
        protein sequences are analyzed by BLAST against GO gene association\n    sequence
        files, identifying proteins in other organisms that align with Dictyostelium\n
        \   proteins with an E value less than or equal to e-50. GO annotations that
        have\n    been manually assigned to these proteins from other species are
        then imported\n    and attached to the corresponding gene product in dictyBase.
        The proteins from\n    which the annotations are derived are displayed in
        the 'Evidence' column on the\n    Gene Ontology evidence and references page.\n
        \ authors: DictyBase Curators\n  external_accession:\n    - dictyBase_REF:10158\n
        \ is_obsolete: true\n  year: 2005\n- id: GO_REF:0000019\n  title: OBSOLETE
        Automatic transfer of experimentally verified manual GO annotation\n    data
        to orthologs using Ensembl Compara\n  description: |-\n    GO terms from a
        source species are projected on to one or more target species\n    based on
        gene orthology obtained from the Ensembl Compara system. Only one to\n    one
        and apparent one to one orthologies are used for a restricted range of species.\n
        \   Only GO annotations with a manual experimental evidence type of IDA, IEP,
        IGI,\n    IMP or IPI are projected. Projected GO annotations using this technique
        will receive\n    the evidence code, inferred from electronic annotation,
        'IEA'. The Ensembl protein\n    identifier of the annotation source is indicated
        in the 'With' column of the GOA\n    association file.\n  authors: Ensembl
        Curators, GOA Curators\n  is_obsolete: true\n  year: 2006\n- id: GO_REF:0000020\n
        \ title: OBSOLETE Electronic Gene Ontology annotations created by transferring
        manual\n    GO annotations between orthologous microbial proteins\n  description:
        |-\n    GO terms are manually assigned to each HAMAP family rule. High-quality
        Automated\n    and Manual Annotation of microbial Proteins (HAMAP) family
        rules are a collection\n    of orthologous microbial protein families, from
        bacteria, archaea and plastids,\n    generated manually by expert curators.
        The assigned GO terms are then transferred\n    to all the proteins that belong
        to each HAMAP family. Only GO terms from the molecular\n    function and biological
        process ontologies are assigned. GO annotations using\n    this technique
        will receive the evidence code Inferred from Electronic Annotation\n    (IEA).
        These annotations are updated monthly by HAMAP and are available for download\n
        \   on both GO and GOA EBI ftp sites. To report an annotation error or inconsistency,\n
        \   or for further information, please contact the GO Consortium at help@geneontology.org\n
        \   or submit a comment the SourceForge Annotation Issues tracker\n    (http://sourceforge.net/projects/geneontology/).
        HAMAP is a project based at the Swiss\n    Institute of Bioinformatics (Gattiker
        et al. 2003, Comp. Biol and Chem. 27: 49-58).\n    For further information,
        please see http://www.expasy.org/sprot/hamap/.\n  authors: Swiss Institute
        of Bioinformatics (SIB) Curators, GOA Curators\n  is_obsolete: true\n  year:
        2006\n- id: GO_REF:0000021\n  title: Improving the representation of central
        nervous system development in the\n    biological process ontology\n  description:
        |-\n    Current genetic and molecular studies in many model organisms are
        aimed at understanding\n    formation and development of the nervous system.
        Up until this point, the GO has\n    had a very shallow representation of
        processes pertaining to the nervous system.\n    In June 2006, curators from
        MGI and ZFIN met with researchers studying central\n    nervous system development
        to improve the representation of these processes in\n    GO. In particular,
        emphasis was placed on three areas that are being addressed\n    actively
        in current research: forebrain development, hindbrain development and\n    neural
        tube development. This collaboration resulted in the addition of over 500\n
        \   terms that reflect the development of the forebrain, the hindbrain, and
        the neural\n    tube from the perspective of biological process and anatomical
        structure.\n  authors: Judith Blake (1, 2), William Bug (3), Rex Chisholm
        (1, 4), Jennifer Clark (1,\n    5), Erika Feltrin (6), Jacqueline Finger (2),
        David Hill (1, 2), Midori Harris\n    (1, 5), Terry Hayamizu (2), Doug Howe
        (9), Maryanne Martone (7), Kathleen Millen\n    (8), Francis Sele (4) (1.
        The Gene Ontology Consortium, 2. Mouse Genome Informatics,\n    Bar Harbor,
        ME, 3. Drexel University, Philadelphia, PA, 4. Northwestern University,\n
        \   Chicago, IL, 5. EMBL-EBI, Hinxton, Cambridgeshire, UK, 6. The University
        of Padua,\n    Padua, Italy, 7. The University of California at San Diego,
        San Diego, CA, 8.\n    The University of Chicago, Chicago, IL, 9. The Zebrafish
        Information Network,\n    University of Oregon, Eugene, OR)\n  is_obsolete:
        false\n  year: 2006\n- id: GO_REF:0000022\n  title: Improving the representation
        of immunology in the biological process Ontology\n  description: |-\n    GO
        terms describing processes, functions, and cellular components related to
        the\n    immune system have existed in the GO from its beginning and been
        used extensively\n    in the annotation of gene products. However, particularly
        in the biological process\n    ontology, the initial set of terms relating
        to immunology failed to cover the\n    breadth of known immunological processes,
        and in many cases diverged from current\n    usage and understanding in their
        names, definitions, and ontological placement.\n    As part of a larger effort
        to improve the representation of immunology in the\n    GO, a GO Content Meeting
        was held November 15-16, 2005, at The Institute for Genomic\n    Research,
        to discuss improvements to representation of immunology in the biological\n
        \   process ontology of the GO. As a result of the meeting, a number of high
        level\n    terms for immunological processes were created, an overall structure
        for immunologically\n    related terms was established, and certain existing
        terms were renamed or redefined\n    as well to bring them in line with current
        usage.\n  authors: Alison Deckhut Augustine (1), Alan Collmer (2), Judith
        A. Blake (3, 4), Candace\n    W. Collmer (2, 3), Shane C. Burgess (5), Lindsay
        Grey Cowell (6), Jennifer I.\n    Clark (3, 7), Bernard de Bono (7), Russell
        T. Collins (8), Alexander D. Diehl\n    (3, 4), Michelle Gwinn Giglio (3,
        9), Jamie A. Lee (10), Linda Hannick (3, 9),\n    Jane Lomax (3, 7), Midori
        A. Harris (3, 7), Christopher J. Mungall (3, 11), David\n    P. Hill (3, 4),
        Richard H. Scheuermann (10), Amelia Ireland (3, 7), Alessandro\n    Sette
        (12) (1. NIAID, 2. Cornell University, 3. The GO Consortium, 4. Mouse Genome\n
        \   Informatics, 5. Mississippi State University, 6. Duke University, 7. EMBL-EBI,\n
        \   8. University of Cambridge, 9. The Institute for Genomic Research, 10.
        U.T. Southwestern\n    Medical Center, 11. HHMI, 12. La Jolla Institute for
        Allergy and Immunology)\n  is_obsolete: false\n  year: 2005\n- id: GO_REF:0000023\n
        \ title: Gene Ontology annotation based on UniProtKB Subcellular Location
        vocabulary\n    mapping\n  description: |-\n    Transitive assignment of GO
        terms based on the UniProtKB Subcellular Location\n    vocabulary. UniProtKB
        Subcellular Location is a controlled vocabulary used to\n    supply subcellular
        location information to UniProtKB entries in the SUBCELLULAR\n    LOCATION
        lines. Terms from this vocabulary are annotated manually to UniProtKB/Swiss-Prot\n
        \   entries but  are automatically assigned to UniProtKB/TrEMBL entries from
        the underlying\n    nucleic acid databases and/or by the UniProt automatic
        annotation program.\n\n    Further information on these two different annotation
        methods is available at\n    http://www.uniprot.org/faq/45 and\n    http://www.uniprot.org/program/automatic_annotation.\n\n
        \   When a UniProtKB Subcellular Location term describes a concept that is
        within\n    the scope of the Gene Ontology, it is investigated to determine
        whether it is\n    appropriate to map the term to an equivalent term in GO.
        The mapping between UniProtKB\n    Subcellular Location terms and GO terms
        is carried out manually. Definitions and\n    hierarchies of the terms in
        the two resources are compared and the mapping generated\n    will reflect
        the most correct correspondence. The translation table between GO\n    terms
        and UniProtKB Subcellular Location term is maintained by the UniProt-GOA\n
        \   team and available at http://www.geneontology.org/external2go/spsl2go.\n
        \ authors: GOA Curators, UniProt Curators\n  external_accession:\n    - SGD_REF:S000125578\n
        \ is_obsolete: true\n  year: 2007\n- id: GO_REF:0000024\n  title: Manual transfer
        of experimentally-verified manual GO annotation data to orthologs\n    by
        curator judgment of sequence similarity\n  description: |-\n    Method for
        transferring manual annotations to an entry based on a curator's judgment\n
        \   of its similarity to a putative ortholog that has annotations that are
        supported\n    with experimental evidence. Annotations are created when a
        curator judges that\n    the sequence of a protein shows high similarity to
        another protein that has annotation(s)\n    supported by experimental evidence
        (and therefore display one of the evidence\n    codes EXP, IDA, IGI, IMP,
        IPI or IEP). Annotations resulting from the transfer\n    of GO terms display
        the 'ISS' evidence code and include an accession for the protein\n    from
        which the annotation was projected in the 'with' field (column 8). This field\n
        \   can contain either a UniProtKB accession or an IPI (International Protein
        Index)\n    identifier. Only annotations with an experimental evidence code
        and which do not\n    have the 'NOT' qualifier are transferred. Putative orthologs
        are chosen using\n    information combined from a variety of complementary
        sources. Potential orthologs\n    are initially identified using sequence
        similarity search programs such as BLAST.\n    Orthology relationships are
        then verified manually using a combination of resources\n    including sequence
        analysis tools, phylogenetic and comparative genomics databases\n    such
        as Ensembl Compara, INPARANOID and OrthoMCL, as well as other specialised\n
        \   databases such as species-specific collections (e.g. HGNC's HCOP). In
        all cases\n    curators check each alignment and use their experience to assess
        whether similarity\n    is considered to be strong enough to infer that the
        two proteins have a common\n    function so that they can confidently project
        an annotation. While there is no\n    fixed cut-off point in percentage sequence
        similarity, generally proteins which\n    have greater than 30% identity that
        covers greater than 80% of the length of both\n    proteins are examined further.
        For mammalian proteins this cut-off tends to be\n    higher, with an average
        of 80% identity over 90% of the length of both proteins.\n    Strict orthologs
        are desirable but not essential. In general, when there is evidence\n    of
        multiple paralogs for a single species, annotations using less specific GO\n
        \   terms are transferred to the paralogs, however, annotations using more
        specific\n    GO terms may be transferred to the most similar paralog in each
        species, this\n    decision is taken on a case by case basis and may be influenced
        by statements\n    by researchers in the field. Further detailed information
        on this procedure, including\n    how ISS annotations are made to protein
        isoforms, can be found at:\n    https://wiki.geneontology.org/Inferred_from_Sequence_or_structural_Similarity_(ISS).\n
        \ authors: AgBase, BHF-UCL, Parkinson's UK-UCL, dictyBase, HGNC, Roslin Institute,\n
        \   FlyBase and UniProtKB Curators\n  external_accession:\n    - dictyBase_REF:9\n
        \   - J:342587\n    - FB:FBrf0255270\n    - SGD_REF:S000250423\n    - ZFIN:ZDB-PUB-110105-1\n
        \   - ZFIN:ZDB-PUB-040216-1\n    - ZFIN:ZDB-PUB-071010-1\n  is_obsolete: false\n
        \ year: 2011\n- id: GO_REF:0000025\n  title: DEPRECATED Operon structure as
        IGC evidence\n  description: |-\n    Genes in prokaryotic organisms are often
        arranged in operons. Genes in an operon\n    are all transcribed into one
        mRNA. Generally the genes in the operons code for\n    proteins that all have
        related functions. For example, they may be the steps in\n    a biochemical
        pathway, or they may be the subunits of a protein complex. Often\n    the
        genes in operons shared between organisms are syntenic; that is, the same\n
        \   genes are in the same order in the operon in different species. When assessing\n
        \   sequence-comparison-based evidence during the process of manual annotation
        of\n    a genome, it is often the case that some of the genes in the operon
        will have\n    strong sequence-based evidence while others will have weak
        evidence. If seen alone,\n    not in the presence of an operon, the weak evidence
        in question may not be sufficient\n    to make a functional annotation. However,
        in the presence of an operon in which\n    there is strong evidence for some
        of the genes, the very presence of the gene\n    in the operon is a strong
        indication that the gene shares in the process carried\n    out by the operon.
        If the putative function is one expected to exist for the process\n    in
        question and particularly if that function has been observed in the same operon\n
        \   in another species, then the annotation should be made. This type of evidence\n
        \   is inferred from the context of the gene in an operon, and therefore the
        evidence\n    code is IGC \"inferred from genomic context.\"\n  authors: Michelle
        Gwinn, TIGR Curators\n  is_obsolete: true\n  year: 2007\n- id: GO_REF:0000026\n
        \ title: OBSOLETE Improving the representation of muscle biology in the biological\n
        \   process and cellular component ontologies\n  description: |-\n    A meeting
        focused on the biology of skeletal and smooth muscle has been held on\n    24-25
        July 2007 at the University of Padua, Italy, as a collaboration with the\n
        \   GO consortium and CRIBI Biotechnology Center. The aims of this effort
        were to\n    provide a comprehensive representation of muscle biology in the
        biological process\n    and cellular component ontologies and to improve the
        organization of muscle-specific\n    terms to better describe the current
        knowledge of biological mechanisms in muscle\n    tissue. Thus, the collaboration
        brought together experts in several areas of muscle\n    biology and physiology
        who carried out a thorough review of the existing GO muscle\n    terms as
        these terms were largely created by non-muscle experts using older definitions.\n
        \   In particular, several areas are being addressed actively in current research:\n
        \   the biological processes of muscle contraction, muscle plasticity, muscle
        development,\n    and muscle regeneration; and the sarcoplasmic reticulum
        and membrane delimited\n    compartments. This work resulted in the addition
        of 159 new terms and in the modification\n    of 57 terms to bring them in
        line with current usage. Funding for the meeting\n    was provided by Italian
        Telethon Foundation.\n  authors: Jennifer Deegan nee Clark (1, 5), Alexander
        D. Diehl (1,7), Elisabeth Ehler (2),\n    Georgine Faulkner (3), Erika Feltrin
        (4), Jennifer Fordham (2), Midori Harris\n    (1, 5), Ralph Knoell (6) David
        Hill (1, 7), Paolo Laveder (8), Alessandra Nori\n    (8), Carlo Reggiani (8),
        Vincenzo Sorrentino (9), Giorgio Valle (4), Pompeo Volpe\n    (8) (1. The
        Gene Ontology Consortium, 2. King's College, London, UK, 3. ICGEB,\n    Trieste,
        Italy, 4. CRIBI - University of Padua, Padua, Italy 5. EMBL-EBI, Hinxton,\n
        \   Cambridgeshire, UK, 6. University of Goettingen, Goettingen, Germany 7.
        Mouse\n    Genome Informatics, Bar Harbor, ME, 8. University of Padua, Padua,
        Italy, 9. University\n    of Siena, Siena, Italy)\n  citation: PMID:19178689\n
        \ is_obsolete: true\n  year: 2007\n- id: GO_REF:0000027\n  title: BLAST search
        criteria for ISS assignment in PAMGO_GAT\n  description: |-\n    This GO reference
        describes the criteria used in assigning the evidence code of\n    ISS via
        BLAST searches to annotate gene products from PAMGO_GAT. Standard BLASTP\n
        \   from NCBI was used (http://www.ncbi.nih.gov/blast) to query the non-redundant\n
        \   (NR) database. Hits are considered to be significant if the E-value is
        at or less\n    than 10^-4. All other parameters are default according to
        http://www.ncbi.nih.gov/blast.\n  authors: PAMGO_GAT Curators\n  year: 2007\n
        \ is_obsolete: false\n- id: GO_REF:0000028\n  title: DEPRECATED Criteria for
        IDA, IEP, ISS, IGC, RCA, and IEA assignment in PAMGO_MGG\n  description: |-\n
        \   This GO reference describes the criteria used in assigning the evidence
        codes\n    of IDA (ECO:0000314), IEP (ECO:0000270), ISS (ECO:0000250), IGC
        (ECO_0000317),\n    RCA (ECO:0000245) and IEA (ECO:0000501) to annotate gene
        products from PAMGO_MGG.\n    Standard BLASTP from NCBI was used (http://www.ncbi.nih.gov/blast)
        to iteratively\n    search reciprocal best hits and thus identify orthologs
        between predicted proteins\n    of Magnaporthe grisea and GO proteins from
        multiple organisms with published association\n    to GO terms. The alignments
        were manually reviewed for those hits with e-value\n    equal to zero and
        with 80% or better coverage of both query and subject sequences,\n    and
        for those hits with e<=10^-20, pid >=35 and sequence coverage >=80%. Furthermore,\n
        \   experimental or reviewed data from literature and other sources were incorporated\n
        \   into the GO annotation. IDA was assigned to an annotation if normal function
        of\n    its gene was determined through transfections into a cell line and
        overexpression.\n    IEP was assigned to an annotation if according to microarray
        experiments, its\n    gene was upregulated in a biological process and the
        fold change was equal to\n    or bigger than 10, or if according to Massively
        Parallel Signature Sequencing\n    (MPSS), its gene was upregulated only in
        a certain biological process and the\n    fold change was equal to or bigger
        than 10. ISS was assigned to an annotation\n    if the entry at the With_column
        was experimentally characterized and the pairwise\n    alignments were manually
        reviewed. IGC was assigned to an annotation if it based\n    on comparison
        and analysis of gene location and structure, clustering of genes,\n    and
        phylogenetic reconstruction of these genes. RCA was assigned to an annotation\n
        \   if it based on integrated computational analysis of whole genome microarray
        data,\n    and matches to InterPro, pfam, and COG etc. IEA was assigned to
        an annotation\n    if its function assignment based on computational work,
        and no manual review was\n    done.\n  authors: PAMGO_MGG Curators\n  is_obsolete:
        true\n  year: 2008\n- id: GO_REF:0000029\n  title: OBSOLETE Gene Ontology
        annotation based on information extracted from curated\n    UniProtKB entries\n
        \ description: |-\n    Active 2001-2007.\n\n    Method by which GO terms were
        manually assigned to UniProt KnowledgeBase accessions,\n    using either a
        NAS or TAS evidence code, by applying information extracted from\n    the
        corresponding publicly-available, manually curated UniProtKB entry. Such GO\n
        \   annotations were submitted by the GOA-UniProt group from 2001, but this
        annotation\n    practice was discontinued in 2007.\n  authors: GOA-UniProt
        Curators\n  is_obsolete: true\n  year: 2007\n- id: GO_REF:0000030\n  title:
        OBSOLETE Portable Annotation Rules\n  description: |-\n    The JCVI is developing
        a collection of mixed-evidence annotation rules, under\n    the working name
        BrainGrab/RuleBase (BGRB). A rule has two parts. The first is\n    the set
        of conditions that must be met for the rule to fire. The second is the\n    set
        actions to be taken for rules that have fired. BGRB rules are designed to\n
        \   serve as proxies for the annotators that create them. They have very high
        fidelity\n    but may have low coverage. Types of evidence used in combination
        include HMM hits\n    and BLAST matches, hits to neighboring genes, pathway
        reconstruction reports from\n    the Genome Properties system, and species
        taxonomy. BLAST matches are described\n    by a number of separate parameters
        for raw score, percent sequence identity, and\n    coverage of total sequence
        length by the match region. These parameters are customized\n    for each
        protein family in order to achieve high fidelity in automated annotation\n
        \   systems. The flexible syntax makes it possible to use existing protein
        family\n    classifiers, such as Pfam and TIGRFAMs HMMs, in new ways. It is
        especially useful\n    in assigning GO terms to proteins such as SelD (selenide,
        water dikinase) that\n    have different roles in different contexts.\n  authors:
        Daniel Haft, JCVI\n  year: 2008\n  is_obsolete: true\n- id: GO_REF:0000031\n
        \ title: OBSOLETE NIAID Cell Ontology Workshop\n  description: |-\n    The
        NIAID sponsored a Cell Ontology Workshop, May 13-14, 2008, in Bethesda, focusing\n
        \   on improving representation of immune cell types in the Cell Ontology.
        The participants\n    in the workshop worked together to extend the current
        ontology in the area of\n    immune cell types and to provide the necessary
        information for the upcoming restructuring\n    of the Cell Ontology in single-inheritance
        form with genus-differentia definitions.\n  authors: Alexander D. Diehl, Alison
        Deckhut Augustine, Judith A. Blake, Lindsay G. Cowell,\n    Elizabeth S. Gold,
        Timothy A. Gondre-Lewis, Anna Maria Masci, Terrence F. Meehan,\n    Penelope
        A. Morel, Anastasia Nijnik, Bjoern Peters, Bali Pulendran, Richard H.\n    Scheuermann,
        Q. Alison Yao, Martin S. Zand, Christopher J. Mungall\n  url: http://www.bioontology.org/wiki/index.php/NIAID_Cell_Ontology_Workshop_May_2008\n
        \ year: 2008\n  is_obsolete: true\n- id: GO_REF:0000032\n  title: OBSOLETE
        Inference of Biological Process annotations from inter-ontology\n    links\n
        \ description: |-\n    We use the GOBO library to propagate annotations from
        Molecular Function to Biological\n    Process. This results in both increased
        numbers of annotations, and increased\n    consistency between curators.\n\n
        \   Duplicate of GO_REF:0000108.\n  authors: Christopher J. Mungall, Tanya
        Z. Berardini, David P. Hill\n  is_obsolete: true\n  url: http://wiki.geneontology.org/index.php/GAF_Inference\n-
        id: GO_REF:0000033\n  title: Annotation inferences using phylogenetic trees\n
        \ description: |-\n    The Phylogenetic ANnotation using Gene Ontology (PAN-GO)
        method annotates evolutionary\n    trees from the PANTHER database with GO
        terms describing molecular function, biological\n    process and cellular
        component. The GO terms are manually selected by a curator\n    and used to
        annotate ancestral genes in the phylogenetic tree using the evidence\n    code
        IBA (Inferred from Biological Ancestor). All supporting annotations must\n
        \   be based on experimental data from the scientific literature. The PAN-GO
        annotations\n    are fully traceable from the data in the 'with/from' column
        of the annotation,\n    which provides the PANTHER node ID (PTN) from which
        the annotation is derived,\n    as well as all descendants sequences that
        support the annotation of the ancestral\n    node.\n\n    The full method
        is described in PMID:21873635.\n  authors: Marc Feuermann, Huaiyu Mi, Pascale
        Gaudet, Dustin Ebert, Anushya Muruganujan,\n    Paul Thomas\n  external_accession:\n
        \   - SGD_REF:S000185201\n    - TAIR:Communication:501741973\n    - MGI:MGI:4459044\n
        \   - J:161428\n    - ZFIN:ZDB-PUB-110330-1\n    - FB:FBrf0258542\n  is_obsolete:
        false\n  url: https://wiki.geneontology.org/Phylogenetic_Annotation_Project\n
        \ year: 2010\n- id: GO_REF:0000034\n  title: Phenoscape Skeletal Anatomy Jamboree\n
        \ description: |-\n    Skeletal cell terms and relationships were added and
        revised at the Skeletal Anatomy\n    Jamboree held by Phenoscape (NSF grant
        BDI-0641025) and hosted by the National\n    Evolutionary Synthesis Center
        (NESCent), April 9-10, 2010.\n  authors: Brian K. Hall (Dalhousie University),
        Matthew Vickaryous (Ontario Veterinary College,\n    University of Guelph),
        David Blackburn, University of Kansas; Wasila Dahdul, University\n    of South
        Dakota and NESCent; Alexander Diehl, Mouse Genome Informatics (MGI);\n    Melissa
        Haendel, Oregon Health Sciences University; John G. Lundberg, Department\n
        \   of Ichthyology, Academy of Natural Sciences, Philadelphia; Paula Mabee,
        Department\n    of Biology, University of South Dakota; Martin Ringwald, Mouse
        Genome Informatics\n    (MGI); Erik Segerdell, Oregon Health Sciences University;
        Ceri Van Slyke, Zebrafish\n    Information Network (ZFIN); Monte Westerfield,
        Zebrafish Information Network (ZFIN)\n    and Institute of Neuroscience, University
        of Oregon\n  year: 2010\n- id: GO_REF:0000035\n  title: OBSOLETE Automatic
        transfer of experimentally verified manual GO annotation\n    data to plant
        orthologs using Ensembl Compara\n  description: |-\n    GO terms from a source
        species are projected onto one or more target species based\n    on gene orthology
        obtained from the Ensembl Compara system. One to one, one to\n    many and
        many to many orthologies are used but annotations are only projected\n    between
        orthologs that have at least a 40% peptide identity to each other. Only\n
        \   GO annotations with an evidence type of IDA, IEP, IGI, IMP or IPI are
        projected,\n    no annotations with a 'NOT' qualifier are projected and annotations
        to the GO:0005515\n    protein binding term are not projected. Projected GO
        annotations using this technique\n    will receive the evidence code Inferred
        from Electronic Annotation (IEA). The\n    model organism database identifier
        of the annotation source will be indicated\n    in the 'With' column of the
        GOA association file.\n\n    Duplicate of GO_REF:0000107.\n  authors: Ensembl,
        GRAMENE, GOA Curators\n  is_obsolete: true\n  year: 2011\n- id: GO_REF:0000036\n
        \ title: Manual annotations that require more than one source of functional
        data to\n    support the assignment of the associated GO term\n  description:
        |-\n    The Gene Ontology Consortium uses the IC (Inferred by Curator) evidence
        code when\n    an annotation cannot be supported by any direct evidence, but
        can be inferred\n    by GO annotations that have been annotated to the same
        gene/gene product identifier\n    in conjunction with the curator's knowledge
        of biology (supporting GO annotations\n    must not be IC-evidenced). In many
        cases an IC-evidenced annotation simply applies\n    the same reference that
        was used in the supporting GO annotation.  The use of\n    IC evidence code
        in an annotation with reference GO_REF:0000036 signifies a curator\n    inferred
        the GO term based on evidence from multiple sources of evidence/GO annotations.\n
        \   The 'with/from' field in these annotations will therefore supply more
        than one\n    GO identifier, obtained from the set of supporting GO annotations
        assigned to\n    the same gene/gene product identifier which cite publicly-available
        references.\n  authors: GO Annotation working group\n  external_accession:\n
        \   - SGD_REF:S000147045\n    - J:342596\n  year: 2011\n- id: GO_REF:0000037\n
        \ title: OBSOLETE Gene Ontology annotation based on manual assignment of UniProtKB\n
        \   keywords in UniProtKB/Swiss-Prot entries\n  description: |-\n    Transitive
        assignments using UniProtKB keywords. The UniProtKB keyword controlled\n    vocabulary
        has been created and used by the UniProt Knowledgebase (UniProtKB)\n    to
        supply 10 different categories of information to UniProtKB entries. Further\n
        \   information on the UniProtKB keyword resource can be found at\n    http://www.uniprot.org/docs/keywlist.
        UniProtKB keywords are manually applied to\n    UniProtKB/Swiss-Prot entries
        by UniProt curators. Further information on the\n    UniProtKB manual annotation
        process is available at http://www.uniprot.org/faq/45.\n\n    When a UniProtKB
        keyword describes a concept that is within the scope of the Gene\n    Ontology,
        it is investigated to determine whether it is appropriate to map the\n    keyword
        to an equivalent term in GO. The mapping between UniProtKB keywords and\n
        \   GO terms is carried out manually. Definitions and hierarchies of the terms
        in\n    the two resources are compared and the mapping generated will reflect
        the most\n    correct correspondence. The translation table between GO terms
        and UniProtKB keywords\n    is maintained by the UniProt-GOA team and available
        at\n    http://www.geneontology.org/external2go/uniprotkb_kw2go.\n\n    Duplicate
        of GO_REF:0000043.\n  authors: UniProt-GOA\n  is_obsolete: true\n  year: 2011\n
        \ evidence_codes:\n    - ECO:0000501\n- id: GO_REF:0000038\n  title: OBSOLETE
        Gene Ontology annotation based on automatic assignment of UniProtKB\n    keywords
        in UniProtKB/TrEMBL entries\n  description: |-\n    Transitive assignments
        using UniProtKB keywords. The UniProtKB keyword controlled\n    vocabulary
        has been created and used by the UniProt Knowledgebase (UniProtKB)\n    to
        supply 10 different categories of information to UniProtKB entries. Further\n
        \   information on the UniProtKB keyword resource can be found at\n    http://www.uniprot.org/docs/keywlist.
        UniProtKB keywords are automatically assigned\n    to UniProtKB/TrEMBL entries
        from the underlying nucleic acid databases and/or by\n    the UniProt automatic
        annotation program. Further information on the prediction\n    systems applied
        by UniProt is available here:\n    http://www.uniprot.org/program/automatic_annotation.\n\n
        \   When a UniProtKB keyword describes a concept that is within the scope
        of the Gene\n    Ontology, it is investigated to determine whether it is appropriate
        to map the\n    keyword to an equivalent term in GO. The mapping between UniProtKB
        keywords and\n    GO terms is carried out manually. Definitions and hierarchies
        of the terms in\n    the two resources are compared and the mapping generated
        will reflect the most\n    correct correspondence. The translation table between
        GO terms and UniProtKB keywords\n    is maintained by the UniProt-GOA team
        and available at\n    http://www.geneontology.org/external2go/uniprotkb_kw2go.\n\n
        \   Duplicate of GO_REF:0000043.\n  authors: UniProt-GOA\n  is_obsolete: true\n
        \ year: 2011\n- id: GO_REF:0000039\n  title: OBSOLETE Gene Ontology annotation
        based on the manual assignment of UniProtKB\n    Subcellular Location terms
        in UniProtKB/Swiss-Prot entries\n  description: |-\n    Transitive assignment
        of GO terms based on the UniProtKB Subcellular Location\n    vocabulary. UniProtKB
        Subcellular Location is a controlled vocabulary used to\n    supply subcellular
        location information to UniProtKB entries in the SUBCELLULAR\n    LOCATION
        lines. Terms from this vocabulary are annotated manually to UniProtKB/Swiss-Prot\n
        \   entries. Further information on the UniProtKB manual annotation method
        is available\n    at http://www.uniprot.org/faq/45.\n\n    When a UniProtKB
        Subcellular Location term describes a concept that is within\n    the scope
        of the Gene Ontology, it is investigated to determine whether it is\n    appropriate
        to map the term to an equivalent term in GO. The mapping between UniProtKB\n
        \   Subcellular Location terms and GO terms is carried out manually. Definitions
        and\n    hierarchies of the terms in the two resources are compared and the
        mapping generated\n    will reflect the most correct correspondence. The translation
        table between GO\n    terms and UniProtKB Subcellular Location terms is maintained
        by the UniProt-GOA\n    team and available at http://www.geneontology.org/external2go/spsl2go.\n
        \ authors: UniProt-GOA\n  is_obsolete: true\n  year: 2011\n- id: GO_REF:0000040\n
        \ title: OBSOLETE Gene Ontology annotation based on the automatic assignment
        of UniProtKB\n    Subcellular Location terms in UniProtKB/TrEMBL entries\n
        \ description: |-\n    Transitive assignment of GO terms based on the UniProtKB
        Subcellular Location\n    vocabulary. UniProtKB Subcellular Location is a
        controlled vocabulary used to\n    supply subcellular location information
        to UniProtKB entries in the SUBCELLULAR\n    LOCATION lines. Terms from this
        vocabulary are applied automatically to UniProtKB/TrEMBL\n    entries from
        the underlying nucleic acid databases and/or by the UniProt automatic\n    annotation
        program. Further information on the UniProtKB automatic annotation\n    program
        is available at http://www.uniprot.org/faq/45.\n\n    When a UniProtKB Subcellular
        Location term describes a concept that is within\n    the scope of the Gene
        Ontology, it is investigated to determine whether it is\n    appropriate to
        map the term to an equivalent term in GO. The mapping between UniProtKB\n
        \   Subcellular Location terms and GO terms is carried out manually. Definitions
        and\n    hierarchies of the terms in the two resources are compared and the
        mapping generated\n    will reflect the most correct correspondence. The translation
        table between GO\n    terms and UniProtKB Subcellular Location terms is maintained
        by the UniProt-GOA\n    team and available at http://www.geneontology.org/external2go/spsl2go.\n
        \ authors: UniProt-GOA\n  is_obsolete: true\n  year: 2011\n- id: GO_REF:0000041\n
        \ title: Gene Ontology annotation based on UniPathway vocabulary mapping\n
        \ description: |-\n    Transitive assignment of GO terms based on the UniPathway
        pathway vocabulary.\n    UniPathway is not maintained anymore. It was a manually
        curated resource of enzyme-catalyzed and spontaneous\n    chemical reactions
        that provided a hierarchical representation of metabolic pathways. The last
        release of UniPathway \n    was in March 2015 and is archived at NCBO: \n
        \   https://bioportal.bioontology.org/ontologies/UPA.\n  authors: UniProt-GOA\n
        \ external_accession:\n    - ZFIN:ZDB-PUB-130131-1\n    - J:342601\n    -
        SGD_REF:S000150560\n  year: 2012\n- id: GO_REF:0000042\n  title: OBSOLETE
        Gene Ontology annotation through association of InterPro records\n    with
        GO terms, accompanied by conservative changes to GO terms applied by UniProt\n
        \ description: |-\n    Transitive assignment of GO terms based on InterPro
        classification. For any database\n    entry (representing a protein or protein-coding
        gene) that has been annotated\n    with one or more InterPro domains, The
        corresponding GO terms are obtained from\n    a translation table of InterPro
        entries to GO terms (interpro2go) generated manually\n    by the InterPro
        team at EBI. The mapping file is available at\n    http://www.geneontology.org/external2go/interpro2go.\n\n
        \   Please note that the GO term in the annotation assigned with this GO reference\n
        \   has been changed from that originally applied by the InterPro2GO mapping.
        This\n    change has been carried out by the UniProt group to ensure the GO
        annotation obeys\n    the GO Consortium\u2019s ontology structure and taxonomic
        constraints. Further information\n    on the rules used by UniProt to transform
        specific incorrect IEA annotations is\n    available at http://www.ebi.ac.uk/QuickGO/AnnotationPostProcessing.html.\n\n
        \   Duplicate of GO_REF:0000002.\n  authors: UniProt-GOA\n  is_obsolete: true\n
        \ year: 2012\n- id: GO_REF:0000043\n  title: Gene Ontology annotation based
        on UniProtKB/Swiss-Prot keyword mapping\n  description: |-\n    Transitive
        assignments using UniProtKB/Swiss-Prot keywords. The UniProtKB keyword\n    controlled
        vocabulary contains 10 different categories of information to UniProtKB\n
        \   entries. Further information on the UniProtKB keyword resource can be
        found at\n    https://www.uniprot.org/keywords/. UniProtKB keywords are assigned
        to UniProtKB/Swiss-Prot\n    entries by UniProt curators as part of the UniProtKB
        manual curation process.\n    UniProtKB keywords are also automatically assigned
        to UniProtKB/TrEMBL entries\n    from the underlying nucleic acid databases
        and/or by the UniProt automatic annotation\n    program. Further information
        on the two different UniProt annotation methods is\n    available at https://www.uniprot.org/help/keywords..
        When a UniProtKB keyword\n    describes a concept that is within the scope
        of the Gene Ontology, a mapping is\n    manually made to the corresponding
        GO term.The translation table between GO terms\n    and UniProtKB keywords
        is maintained by the EBI GOA team and available at\n    http://www.geneontology.org/external2go/uniprotkb_kw2go.\n
        \ authors: UniProt-GOA\n  external_accession:\n    - SGD_REF:S000148669\n
        \   - TAIR:AnalysisReference:501756968\n    - TAIR:AnalysisReference:501756970\n
        \   - ZFIN:ZDB-PUB-020723-1\n  year: 2012\n- id: GO_REF:0000044\n  title:
        Gene Ontology annotation based on UniProtKB/Swiss-Prot Subcellular Location\n
        \   vocabulary mapping, accompanied by conservative changes to GO terms applied
        by\n    UniProt\n  description: |-\n    Transitive assignment of GO terms
        based on the UniProtKB/Swiss-Prot Subcellular\n    Location vocabulary. UniProtKB
        Subcellular Location is a controlled vocabulary\n    used to supply subcellular
        location information to UniProtKB entries in the SUBCELLULAR\n    LOCATION
        lines. Terms from this vocabulary are annotated manually to UniProtKB/Swiss-Prot\n
        \   entries but are automatically assigned to UniProtKB/TrEMBL entries from
        the underlying\n    nucleic acid databases and/or by the UniProt automatic
        annotation program. Further\n    information on these two different annotation
        methods is available\n    https://www.uniprot.org/help/keywords.\n    When
        a UniProtKB Subcellular Location term describes a concept that is within\n
        \   the scope of the Gene Ontology, a mapping is made to the corresponding\n
        \   GO term. The translation table between GO terms and UniProtKB Subcellular
        Location\n    term is maintained by the EBI GOA team and available at\n    http://current.geneontology.org/ontology/external2go/uniprotkb_sl2go.\n
        \ authors: UniProt-GOA\n  external_accession:\n    - TAIR:AnalysisReference:501756971\n
        \   - TAIR:AnalysisReference:50175724\n    - J:342604\n    - ZFIN:ZDB-PUB-120306-4\n
        \   - SGD_REF:S000250403\n  year: 2012\n- id: GO_REF:0000045\n  title: OBSOLETE
        Gene Ontology annotation based on UniProtKB/TrEMBL entries keyword\n    mapping,
        accompanied by conservative changes to GO terms applied by UniProt\n  description:
        |-\n    Transitive assignments using UniProtKB/TrEMBL keywords. The UniProtKB
        keyword\n    controlled vocabulary has been created and used by the UniProt
        Knowledgebase (UniProtKB)\n    to supply 10 different categories of information
        to UniProtKB/TrEMBL entries entries.\n    Further information on the UniProtKB
        keyword resource can be found at\n    http://www.uniprot.org/docs/keywlist.\n\n
        \   UniProtKB keywords are assigned to UniProtKB/UniProtKB entries by UniProt
        curators\n    as part of the UniProtKB manual curation process. In contrast
        however, UniProtKB\n    keywords are automatically assigned to UniProtKB/TrEMBL
        entries from the underlying\n    nucleic acid databases and/or by the UniProt
        automatic annotation program.\n\n    Further information on the two different
        UniProt annotation methods is available\n    at http://www.uniprot.org/faq/45
        and http://www.uniprot.org/program/automatic_annotation.\n\n    When a UniProtKB
        keyword describes a concept that is within the scope of the Gene\n    Ontology,
        it is investigated to determine whether it is appropriate to map the\n    keyword
        to an equivalent term in GO. The translation table between GO terms and\n
        \   UniProtKB keywords is maintained by the UniProt-GOA team and available
        at\n    http://www.geneontology.org/external2go/uniprotkb_kw2go.\n\n    Please
        note that the GO term in the annotation assigned with this GO reference\n
        \   has been changed from that originally applied by the UniProtKB keywords
        2GO mapping.\n    This change has been carried out by the UniProt group to
        ensure the GO annotation\n    obeys the GO Consortium\u2019s ontology structure
        and taxonomic constraints. Further\n    information on the rules used by UniProt
        to transform specific incorrect IEA annotations\n    is available at http://www.ebi.ac.uk/QuickGO/AnnotationPostProcessing.html.\n\n
        \   Duplicate of GO_REF:0000004.\n  authors: UniProt-GOA\n  is_obsolete: true\n
        \ year: 2012\n- id: GO_REF:0000046\n  title: OBSOLETE Gene Ontology annotation
        based on UniProtKB/TrEMBL Subcellular Location\n    vocabulary mapping, accompanied
        by conservative changes to GO terms applied by\n    UniProt\n  description:
        |-\n    Transitive assignment of GO terms based on the UniProtKB/TrEMBL Subcellular
        Location\n    vocabulary. UniProtKB Subcellular Location is a controlled vocabulary
        used to\n    supply subcellular location information to UniProtKB entries
        in the SUBCELLULAR\n    LOCATION lines. Terms from this vocabulary are annotated
        manually to UniProtKB/Swiss-Prot\n    entries but are automatically assigned
        to UniProtKB/TrEMBL entries from the underlying\n    nucleic acid databases
        and/or by the UniProt automatic annotation program.\n\n    Further information
        on these two different annotation methods is available at\n    http://www.uniprot.org/faq/45
        and http://www.uniprot.org/program/automatic_annotation.\n\n    The translation
        table between GO terms and UniProtKB Subcellular Location term\n    is maintained
        by the UniProt-GOA team and available at\n    http://www.geneontology.org/external2go/spsl2go.\n\n
        \   Please note that the GO term in the annotation assigned with this GO reference\n
        \   has been changed from that originally applied by the UniProtKB Subcellular
        Location2GO\n    mapping. This change has been carried out by the UniProt
        group to ensure the GO\n    annotation obeys the GO Consortium\u2019s ontology
        structure and taxonomic constraints.\n    Further information on the rules
        used by UniProt to transform specific incorrect\n    IEA annotations is available
        at http://www.ebi.ac.uk/QuickGO/AnnotationPostProcessing.html.\n\n    Duplicate
        of GO_REF:0000023.\n  authors: UniProt-GOA\n  is_obsolete: true\n  year: 2012\n-
        id: GO_REF:0000047\n  title: Gene Ontology annotation based on absence of
        key sequence residues\n  description: |-\n    This describes a method for
        supplying a NOT-qualified, IKR-evidenced GO annotation\n    to a gene product,
        when general sequence homology considerations would suggest\n    a function
        or location, or a role in a biological process, but where a curator\n    has
        determined that the absence of key sequence residues, known to be required\n
        \   for an expected activity or location, indicating the gene product is unlikely\n
        \   to be able to carry out the implied activity, involvement in a process
        or cellular\n    component location. This reference should only be used used
        when an IKR-evidenced\n    annotation is made based on curator judgement from
        manually reviewing the sequence\n    of the gene product and where no publication
        can be found to support the curators\n    conclusion. It is preferable to
        cite a peer-reviewed publication (such as a PubMed\n    identifier) for IKR-evidenced
        annotations whenever possible. Curators will have\n    carefully reviewed
        the sequence of the annotated protein, and established that\n    the key residues
        known to be required for an expected activity or location are\n    not present.
        Inclusion of an identifier in the 'with/from' field, that highlights\n    to
        the user the lacking residues(e.g. an alignment, domain or rule identifier)\n
        \   is absolutely required when annotating to IKR with this GO_REF. Documentation\n
        \   on the GOC website provides more details on the\n    <a href=\"http://www.geneontology.org/GO.evidence.shtml#ikr\">correct
        use of the\n    IKR evidence code</a>.\n  authors: GO Curators\n  external_accession:\n
        \   - FB:FBrf0254415\n  year: 2012\n- id: GO_REF:0000048\n  title: OBSOLETE
        TIGR's Eukaryotic Manual Gene Ontology Assignment Method\n  description: |-\n
        \   This describes TIGR curators' interpretation of a combination of evidence.
        Our\n    internal software tools present us with a great deal of evidence
        based on domains,\n    sequence similarities, signal sequences, paralogous
        proteins, etc. The curator\n    interprets the body of evidence to make a
        decision about a GO assignment when\n    an external reference is not available.
        The curator places one or more accessions\n    that informed the decision
        in the \"with\" field.\n  authors: TIGR Arabidopsis annotation team\n  external_accession:\n
        \   - TAIR:Communication:501714663\n  is_obsolete: true\n  year: 2005\n- id:
        GO_REF:0000049\n  title: OBSOLETE Automatic transfer of experimentally verified
        manual GO annotation\n    data to fungal orthologs using Ensembl Compara\n
        \ description: |-\n    GO terms from a source species are projected onto one
        or more target species based\n    on gene orthology obtained from the Ensembl
        Compara system. One to one, one to\n    many and many to many orthologies
        are used but annotations are only projected\n    between orthologs that have
        at least a 40% peptide identity to each other. Only\n    GO annotations with
        an evidence type of IDA, IEP, IGI, IMP or IPI are projected,\n    no annotations
        with a 'NOT' qualifier are projected and annotations to the GO:0005515\n    protein
        binding term are not projected. Projected GO annotations using this technique\n
        \   will receive the evidence code Inferred from Electronic Annotation (IEA).
        The\n    model organism database identifier of the annotation source will
        be indicated\n    in the 'With' column of the GOA association file.\n\n    Duplicate
        of GO_REF:0000107.\n  authors: Ensembl Genomes\n  is_obsolete: true\n  year:
        2012\n- id: GO_REF:0000050\n  title: Manual transfer of GO annotation data
        to genes by curator judgment of sequence\n    model\n  description: |-\n    Transitive
        assignment of GO terms to a gene based on a curator's judgment of its\n    match
        to a sequence model,such as a Pfam or InterPro entry, that has manually\n
        \   curated GO annotations, mappings to GO terms, or a description from which
        GO terms\n    can be inferred. A statistical model of a sequence or group
        of sequences is used\n    to make a prediction about the function of a protein
        or RNA. Annotations are created\n    when a curator evaluates the results,
        using criteria that include excluding false\n    positives and ensuring that
        the annotation is accurate for all matches. Statistical\n    scores (such
        as e values and cutoff scores) and the functional specificity of\n    the
        model may also be (but are not always) considered. Annotations resulting from\n
        \   the transfer of GO terms use the 'ISM' evidence code and include an accession\n
        \   for the model from which the annotation was projected in the 'with' field
        (column\n    8).\n  authors: PomBase Curators\n  external_accession:\n    -
        FB:FBrf0231277\n  year: 2012\n- id: GO_REF:0000051\n  title: S. pombe keyword
        mapping\n  description: |-\n    Keywords derived from manually curated primary
        annotation, e.g. gene product descriptions,\n    are mapped to GO terms. Annotations
        made by this method have the evidence code\n    Non-traceable Author Statement
        (NAS), and are filtered from the PomBase annotation\n    files wherever another
        annotation exists that is equally or more specific, and\n    supported by
        experimental or manually evaluated comparative evidence (such as\n    ISS
        and its subtypes). Formerly GOC:pombekw2GO.\n  authors: PomBase Curators\n
        \ is_obsolete: false\n  year: 2012\n- id: GO_REF:0000052\n  title: Gene Ontology
        annotation based on curation of immunofluorescence data\n  description: |-\n
        \   GO Cellular Component terms are manually assigned by curators studying\n
        \   high resolution confocal microscopy images of immunohistochemically stained\n
        \   tissue. The methodology uses antibody-based proteomics which combines
        high-throughput\n    generation of affinity-purified antibodies with protein
        profiling in a variety\n    of cells and tissues. Further information on the
        annotation methods can be found\n    at http://www.proteinatlas.org/about/assays+annotation\n\n
        \   Annotations are only\n    exported to the GO Consortium if the localizations
        are supported by literature,\n    according to the following validation grading:\n\n
        \   Supportive - Subcellular localization\n    supported by literature.\n\n
        \   1) One/multiple localizations supported by literature.\n    2) Multiple
        localizations partly supported (at least one) by literature.\n    3) One/multiple\n
        \   localizations in cytoplasm (i.e. Golgi, mitochondria, ER etc) with literature\n
        \   supporting cytoplasmic localization.\n\n    Prior to February 2013, all
        Human Protein\n    Atlas annotations were referenced by PMID:18029348 (Barbe
        et al. 2008 Mol. Cell\n    Proteomics. 7:499-508), a paper describing the
        protein localization pilot study\n    and methodology used by the Human Protein
        Atlas. However, it has been decided\n    that these annotations are more correctly
        described by a GO reference.\n\n    Resource\n    URL: http://www.proteinatlas.org\n\n
        \   Protein subcellular localization images can\n    be viewed on the Human
        Protein Atlas website, e.g.\n    http://www.proteinatlas.org/ENSG00000175899/summary#ifcelline\n
        \ authors: Human Protein Atlas\n  year: 2013\n- id: GO_REF:0000053\n  title:
        OBSOLETE Automatic classification of GO using the ELK reasoner\n  description:
        |-\n    We use the <a href=\"http://code.google.com/p/elk-reasoner/\">ELK
        reasoner</a> as\n    part of an ontology development and release pipeline
        to automatically construct\n    and check a large portion of the GO graph.
        The editors version of the GO\n    (gene_ontology_write.obo) contains additional
        metadata, including provenance of\n    graph links. Every week, the GO pipeline
        executes a process which first removes\n    all links tagged as \"is_inferred\".
        The reasoner then generates a list of inferred\n    links which are automatically
        added to the ontology with the \"is_inferred\" tag\n    set. The pipeline
        generates a report describing which links have changed as a\n    part of this
        process.\n  authors: GO Ontology Editors\n  year: 2013\n  is_obsolete: true\n-
        id: GO_REF:0000054\n  title: Gene Ontology annotation based on curation of
        intracellular localizations\n    of expressed fusion proteins in living cells\n
        \ description: |-\n    LIFEdb is a database that was created to manage the
        experimental data\n    produced by the German Cancer Research Institute (DKFZ)
        and its collaborators,\n    from work on cDNAs contained in the German cDNA
        Consortium collection.\n\n    A novel cloning technology was used to rapidly
        generate N- and C-terminal green fluorescent\n    protein fusions of cDNAs
        to examine the intracellular localizations of expressed\n    fusion proteins
        in living cells. GO Cellular Component terms are manually assigned\n    by
        curators studying fluorescence microscope images of cells labelled with GFP-fused\n
        \   cDNAs. Protein coding regions of novel full length cDNAs are tagged with
        the\n    coding sequence of the green fluorescent protein, the fusion proteins
        are then\n    expressed and analyzed for their subcellular localization.\n\n
        \   Prior to February 2013, all LIFEdb annotations were referenced by PMID:
        11256614 (Simpson et al.\n    2000 EMBO Rep. 1:287-292), a paper describing
        the protein subcellular localization\n    pilot study and methodology used
        by LIFEdb. However, it has been decided that\n    these annotations are more
        correctly described by a GO reference.\n\n    Resource URL: http://www.dkfz.de/en/mga/Groups/LIFEdb-Database.html\n\n
        \   Protein subcellular localization images can be viewed on the LIFEdb website,\n
        \   http://www.dkfz.de/gpcf/lifedb.php\n  authors: LIFEdb\n  year: 2013\n-
        id: GO_REF:0000055\n  title: OBSOLETE Gene Ontology Cellular Component annotation
        based on cellular fractionation\n  description: |-\n    Assignment of GO Cellular
        Component terms based on experimental evidence of cellular\n    localization
        from Differential Detergent Fractionation (DDF). Cellular proteins\n    are
        differentially fractionated and detected using mass spectrometry. Subcellular\n
        \   localization is based upon identification of proteins in different fractions
        and\n    analysis of their predicted transmembrane domains. Proteins are assigned
        GO CC\n    based upon a manually reviewed DDF2GO mapping file.\n  authors:
        AgBase Biocurators\n  year: 2013\n  is_obsolete: true\n- id: GO_REF:0000056\n
        \ title: OBSOLETE Taxon constraints to detect inconsistencies in annotation
        and ontology\n    structure\n  description: |-\n    GO is intended to cover
        the full range of species, therefore GO terms are defined\n    to be taxon
        neutral, avoiding reliance on taxon information for full definition\n    of
        the given process, function, or component. For certain terms, however, there\n
        \   is obvious implicit taxon specificity, such that the term should only
        be used\n    to categorize gene products from particular species. Taxon specificity
        of GO terms\n    is captured using relationships such as \"only_in_taxon\"
        and \"never_in_taxon\".\n    All taxon constraints are inherited by sub-types
        and parts of the GO term they\n    are applied to. Taxon constraints are used
        to prevent inappropriate annotations\n    from being made by curators as well
        as to identify pre-existing annotations that\n    violate the taxon constraints.
        Errors in annotations are automatically detected\n    by looking for inconsistencies
        between the taxonomic origin of the annotated gene\n    products and the implicit
        taxon specificity of the GO terms. The inconsistencies\n    are passed on
        to curators for correction, in some cases the constraints need to\n    be
        tightened or relaxed or the structure of the ontology needs to be adjusted.\n
        \   The taxon constraints are further described in this publication: Deegan,
        Dimmer\n    and Mungall. BMC Bionformatics (2010) Formalization of taxon-based
        constraints\n    to detect inconsistencies in annotaiton and ontology development.
        (PMID:20973947).\n  authors: The GO Consortium\n  year: 2013\n  is_obsolete:
        true\n- id: GO_REF:0000058\n  title: Representation of regulation in the Gene
        Ontology (biological process)\n  description: |-\n    We have created a standard
        template for the definition of classes for the regulation\n    of a biological
        process. This includes the definitions for positive and negative\n    regulation.
        The equivalence axiom templates are \"GO:0065007 and 'regulates' some\n    X\"
        (regulation), \"GO:0065007 and 'negatively_regulates' some X\" (negative regulation),\n
        \   and \"GO:0065007 and 'positively_regulates' some X\" (positive regulation),
        where\n    X is a biological process.\n  authors: GO Ontology Editors\n  year:
        2013\n- id: GO_REF:0000059\n  title: Representation of regulation in the Gene
        Ontology (molecular function)\n  description: |-\n    We have created a standard
        template for the definition of classes for the regulation\n    of a molecular
        function. This includes the definitions for positive and negative\n    regulation.
        The equivalence axiom templates are \"GO:0065007 and 'regulates' some\n    X\"
        (regulation), \"GO:0065007 and 'negatively_regulates' some X\" (negative regulation),\n
        \   and \"GO:0065007 and 'positively_regulates' some X\" (positive regulation),
        where\n    X is a molecular function.\n  authors: GO Ontology Editors\n  year:
        2013\n- id: GO_REF:0000060\n  title: Representation of processes involved
        in other process in the Gene Ontology\n  description: |-\n    We have created
        a standard template for classes describing processes involved\n    in other
        processes. The underlying equivalence axiom template is \"P and 'part_of'\n
        \   some W\", where P and W are biological processes.\n  authors: GO Ontology
        Editors\n  year: 2013\n- id: GO_REF:0000061\n  title: Representation of a
        molecular function involved in a biological process in\n    the Gene Ontology\n
        \ description: |-\n    We have created a standard template for classes describing
        molecular function\n    involved in other biological processes. The underlying
        equivalence axiom template\n    is \"P and 'part_of' some W\", where P is
        a molecular function and W is a biological\n    processes.\n  authors: GO
        Ontology Editors\n  year: 2013\n- id: GO_REF:0000062\n  title: Representation
        of processes occurring in parts of the cell in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing processes
        occurring\n    in parts of the cell. The underlying equivalence axiom template
        is \"P and 'occurs\n    in' some C\", where P is a biological process and
        C is a cellular component.\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000063\n  title: Representation of processes regulated by other
        regulating processes in the\n    Gene Ontology\n  description: |-\n    We
        have created a standard template for classes describing processes regulated\n
        \   by other regulating processes. The underlying equivalence axiom template
        is \"R\n    and 'results_in' some P\", where R is a biological process and
        P is a regulation\n    of biological process subclass.\n  authors: GO Ontology
        Editors\n  year: 2013\n- id: GO_REF:0000064\n  title: Representation of cell
        components as part of other cell components in the\n    Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing cell components
        as\n    part of other cell components. The underlying equivalence axiom template
        is \"P\n    and 'part_of' some W\", where P and W are cell components.\n  authors:
        GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000065\n  title: Representation
        of transport of a chemical entity as a biological process\n    in the Gene
        Ontology\n  description: |-\n    We have created a standard template for classes
        describing transport of a chemical\n    entity (ChEBI) as a biological process.
        The underlying equivalence axiom template\n    is \"GO:0006810 and 'transports
        or maintains localization of' some X\", where X\n    is a chemical entity
        (CHEBI:24431). The approach to combine GO and ChEBI has been\n    described
        in the following publication: PMID:23895341.\n  authors: GO Ontology Editors\n
        \ year: 2013\n- id: GO_REF:0000066\n  title: Representation of transport of
        a chemical entity as molecular function in\n    the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the transport
        of a\n    chemical entity (ChEBI) as a molecular function. The underlying
        equivalence axiom\n    template is \"GO:0005215 and 'transports or maintains
        localization of' some X\",\n    where X is a chemical entity (CHEBI:24431).
        The approach to combine GO and ChEBI\n    has been described in the following
        publication: PMID:23895341.\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000067\n  title: Representation of binding to a chemical entity
        as molecular function in the\n    Gene Ontology\n  description: |-\n    We
        have created a standard template for classes describing the binding to a chemical\n
        \   entity (ChEBI) as a molecular function. The underlying equivalence axiom
        template\n    is \"GO:0005488 and 'has input' some X\", where X is a chemical
        entity (CHEBI:24431).\n    The approach to combine GO and ChEBI has been described
        in the following publication:\n    PMID:23895341.\n  authors: GO Ontology
        Editors\n  year: 2013\n- id: GO_REF:0000068\n  title: Representation of metabolic
        triad (metabolism, catabolism, biosynthesis)\n    as biological process in
        the Gene Ontology\n  description: |-\n    We have created a standard template
        for classes each describing the metabolism,\n    catabolism, or biosynthesis
        of a chemical entity (ChEBI) as a process. The underlying\n    equivalence
        axiom templates are \"GO:0008152 and 'has participant' some X\" (metabolism),\n
        \   \"GO:0009056 and 'has input' some X\" (catabolism), \"GO:0009058 and 'has
        output'\n    some X\" and (biosynthesis),  where X is a chemical entity (CHEBI:24431).
        The approach\n    to combine GO and ChEBI has been described in the following
        publication: PMID:23895341.\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000069\n  title: Representation of transmembrane transport of
        a chemical as biological process\n    in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the transmembrane
        transport\n    of a chemical entity (ChEBI) as a biological process. The underlying
        equivalence\n    axiom template is \"GO:0055085 and 'transports or maintains
        localization of' some\n    X\", where X is a chemical entity (CHEBI:24431).
        The approach to combine GO and\n    ChEBI has been described in the following
        publication: PMID:23895341.\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000070\n  title: Representation of transmembrane transporter activity
        as molecular function\n    in the Gene Ontology\n  description: |-\n    We
        have created a standard template for classes describing the transmembrane
        transporter\n    activity a chemical entity (ChEBI) as molecular function.
        This includes variants\n    for secondary active transmembrane transporter
        activity (GO:0015291), uptake transmembrane\n    transporter activity (GO:0015563),
        and ATPase activity, coupled to transmembrane\n    movement of substances
        (GO:0042626). The underlying equivalence axiom template\n    is \"G and 'transports
        or maintains localization of' some X\",  where the genus\n    G is either
        GO:0022857 (transmembrane transporter activity), GO:0015291, GO:0015563,\n
        \   or GO:0042626 depending on the variant. The variable X is a chemical entity
        (CHEBI:24431).\n    The approach to combine GO and ChEBI has been described
        in the following publication:\n    PMID:23895341.\n  authors: GO Ontology
        Editors\n  year: 2013\n- id: GO_REF:0000071\n  title: Representation of response
        to and cellular response to a chemical as biological\n    process in the Gene
        Ontology\n  description: |-\n    We have created a standard template for classes
        describing the response to and\n    cellular response to a chemical entity
        (ChEBI) as a biological process. The underlying\n    equivalence axiom templates
        are \"GO:0050896 and 'has input' some X\" (response\n    to) and \"GO:0070887
        and 'has input' some X\" (cellular response to), where X is\n    a chemical
        entity (CHEBI:24431). The approach to combine GO and ChEBI has been\n    described
        in the following publication: PMID:23895341.\n  authors: GO Ontology Editors\n
        \ year: 2013\n- id: GO_REF:0000072\n  title: Representation of chemical homeostasis
        and cellular chemical homeostasisl\n    as biological process in the Gene
        Ontology\n  description: |-\n    We have created a standard template for classes
        describing the homeostasis and\n    cellular homeostasis for a chemical entity
        (ChEBI) as a biological process. The\n    underlying equivalence axiom templates
        are \"GO:0048878 and 'regulates level of'\n    some X\" (homeostasis) and
        \"GO:0055082 and 'regulates level of' some X\" (cellular\n    homeostasis),
        where X is a chemical entity (CHEBI:24431). The approach to combine\n    GO
        and ChEBI has been described in the following publication: PMID:23895341.\n
        \ authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000073\n  title:
        Representation of import of a chemical as biological process in the Gene\n
        \   Ontology\n  description: |-\n    We have created a standard template for
        classes describing the import of a chemical\n    entity (ChEBI) as a biological
        process. The underlying equivalence axiom template\n    is \"GO:0006810 and
        'imports' some X\", where X is a chemical entity (CHEBI:24431).\n    The approach
        to combine GO and ChEBI has been described in the following publication:\n
        \   PMID:23895341.\n  authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000074\n
        \ title: Representation of export of a chemical as biological process in the
        Gene\n    Ontology\n  description: |-\n    We have created a standard template
        for classes describing the export of a chemical\n    entity (ChEBI) as a biological
        process. The underlying equivalence axiom template\n    is \"GO:0006810 and
        'exports' some X\", where X is a chemical entity (CHEBI:24431).\n    The approach
        to combine GO and ChEBI has been described in the following publication:\n
        \   PMID:23895341.\n  authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000075\n
        \ title: Representation of transport of a chemical into a cellular component
        as biological\n    process in the Gene Ontology\n  description: |-\n    We
        have created a standard template for classes describing the transport of a\n
        \   chemical entity (ChEBI) into a cellular component as a biological process.
        The\n    underlying equivalence axiom template is \"GO:0006810 and 'has_target_end_location'\n
        \   some T and 'imports' some S\", where T is a cellular component and S is
        a chemical\n    entity (CHEBI:24431). The approach to combine GO and ChEBI
        has been described\n    in the following publication: PMID:23895341.\n  authors:
        GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000076\n  title: Representation
        of transport or vesicle-mediated transport from cell component\n    to cell
        component as biological process in the Gene Ontology\n  description: |-\n
        \   We have created a standard template for classes describing the transport
        or vesicle-mediated\n    transport from cellular component to cellular component
        as a biological process.\n    The underlying equivalence axiom templates are
        \"GO:0006810 and 'has_target_start_location'\n    some F and 'has_target_end_location'
        some T\" (transport) and \"GO:0016192 and\n    'has_target_start_location'
        some F and 'has_target_end_location' some T\" (vesicle-mediated\n    transport),
        where F and T are a cellular components.\n  authors: GO Ontology Editors\n
        \ year: 2013\n- id: GO_REF:0000077\n  title: OBSOLETE Representation of transport
        of a cellular component as biological\n    process in the Gene Ontology\n
        \ description: |-\n    We have created a standard template for classes describing
        the transport or vesicle-mediated\n    transport of a cellular component as
        a biological process. The underlying equivalence\n    axiom templates are
        \"GO:0006810 and 'transports or maintains localization of'\n    some C\" (transport)
        and \"GO:0016192 and 'transports or maintains localization\n    of' some C\"
        (vesicle-mediated transport), where C is a cellular component.\n  authors:
        GO Ontology Editors\n  year: 2013\n  is_obsolete: true\n- id: GO_REF:0000078\n
        \ title: Representation for the transport or vesicle-mediated transport of
        a chemical\n    from and/or to a cell component as biological process in the
        Gene Ontology\n  description: |-\n    We have created a standard template
        for classes describing the transport or vesicle-mediated\n    transport of
        a chemical entity (ChEBI) from and/or to a cellular component as\n    a biological
        process. The underlying equivalence axiom templates are \"GO:0006810\n    and
        'transports or maintains localization of' some X [ and 'has_target_start_location'\n
        \   some F] [ and 'has_target_end_location' some T]\" (transport) and \"GO:0016192
        and\n    'transports or maintains localization of' some X [ and 'has_target_start_location'\n
        \   some F] [ and 'has_target_end_location' some T]\" (vesicle-mediated transport),\n
        \   where F and T are cellular components and X is a chemical entity (CHEBI:24431).\n
        \   The approach to combine GO and ChEBI has been described in the following
        publication:\n    PMID:23895341.\n  authors: GO Ontology Editors\n  year:
        2013\n- id: GO_REF:0000079\n  title: Representation of assembly or disassembly
        of a cell component as biological\n    process in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the assembly
        or disassembly\n    of a cellular component as a biological process. The underlying
        equivalence axiom\n    templates are \"GO:0022607 and 'results_in_assembly_of'
        some C\" (assembly) and\n    \"GO:0022411 and 'results_in_disassembly_of'
        some C\" (disassembly), where C is\n    a cellular component.\n  authors:
        GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000080\n  title: Representation
        of plant development as biological process in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the development
        of\n    a plant structure as a biological process. The underlying equivalence
        axiom template\n    is \"'anatomical structure development' and 'results in
        development of' some P\",\n    where P is a plant anatomical entity (PO:0025131).\n
        \ authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000081\n  title:
        Representation of plant formation as biological process in the Gene Ontology\n
        \ description: |-\n    We have created a standard template for classes describing
        the formation of a\n    plant structure as a biological process. The underlying
        equivalence axiom template\n    is \"'anatomical structure formation involved
        in morphogenesis' and 'results in\n    formation of' some P\", where P is
        a plant anatomical entity (PO:0025131).\n  authors: GO Ontology Editors\n
        \ year: 2013\n- id: GO_REF:0000082\n  title: OBSOLETE Representation of plant
        maturation as biological process in the\n    Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the maturation
        of a\n    plant structure as a biological process. The underlying equivalence
        axiom template\n    is \"'developmental maturation' and 'results in developmental
        progression of' some\n    P\", where P is a plant anatomical entity (PO:0025131).\n
        \ authors: GO Ontology Editors\n  is_obsolete: true\n  year: 2013\n- id: GO_REF:0000083\n
        \ title: Representation of plant morphogenesis as biological process in the
        Gene Ontology\n  description: |-\n    We have created a standard template
        for classes describing the morphogenesis of\n    a plant structure as a biological
        process. The underlying equivalence axiom template\n    is \"'anatomical structure
        morphogenesis' and 'results in morphogenesis of' some\n    P\", where P is
        a plant anatomical entity (PO:0025131).\n  authors: GO Ontology Editors\n
        \ year: 2013\n- id: GO_REF:0000084\n  title: Representation of plant structural
        organization as biological process in\n    the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the structural
        organization\n    of a plant structure as a biological process. The underlying
        equivalence axiom\n    template is \"'anatomical structure arrangement' and
        'results in structural organization\n    of' some P\", where P is a plant
        anatomical entity (PO:0025131).\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000085\n  title: Representation of cell apoptotic process as biological
        process in the Gene\n    Ontology\n  description: |-\n    We have created
        a standard template for classes describing the apoptotic process\n    for
        a cell type as a biological process. The underlying equivalence axiom template\n
        \   is \"'apoptotic process' and 'occurs in' some C\", where C is a native
        cell (CL:0000003).\n  authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000086\n
        \ title: Representation of cell differentiation as biological process in the
        Gene\n    Ontology\n  description: |-\n    We have created a standard template
        for classes describing the differentiation\n    process for a cell type as
        a biological process. The underlying equivalence axiom\n    template is \"GO:0030154
        and 'results in acquisition of features of' some C\", where\n    C is a native
        cell (CL:0000003).\n  authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000087\n
        \ title: Representation of protein localization and establishment of protein
        localization\n    as biological process in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the protein
        localization\n    and establishment of protein localization to a cellular
        component as a biological\n    process. The underlying equivalence axiom templates
        are \"GO:0008104 and\n    'has_target_end_location' some C\" (protein localization)
        and \"GO:0045184 and\n    'has_target_end_location' some C\" (establishment
        of protein localization), where C\n    is cellular component.\n  authors:
        GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000088\n  title: Representation
        of protein complex by molecular function in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes defining a protein
        complex by\n    a molecular function as a cellular component. The underlying
        equivalence axiom\n    template is \"GO:0043234 and 'capable_of' some ?A\",
        where A is a molecular function.\n  authors: GO Ontology Editors\n  year:
        2013\n- id: GO_REF:0000089\n  title: Representation of single-organism and
        multi-organism biological processes\n    in the Gene Ontology\n  description:
        |-\n    We have created a standard template for classes describing the single-organism\n
        \   and multi-organism biological processes. The underlying equivalence axiom
        templates\n    are \"P and 'bearer_of' some PATO:0002487\" (single-organism)
        and \"P and 'bearer_of'\n    some PATO:0002486\" (multi-organism), where P
        is a biological process.\n  authors: GO Ontology Editors\n  year: 2013\n-
        id: GO_REF:0000090\n  title: Automatic creation of relationships between ontology
        branches in the Gene\n    Ontology\n  description: |-\n    We have created
        a rule-based approach to create relations between the branches\n    of the
        Gene Ontology. The approach uses the equivalence axioms and a given pattern\n
        \   to create non-subClassOf relationships between the three different branches
        of\n    the Gene Ontology (biological process, molecular function, cellular
        component).\n    Currently, there are the following rules: \"'transporter
        activity' and\n    'transports_or_maintains_localization_of' some X' -part_of->
        \"transport and\n    'transports_or_maintains_localization_of' some X\"; \"'transmembrane
        transporter activity'\n    and 'transports_or_maintains_localization_of' some
        X -part_of-> 'transmembrane transport'\n    and 'transports_or_maintains_localization_of'
        some X\"\n  authors: GO Ontology Editors\n  year: 2013\n- id: GO_REF:0000091\n
        \ title: Representation of cell migration as biological processes in the Gene
        Ontology\n  description: |-\n    We have created a standard template for classes
        describing the cell migration\n    process for a cell type as a biological
        process. The underlying equivalence axiom\n    template is \"'cell migration'
        and 'alters_location_of' some C\", where C is a native\n    cell (CL:0000004).\n
        \ authors: GO Ontology Editors\n  year: 2014\n- id: GO_REF:0000092\n  title:
        Representation for the biosynthesis from or via a chemical as biological\n
        \   process in the Gene Ontology\n  description: |-\n    We have created a
        standard template for classes describing the biosynthesis of\n    a chemical
        entity from or via an other chemical entity as biological processes.\n    The
        underlying equivalence axiom templates are \"GO:0009058 and 'has output' some\n
        \   T and 'has input' some F\" (biosynthesis from) and \"GO:0009058 and 'has
        output'\n    some T and 'has intermediate' some I\" (biosynthesis via), where
        T,F, and I are\n    chemical entities (CHEBI:24431). The approach to combine
        GO and ChEBI has been\n    described in the following publication: PMID:23895341.\n
        \ authors: GO Ontology Editors\n  year: 2014\n- id: GO_REF:0000093\n  title:
        Representation for the degradation to or via a chemical as biological process\n
        \   in the Gene Ontology\n  description: |-\n    We have created a standard
        template for classes describing the degradation of\n    a chemical entity
        to or via an other chemical entity as biological processes.\n    The underlying
        equivalence axiom templates are \"GO:0009056 and 'has input' some\n    S and
        'has output' some T\" (catabolism to) and \"GO:0009056 and 'has input' some\n
        \   S and 'has intermediate' some I\" (catabolism via), where S,T, and I are
        chemical\n    entities (CHEBI:24431). The approach to combine GO and ChEBI
        has been described\n    in the following publication: PMID:23895341.\n  authors:
        GO Ontology Editors\n  year: 2014\n- id: GO_REF:0000094\n  title: Representation
        of metazoan development as biological process in the Gene\n    Ontology\n
        \ description: |-\n    We have created a standard template for classes describing
        the development of\n    a metazoan structure as a biological process. The
        underlying equivalence axiom\n    template is \"'anatomical structure development'
        and 'results in development of'\n    some E\", where E is a anatomical entity
        (UBERON:0001062).\n  authors: GO Ontology Editors\n  year: 2014\n- id: GO_REF:0000095\n
        \ title: Literature reference not indexed by PubMed\n  description: This article
        is not referenced in PubMed. Please see contributing data\n    resource for
        details.\n  authors: Mouse Genome Informatics Scientific Curators and FlyBase\n
        \ year: 2014\n- id: GO_REF:0000096\n  title: Automated transfer of experimentally-verified
        manual GO annotation data to \n    mouse-rat orthologs\n  description: |-\n
        \   The Alliance of Genome Resources (https://www.alliancegenome.org/) has
        procedures in \n    place to establish orthology relationships between genes.
        The experimentally-based \n    annotations (IDA, IMP IPI, IGI, and EXP) annotated
        by Rat Genome Database (RGD) and \n    The Mouse Genome Database (MGD) are
        used to provide annotations to the respective \n    mouse and rat orthologs,
        and given the ISO evidence code and an entry in the \"With \n    (or) From\"
        field to indicate the orthologous entity.\n  authors: The Gene Ontology Consortium\n
        \ external_accession:\n    - J:155856\n  year: 2014\n- id: GO_REF:0000097\n
        \ title: Gene Ontology annotation based on personal communication to FlyBase\n
        \ description: |-\n    FlyBase occasionally makes GO annotations based on
        information that has been sent\n    to us directly by researchers as a personal
        communication to FlyBase. In each\n    case, the full details of the communication
        including any associated data and\n    analyses are recorded in a FlyBase
        publication (FBrf) available from our website\n    (http://flybase.org).\n
        \ authors: FlyBase\n  year: 2014\n- id: GO_REF:0000098\n  title: OBSOLETE
        Gene Ontology annotation based on research conference abstracts\n  description:
        |-\n    Prior to 2008, FlyBase made GO annotations based on information in
        abstracts for\n    research conferences, primarily the Annual Drosophila Research
        Conference and\n    the European Drosophila Research Conference. We no longer
        curate conference abstracts\n    and we are gradually replacing all abstract-based
        GO annotation with annotation\n    based on experimental data in primary research
        papers.\n  authors: FlyBase\n  is_obsolete: true\n  year: 2014\n- id: GO_REF:0000099\n
        \ title: OBSOLETE Gene Ontology annotation based on DNA/RNA sequence records\n
        \ description: |-\n    Prior to 2005, FlyBase made GO annotations based on
        information in DNA/RNA sequence\n    records in GenBank/EMBL/DDBJ. We no longer
        add GO annotations based on sequence\n    records and gradually replacing
        these GO annotations as other sources of evidence\n    become available.\n
        \ authors: FlyBase\n  is_obsolete: true\n  year: 2014\n- id: GO_REF:0000100\n
        \ title: OBSOLETE Gene Ontology annotation by SEA-PHAGE biocurators\n  description:
        |-\n    This GO reference describes the criteria used by biocurators of the
        SEA-PHAGE\n    consortium for the annotation of predicted gene products from
        newly sequenced\n    bacteriophage genomes in the SEA-PHAGE phagesdb.org and
        other databases and in\n    the GenBank records periodically released to NCBI
        for these genomes. In particular,\n    this GO reference describes the criteria
        used to assign evidence codes ISS, ISA,\n    ISO, ISM, IGC and ND. To assign
        ISS, ISA, ISO and ISM evidence codes, SEA-PHAGE\n    biocurators use a varied
        array of bioinformatics tools to establish homology and\n    conservation
        of sequence and structure functional determinants with proteins from\n    multiple
        organisms with published association to experimental GO terms and lacking\n
        \   NOT qualifiers. These proteins are referenced in the WITH field of the
        annotation\n    using their xref database accession. The primary tools for
        homology search in\n    ISS, ISA, ISO and ISM assignments are BLASTP and HHpred,
        using a maximum e-value\n    of 10^-7 for BLASTP and a minimum probability
        of 0.9 for HHpred, and manual inspection\n    of alignments in both cases.
        For ISS and ISA assignments, BLASTP alignments are\n    required to have at
        least 75% coverage and 30% identity. For ISO assignments,\n    orthology is
        further validated using reciprocal BLASTP with the identified hit.\n    For
        HHpred results, ISS or ISM annotations are made only if the source for the\n
        \   original GO annotation explicitly defines a matched domain function, or
        if more\n    than half of the domains of the query protein are identified
        in the matching protein.\n    All ISS, ISA, ISO and ISM assignments entail
        the manual verification of the source\n    for the GO term in the matching
        protein sequence and critical curator assessment\n    of the likelihood of
        preservation of function, process or component in the context\n    of bacteriophage
        biology. IGC codes are assigned on the basis of suggestive evidence\n    for
        function based on synteny, as inferred from whole-genome comparative analyses\n
        \   of multiple bacteriophage genomes using primarily the Phamerator software
        platform,\n    and with special emphasis on the bacteriophage virion structure
        and assembly genes.\n    When extensive review of published literature on
        putative homologs reveals no\n    experimental evidence of function, component
        or process for a particular gene\n    product, it is assigned an ND evidence
        code and annotated to the root term for\n    Cellular Component, Molecular
        Function and Biological Process. As part of the\n    review process for assignment
        of ISS, ISA, ISO, IGC and ISM evidence codes, SEA-PHAGE\n    curators are
        required to analyze the reference literature for identified matches\n    and
        shall perform GO annotations with appropriate evidence codes if these were\n
        \   not available.\n  authors: Ivan Erill, SEA-PHAGE Biocurators\n  is_obsolete:
        true\n  year: 2014\n- id: GO_REF:0000101\n  title: Automated transfer of experimentally-verified
        GO annotation data to close\n    orthologs\n  description: |-\n    This reference
        is used to describe functional annotations transferred from one\n    or more
        reference (\"source\") organisms to a newly annotated (\"target\") organism\n
        \   on the basis of ortholog cluster membership. In detail, predicted (e.g.
        by AUGUSTUS,\n    see doi:10.1186/1471-2105-7-62) or transferred (e.g. via
        RATT, see doi:10:1093/nar/gkg1268)\n    gene models in the target genome are
        translated and processed by OrthoMCL 1.4\n    together with reference protein
        sequences to produce clusters of gene products\n    derived from orthologous
        genes. For each cluster, GO terms are automatically transferred\n    from
        source products to the target gene products if they are experimentally verified\n
        \   (IDA (ECO:0000314), IMP (ECO:0000315), IPI (ECO:0000353), IGI (ECO:0000316),
        (EXP\n    ECO:0000269). They are tagged with the ISO evidence code and the
        \"with/from\" is\n    populated with the source feature references (e.g. \"GeneDB:LmjF.28.0960\").
        OrthoMCL\n    runs are done using the parameterization suggested in the OrthoMCL
        algorithm document\n    (blastall -F 'm S' -e 1e-5).\n  authors: Sascha Steinbiss,
        GeneDB Curators\n  year: 2015\n- id: GO_REF:0000102\n  title: OBSOLETE Representation
        of cellular component binding as molecular functions\n    in the Gene Ontology\n
        \ description: |-\n    We have created a standard template for classes cellular
        component binding as\n    a molecular function. The underlying equivalence
        axiom template is \"'binding'\n    and 'has input' some C\", where C is a
        cellular component (GO:0005575).\n  authors: GO Ontology Editors\n  is_obsolete:
        true\n  year: 2015\n- id: GO_REF:0000103\n  title: OBSOLETE Representation
        of cellular component organization as biological\n    process in the Gene
        Ontology\n  description: |-\n    We have created a standard template for classes
        cellular component organization\n    as a biological process. The underlying
        equivalence axiom template is \"'cellular\n    component organization' and
        'results_in_organization_of' some C\", where C is a\n    cellular component
        (GO:0005575).\n  authors: GO Ontology Editors\n  is_obsolete: true\n  year:
        2015\n- id: GO_REF:0000104\n  title: Electronic Gene Ontology annotations
        created by transferring manual GO annotations\n    between related proteins
        based on shared sequence features\n  description: |-\n    GO terms are manually
        assigned to each rule in UniRule. These rules are prepared\n    manually by
        UniProt curators based on the annotations present in reviewed UniProtKB/Swiss-Prot\n
        \   records that share sequence features, sequence similarity and taxonomy.
        The assigned\n    GO terms are then transferred to all unreviewed UniProtKB/TrEMBL
        proteins that\n    meet the conditions given in the UniRule rule. GO annotations
        using this technique\n    receive the evidence code Inferred from Electronic
        Annotation (IEA; ECO:0000501).\n    These annotations are updated regularly
        by UniProt and are available for download\n    on both the GO and GOA EBI
        ftp sites. To report an annotation error or inconsistency,\n    or for further
        information, please contact the UniProt Automated Annotation team\n    at
        automated_annotation@ebi.ac.uk. UniRule is a collaboration between the European\n
        \   Bioinformatics Institute (EMBL-EBI), the Swiss Institute of Bioinformatics
        (SIB),\n    and the Protein Information Resource at Georgetown University
        (PIR). For further\n    information, please see UniProt: a hub for protein
        information Nucleic Acids Res.\n    2015, 43, D204, doi: 10.1093/nar/gku989
        or www.uniprot.org.\n  authors: UniProt Curators\n  external_accession:\n
        \   - ZFIN:ZDB-PUB-170525-1\n    - J:342612\n    - SGD_REF:S000181514\n  year:
        2015\n- id: GO_REF:0000105\n  title: Gene Ontology annotation of transfer
        RNAs based on tRNAscan-SE analysis of\n    the Drosophila melanogaster genome
        (2002)\n  description: |-\n    Gene Ontology annotation based on predicted
        cytoplasmic tRNAs using tRNAscan-SE\n    analysis (doi: 10.1093/nar/25.5.0955)
        of the Drosophila melanogaster genome (2002).\n    Annotations have been reviewed
        by FlyBase (2015) and found to be consistent when\n    compared with the most
        recent tRNAscan-SE analysis of the genome\n    (http://gtrnadb.ucsc.edu/genomes/eukaryota/Dmela6/).\n
        \ authors: FlyBase\n  external_accession:\n    - FB:FBrf0145624\n  year: 2016\n-
        id: GO_REF:0000106\n  title: OBSOLETE Gene Ontology annotation based on protein
        sequence records\n  description: |-\n    Between 1986 and 2005 GO annotations
        were made by FlyBase curators based on information\n    in UniProtKB/Swiss-Prot
        protein sequence records. We no longer add GO annotations\n    based on sequence
        records and are gradually replacing these GO annotations as\n    other sources
        of evidence become available.\n  authors: FlyBase\n  is_obsolete: true\n  year:
        2016\n- id: GO_REF:0000107\n  title: Automatic transfer of experimentally
        verified manual GO annotation data to\n    orthologs using Ensembl Compara\n
        \ description: |-\n    GO terms from a source species are projected onto one
        or more target species based\n    on gene orthology obtained from Ensembl
        Compara. One-to-one, one-to-many and many-to-many\n    orthology relations
        and anntations are transferred between orthologs that have\n    at least a
        40% peptide identity to each other. Only GO annotations with evidence\n    codes
        ECO:0000314 (IDA), ECO:0000270 (IEP), ECO:0000316 (IGI), ECO:0000315 (IMP),\n
        \   and ECO:0000353 (IPI), or their descendants, are transferred; annotations
        with\n    a 'NOT' qualifier are not transferred, and neither are annotations
        to GO:0005515\n    (protein binding). Annotations that are transferred using
        this method receive\n    the evidence code ECO:0000265 (sequence orthology
        evidence used in automatic assertion),\n    which maps up to the GO Inferred
        from Electronic Annotation (IEA) evidence code.  The\n    model organism database
        identifier of the annotation source will be indicated\n    in the 'With' column
        of the GOA association file.\n  authors: GOA Curators\n  external_accession:\n
        \   - J:342605\n  year: 2016\n- id: GO_REF:0000108\n  title: Automatic assignment
        of GO terms using logical inference, based on on inter-ontology\n    links\n
        \ description: |-\n    GO terms are automatically assigned based on inter-ontology
        links to generate\n    inferred annotations. Annotations from Molecular Function
        to Biological Process\n    can be propagated, as well as between Biological
        Process and Cellular Component.\n    Annotations that are created using this
        inference method receive either the evidence\n    code ECO:0000366 (evidence
        based on logical inference from automatic annotation\n    used in automatic
        assertion) or ECO:0000364 (evidence based on logical inference\n    from manual
        annotation used in automatic assertion), depending on whether the\n    source
        annotation has a manual or automatic evidence code. Both of these codes\n
        \   map up to the GO Inferred from Electronic Annotation (IEA) evidence code.\n
        \ authors: GOA Curators\n  external_accession:\n    - J:346132\n    - SGD_REF:S000204515\n
        \ year: 2016\n- id: GO_REF:0000109\n  title: Gene Ontology annotation based
        on curation of genome-wide subcellular localisation\n    of proteins using
        fluorescent protein tagging in Trypanosoma brucei\n  description: |-\n    Trypanosomes
        are exquisitely structured cells in which protein localisation can\n    be
        extremely informative for likely function. TrypTag is a project using expression\n
        \   of N- and C-terminal mNeonGreen fusion proteins from the endogenous loci
        to determine\n    the subcellular localisation of every gene in the Trypanosoma
        brucei genome. GO\n    Cellular Component terms are manually assigned by curators
        studying fluorescence\n    microscope images of the resulting cells labelled
        with mNeonGreen fusion proteins.\n    As trypanosomes are a pathogenic basal
        eukaryote, this will indicate likely function\n    of both highly conserved
        eukaryote genes and parasite-specific genes. Resource\n    URL: http://www.tryptag.org
        Protein subcellular localisation images can be viewed\n    on the Tryptag
        website, e.g. http://www.tryptag.org?id=Tb927.8.1550\n  authors: TrypTag\n
        \ year: 2016\n- id: GO_REF:0000110\n  title: Gene Ontology annotation of Drosophila
        melanogaster nuclear genes encoding\n    proteins targeted to the mitochondrion\n
        \ description: |-\n    Gene Ontology annotation of Drosophila melanogaster
        nuclear genes encoding proteins\n    targeted to the mitochondrion based on
        analysis by MitoDrome (http://mitodrome.ba.itb.cnr.it/)\n    by comparison
        of human mitochondrial proteins available in SWISSPROT vs. the Drosophila\n
        \   genome, ESTs and cDNA sequences available in the FlyBase database (PMID:12520013).\n
        \ authors: FlyBase\n  external_accession:\n    - FB:FBrf0159903\n  year: 2003\n-
        id: GO_REF:0000111\n  title: Gene Ontology annotations Inferred by Curator
        (IC) using at least one Inferred\n    by Sequence Similarity (ISS) annotation
        to support the inference\n  description: |-\n    The Gene Ontology Consortium
        uses the IC (Inferred by Curator; ECO:0000305) evidence\n    code when assignment
        of a GO term cannot be supported by direct experimental or\n    sequence-based
        evidence, but can, based on a curator\u2019s biological knowledge, be\n    reasonably
        inferred from existing GO annotations to the same gene/gene product.  Use\n
        \   of the IC evidence code with GO_REF:0000111 indicates that a curator inferred\n
        \   the GO term based on at least one supporting annotation with an 'Inferred
        from\n    Sequence Similarity' (ISS; ECO:0000250) evidence code.  Note that
        additional supporting\n    annotations may be experimentally evidenced. When
        using GO_REF:0000111, the 'with/from'\n    field must contain all GO identifiers
        used as supporting annotations.\n  authors: TBD\n  external_accession:\n    -
        FB:FBrf0233689\n    - J:342606\n  year: 2016\n- id: GO_REF:0000112\n  title:
        OBSOLETE Gene Ontology annotation by CACAO biocurators\n  description: |-\n
        \   This GO reference describes the criteria used by biocurators participating
        in\n    the Community Assessment of Community Annotation with Ontologies (CACAO)
        to annotate\n    gene products from genomes of interest through the use of
        computational methods\n    to establish and manually validate function or
        homology to gene products. In particular,\n    this GO reference describes
        the criteria used to make annotations based on evidence\n    codes ISS, ISA,
        ISO, ISM and IGC. To perform ISS-, ISA-, and ISO-based annotations\n    on
        a gene product, CACAO biocurators use sequence- and structure-based search\n
        \   algorithms (e.g. BLASTP, HHPred) to establish homology, conservation of
        sequence\n    and structure functional determinants between the target gene
        product and gene\n    products from other organisms with published GO annotations
        supported by experimental\n    codes and lacking NOT qualifiers. These gene
        products are referenced in the WITH\n    field of the annotation using their
        xref database accession. ISM-based annotations\n    make use of published
        computational methods (e.g. TMHMM, SignalP) to predict gene\n    product structure,
        localization or function. IGC-based annotations are made on\n    the basis
        of suggestive evidence for function based on synteny. Parameters and\n    criteria
        for use of all computational methods (e.g. e-value) are listed and versioned\n
        \   in the publicly available CACAO documentation (http://gowiki.tamu.edu/).
        Annotations\n    made by CACAO biocurators are reviewed by CACAO team instructors
        before their\n    release.\n  authors: Ivan Erill, James Hu, Community Assessment
        of Community Annotation with\n    Ontologies\n  is_obsolete: true\n  year:
        2017\n- id: GO_REF:0000113\n  title: Gene Ontology annotation of human sequence-specific
        DNA binding transcription\n    factors (DbTFs) based on the TFClass database\n
        \ description: |-\n    The TFClass (http://tfclass.bioinf.med.uni-goettingen.de/index.jsf)
        database provides\n    a comprehensive classification of mammalian DNA binding
        transcription factors\n    (DbTFs) based on their DNA binding domains (DBDs)
        (PMID:29087517). TFClass classifies\n    mammalian DbTFs by a five-level classification
        in which the four highest levels\n    represent groups defined by structural
        and sequence similarities (superclass,\n    class, family, subfamily, and
        genera) (more details at\n    http://www.edgar-wingender.de/TFClass_schema.html).
        This classification is based on\n    the combination of background knowledge
        of the molecular structural features of DBDs\n    (PMID:9340487, PMID:23427989)
        and phylogenetic trees constructed via multiple sequence\n    alignment with
        hierarchical clustering of manually validated DBDs and/or full-length\n    protein
        sequences retrieved from UniProt (PMID:23427989, PMID:23180794, PMID:23427989).\n\n
        \   The NTNU curation team has evaluated each family and assigned a molecular
        function\n    annotation, GO:0000981 (DNA-binding transcription factor activity,
        RNA polymerase\n    II-specific), and a cellular component annotation GO:0000790
        (nuclear chromatin),\n    as appropriate. The superclass/class/family or subfamily
        ID is specified in the\n    \"With/From\" field. The annotations are supported
        by the evidence code ECO:0005556\n    (multiple sequence alignment evidence
        used in manual assertion).\n  authors: Marcio Luis Acencio (1), George Georghiou
        (2), Sandra Orchard (2), Liv Thommensen\n    (1), Martin Kuiper (1) and Astrid
        L\xE6greid (1). (1) Norwegian University of Science\n    and Technology (NTNU),
        Trondheim, Norway; (2) European Bioinformatics Institute\n    (EBI), Hinxton,
        Cambridgeshire, United Kingdom\n  year: 2018\n- id: GO_REF:0000114\n  title:
        Manual transfer of experimentally-verified manual GO annotation data to homologous\n
        \   complexes by curator judgment of sequence, composition and function similarity\n
        \ description: |-\n    Method for transferring manual annotations to an entry
        based on a curator's judgment\n    of its similarity to a putative homolog
        that has annotations that are supported\n    with experimental evidence. Annotations
        are created when a curator judges that\n    the sequence, composition and
        function of a complex shows high similarity to another\n    complex that has
        annotation(s) supported by experimental evidence (and therefore\n    display
        one of the evidence codes ECO:0000353 [IPI] or ECO:0005543). Annotations\n
        \   resulting from the transfer of GO terms display the ECO:0005610, ECO:0005544
        or\n    ECO:0005546 evidence codes and include an accession for the complex
        from which\n    the annotation was projected in the 'with/from' field (column
        8). This field MUST\n    contain a Complex Portal accession identifier. Putative
        homologs are chosen using\n    information combined from a variety of complementary
        sources. Potential homologs\n    are initially identified using sequence similarity
        search programs such as BLAST.\n    Homologous relationships are then verified
        manually using a combination of resources\n    including sequence analysis
        tools, phylogenetic and comparative genomics databases\n    such as Ensembl
        Compara, INPARANOID and OrthoMCL, as well as other specialised\n    databases
        such as species-specific collections (e.g. HGNC's HCOP). In all cases\n    curators
        check the alignments for each complex component and use their experience\n
        \   to assess whether similarity is considered to be strong enough to infer
        that the\n    two proteins have a common function so that they can confidently
        project an annotation.\n    While there is no fixed cut-off point in percentage
        sequence similarity, generally\n    proteins which have greater than 70% identity
        that covers greater than 90% of\n    the length of both proteins are examined
        further. Whilst we expect subunit composition\n    to be conserved between
        closely related species, this is not an absolute rule\n    and orthologous
        complexes may differ if a subunit cannot be traced in one species\n    or
        is experimentally shown not to be present. When there is evidence of multiple\n
        \   paralogs for a single species, multiple variants of the complex can be
        inferred.\n  authors: Birgit Meldal and Sandra Orchard (1). (1) European Bioinformatics
        Institute\n    (EBI), Hinxton, Cambridgeshire, United Kingdom\n  external_accession:\n
        \   - J:342607\n    - SGD_REF:S000250427\n  year: 2018\n- id: GO_REF:0000115\n
        \ title: Automatic Gene Ontology annotation of non-coding RNA sequences through
        association\n    of Rfam records with GO terms\n  description: |-\n    Rfam
        (http://rfam.org, PMID:29112718) is a database of non-coding RNA families\n
        \   which are manually annotated with GO terms by Rfam curators. RNAcentral
        (http://rnacentral.org,\n    PMID:27794554) maintains a comprehensive collection
        of non-coding RNA sequences\n    that are regularly annotated with Rfam families
        using the Infernal software (PMID:24008419).\n    When a non-coding RNA sequence
        is matched to one or more Rfam families by sequence\n    similarity, the GO
        terms associated with the Rfam family are transitively assigned\n    to the
        non-coding RNA sequence. Annotations resulting from the transfer of GO\n    terms
        are assigned the ECO:0000256 evidence code (match to sequence model evidence\n
        \   used in automatic assertion) and include RNAcentral and Rfam accessions.
        The annotations\n    are available on the GOA and EMBL-EBI FTP sites. The
        mapping between Rfam families\n    and GO terms is available at http://www.geneontology.org/external2go/rfam2go,\n
        \   and the Infernal software can be downloaded at http://eddylab.org/infernal.
        To\n    report an annotation error or inconsistency, or for further information,
        please\n    visit the RNAcentral website at http://rnacentral.org.\n  authors:
        RNAcentral (1). (1) European Bioinformatics Institute (EMBL-EBI), Hinxton,\n
        \   Cambridgeshire, United Kingdom\n  external_accession:\n    - FB:FBrf0253064\n
        \   - SGD_REF:S000246363\n  year: 2018\n- id: GO_REF:0000116\n  title: Automatic
        Gene Ontology annotation based on Rhea mapping\n  description: |-\n    Rhea
        (https://www.rhea-db.org/, PMID:30272209) is an expert-curated knowledgebase\n
        \   of chemical and transport reactions of biological interest - and the standard\n
        \   for enzyme and transporter annotation in UniProtKB (PMID:31688925). Rhea
        uses\n    the chemical dictionary ChEBI (Chemical Entities of Biological Interest)
        to describe\n    reaction participants and their chemical transformations
        in a computationally\n    tractable manner. GO terms corresponding to Rhea
        reactions are assigned a Rhea\n    database cross-reference. The corresponding
        GO term is automatically applied to\n    all UniProt entries annotated with
        a Rhea reaction. The mapping file is available\n    at: http://current.geneontology.org/ontology/external2go/rhea2go.\n
        \ authors: GO Central Curators, GOA Curators, Rhea Curators\n  external_accession:\n
        \   - J:342608\n    - ZFIN:ZDB-PUB-221108-20\n    - SGD_REF:S000309092\n  citation:
        PMID:30272209\n  year: 2020\n- id: GO_REF:0000117\n  title: Electronic Gene
        Ontology annotations created by ARBA machine learning models\n  description:
        |-\n    Association-Rule-Based Annotator (ARBA) predicts Gene Ontology (GO)
        terms among\n    other types of functional annotation such as Protein Description
        (DE), Keywords\n    (KW), Enzyme Commission numbers (EC), subcellular LOcation
        (LO), etc. For all\n    annotation types, reviewed UniProtKB/Swiss-Prot records
        having manual annotations\n    as reference data are used to perform the machine
        learning phase and generate\n    prediction models. For GO terms, ARBA has
        an additional feature to augment reference\n    data using the relations between
        GO terms in the GO graph. The data augmentation\n    is based on adding more
        general annotations into records containing manual GO\n    terms, which will
        result in richer reference data. The predicted GO terms are\n    then propagated
        to all unreviewed UniProtKB/TrEMBL proteins that meet the conditions\n    of
        ARBA models. GO annotations using this technique receive the evidence code\n
        \   Inferred from Electronic Annotation (IEA; ECO:0000501). Links: ARBA documentation\n
        \   at UniProt (https://www.uniprot.org/help/arba), Blog on ARBA\n    (http://insideuniprot.blogspot.com/2020/09/association-rule-based-annotator-arba.html).\n
        \ authors: UniProt\n  external_accession:\n    - J:342609\n    - ZFIN:ZDB-PUB-221108-21\n
        \   - SGD_REF:S000315490\n  year: 2021\n- id: GO_REF:0000118\n  title: TreeGrafter-generated
        GO annotations\n  description: |-\n    TreeGrafter is a software tool for
        annotating protein sequences using pre-annotated\n    PANTHER phylogenetic
        trees. TreeGrafter takes an input query protein sequence,\n    finds the best
        matching homologous family, and then grafts it to the best location\n    in
        the tree. It then annotates the query sequence by propagating annotations
        from\n    the appropriate ancestral node(s) in the reference tree, which were
        manually annotated\n    using the PAN-GO method (see GOREF_0000033). This
        method is integrated into InterProScan,\n    which produces annotations to
        millions of genes across tens of thousands of organisms.\n\n    The full method
        is described in PMID:30032202.\n  authors: Haiming Tang, Dustin Ebert, Matthias
        Blum, Robert Finn, Paul Thomas\n  year: 2023\n  is_obsolete: false\n- id:
        GO_REF:0000119\n  title: Automated transfer of experimentally-verified manual
        GO annotation data to \n    mouse-human orthologs\n  description: |-\n    The
        Alliance of Genome Resources (https://www.alliancegenome.org/) has procedures
        in \n    place to establish orthology relationships between genes. The experimentally-based
        \n    annotations (IDA, IMP IPI, IGI, and EXP) for human genes generated by
        the GOA pipeline \n    are used to provide annotations to the respective mouse
        orthologs, and given the ISO \n    evidence code and an entry in the \"With
        (or) From\" field to indicate the orthologous \n    entity.\n  authors: The
        Gene Ontology Consortium\n  year: 2023\n  external_accession:\n    - J:164563\n
        \ is_obsolete: false\n- id: GO_REF:0000120\n  title: Combined Automated Annotation
        using Multiple IEA Methods\n  description: |-\n    An automated process that
        integrates identical annotations from multiple electronic pipelines,\n    including
        UniRule(GO_REF:0000104), ARBA(GO_REF:0000117), InterPro2GO(GO_REF:0000002),
        \n    TreeGrafter2GO(GO_REF:0000118), RHEA2GO(GO_REF:0000116), KeyWord2GO(GO_REF:0000004),
        \n    SubCellular2GO(GO_REF:0000109), EC2GO(GO_REF:0000003), and EnsEMBL Compara(GO_REF:0000107).
        \n    This method reduces redundancy in automated GO annotations, offering
        a clearer and less \n    cluttered page view. The combined annotations use
        the ECO:0000501 evidence code, with the \n    sources of GO annotation assignments
        from individual IEA pipelines listed in the \u201Cwith/from\u201D field,\n
        \   separated by a pipe delimiter.\n  authors: UniProt\n  year: 2024\n  is_obsolete:
        false\n- id: GO_REF:0000121\n  title: RGD ISO annotations to rat from other
        mammalian species\n  description: |-\n    RGD (https://rgd.mcw.edu/) imports
        high quality ortholog calls from the Human Gene \n    Nomenclature Committee's
        HCOP tool and the Alliance of Genome Resources for multiple mammalian species
        \n    and manually assigns orthologs between rat genes and those in other
        species where necessary based on \n    sequence similarity and synteny. Experimentally-based
        manual GO annotations (IDA, IMP IPI, IGI, and EXP) \n    from other RGD species
        are used to provide annotations to the respective rat orthologs. The resulting
        \n    annotations are given the ISO evidence code and an entry is made in
        the \"With (or) From\" field \n    to indicate the orthologous entity.\n  authors:
        RGD\n  year: 2025\n  external_accession:\n    - RGD:1624291\n  is_obsolete:
        false\n- id: GO_REF:0000122\n  title: AtSubP analysis\n  description: |-\n
        \   AtSubP predicts the subcellular localization of Arabidopsis protein sequences
        utilizing five diverse prediction modules,  \n    aa composition, PSI-BLAST,
        & Position Spec. Scoring Matrix.\n  authors: TAIR\n  year: 2010\n  external_accession:\n
        \   - TAIR:AnalysisReference:501780126\n  is_obsolete: false\n- id: GO_REF:0000123\n
        \ title: YeastPathways to GO-CAM conversion\n  description: |-\n    YeastPathways
        is a database of metabolic pathways and enzymes in the budding yeast Saccharomyces
        cerevisiae. YeastPathways content is manually curated and maintained by the
        curation team at the Saccharomyces Genome Database (SGD), the model organism
        database for budding yeast. Only genes involved in metabolic pathways and
        reactions are included in the set of 220 YeastPathways, but the YeastPathways
        also contained manual summaries of the pathways and a complete list of references
        used to construct each pathway. YeastPathways were built in from MetaCyc data
        in 2003 using the Pathways Tools software from Bioinformatics Research Group
        at SRI International, and in 2020 Yeast Pathways were converted from biopax3
        to TTL files and loaded into Noctua, the curation tool from the Gene Ontology.
        YeastPathways are available at https://pathway.yeastgenome.org/ and as Noctua
        models.\n    To create complete GO annotations for the individual enzymes
        in each pathway, the annotations logically constructed from the imported Noctua
        models were given the evidence code computational combinatorial evidence used
        in manual assertion (ECO:0000245), which corresponds to the GO evidence code
        RCA. This is further detailed in PMID:39530598.\n  authors: SGD\n  year: 2025\n
        \ is_obsolete: false\n"
    headers:
      Accept-Ranges:
      - bytes
      Access-Control-Allow-Origin:
      - '*'
      Cache-Control:
      - max-age=300
      Connection:
      - keep-alive
      Content-Security-Policy:
      - default-src 'none'; style-src 'unsafe-inline'; sandbox
      Content-Type:
      - text/plain; charset=utf-8
      Cross-Origin-Resource-Policy:
      - cross-origin
      Date:
      - Mon, 09 Feb 2026 22:41:32 GMT
      ETag:
      - W/"8cb3bd0099f8de6c984d9c5766cc8958af2fa38523705539424d10bf6fa83299"
      Expires:
      - Mon, 09 Feb 2026 22:46:32 GMT
      Source-Age:
      - '73'
      Strict-Transport-Security:
      - max-age=31536000
      Vary:
      - Authorization,Accept-Encoding
      Via:
      - 1.1 varnish
      X-Cache:
      - HIT
      X-Cache-Hits:
      - '1'
      X-Content-Type-Options:
      - nosniff
      X-Fastly-Request-ID:
      - 77ee184c1356ccb09206bba67c886f02436b48ff
      X-Frame-Options:
      - deny
      X-GitHub-Request-Id:
      - 0E3A:39F594:25FECE:2DE8B7:698A6252
      X-Served-By:
      - cache-sjc10042-SJC
      X-Timer:
      - S1770676893.632378,VS0,VE1
      X-XSS-Protection:
      - 1; mode=block
      content-length:
      - '120403'
    status:
      code: 200
      message: OK
- request:
    body: null
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://www.ebi.ac.uk/interpro/api/entry/panther/PTHR13763/
  response:
    body:
      string: '{"metadata":{"accession":"PTHR13763","entry_id":null,"type":"family","go_terms":null,"source_database":"panther","member_databases":null,"integrated":"IPR031099","hierarchy":null,"name":{"name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN BRCA1","short":null},"description":null,"wikipedia":null,"literature":null,"set_info":null,"overlaps_with":null,"counters":{"subfamilies":6,"domain_architectures":0,"interactions":0,"matches":5245,"pathways":0,"proteins":5245,"proteomes":1581,"sets":0,"structural_models":{"alphafold":3521,"bfvd":0},"structures":32,"taxa":5955},"entry_annotations":{"hmm":0,"logo":0},"cross_references":{},"is_llm":false,"is_reviewed_llm":false,"is_updated_llm":false,"representative_structure":{"accession":"4igk","name":"Structure
        of human BRCA1 BRCT in complex with ATRIP peptide"}}}'
    headers:
      Access-Control-Allow-Headers:
      - x-requested-with, Content-Type, origin, authorization, accept, client-security-token
      Access-Control-Allow-Methods:
      - GET, HEAD, OPTIONS, POST, PUT
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - Content-Length, InterPro-Version, Cached
      Access-Control-Max-Age:
      - '3600'
      Allow:
      - GET, HEAD
      Connection:
      - Keep-Alive
      Content-Length:
      - '809'
      Content-Type:
      - application/json
      Cross-Origin-Opener-Policy:
      - same-origin
      Date:
      - Mon, 09 Feb 2026 22:41:43 GMT
      InterPro-Version:
      - '108.0'
      InterPro-Version-Minor:
      - '0'
      Referrer-Policy:
      - same-origin
      Server:
      - gunicorn
      Strict-Transport-Security:
      - max-age=0
      Vary:
      - Accept,Cookie,origin
      X-Content-Type-Options:
      - nosniff
      X-Frame-Options:
      - DENY
    status:
      code: 200
      message: OK
- request:
    body: null
    headers:
      Accept:
      - '*/*'
      Accept-Encoding:
      - gzip, deflate
      Connection:
      - keep-alive
      User-Agent:
      - python-requests/2.32.5
    method: GET
    uri: https://www.ebi.ac.uk/interpro/api/protein/reviewed/entry/panther/PTHR13763/
  response:
    body:
      string: '{"count":12,"next":null,"previous":null,"results":[{"metadata":{"accession":"B6VQ60","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":612,"source_organism":{"taxId":"6239","scientificName":"Caenorhabditis
        elegans","fullName":"Caenorhabditis elegans"},"gene":"brc-1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":401,"end":601,"dc-status":"CONTINUOUS"}],"representative":true,"model":"PTHR13763:SF0","score":3.8e-47,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":612,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"F4I443","name":"BRCA1-associated
        RING domain protein 1","source_database":"reviewed","length":714,"source_organism":{"taxId":"3702","scientificName":"Arabidopsis
        thaliana","fullName":"Arabidopsis thaliana (Mouse-ear cress)"},"gene":"BARD1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":3,"end":711,"dc-status":"CONTINUOUS"}],"representative":true,"model":"PTHR13763:SF9","score":0,"subfamily":{"accession":"PTHR13763:SF9","name":"BRCA1-ASSOCIATED
        RING DOMAIN PROTEIN 1"}}],"protein_length":714,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"O54952","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1817,"source_organism":{"taxId":"10116","scientificName":"Rattus
        norvegicus","fullName":"Rattus norvegicus (Rat)"},"gene":"Brca1","in_alphafold":false,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":5,"end":1801,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1817,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"P38398","name":"Breast
        cancer type 1 susceptibility protein","source_database":"reviewed","length":1863,"source_organism":{"taxId":"9606","scientificName":"Homo
        sapiens","fullName":"Homo sapiens (Human)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":566,"end":1854,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1863,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"P48754","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1812,"source_organism":{"taxId":"10090","scientificName":"Mus
        musculus","fullName":"Mus musculus (Mouse)"},"gene":"Brca1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":539,"end":1798,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1812,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q6J6I8","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1863,"source_organism":{"taxId":"9595","scientificName":"Gorilla
        gorilla gorilla","fullName":"Gorilla gorilla gorilla (Western lowland gorilla)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":569,"end":1854,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1863,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q6J6I9","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1863,"source_organism":{"taxId":"9544","scientificName":"Macaca
        mulatta","fullName":"Macaca mulatta (Rhesus macaque)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":572,"end":1854,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1863,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q6J6J0","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1863,"source_organism":{"taxId":"9600","scientificName":"Pongo
        pygmaeus","fullName":"Pongo pygmaeus (Bornean orangutan)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":569,"end":1854,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1863,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q864U1","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1849,"source_organism":{"taxId":"9913","scientificName":"Bos
        taurus","fullName":"Bos taurus (Bovine)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":6,"end":1847,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1849,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q8RXD4","name":"Protein
        BREAST CANCER SUSCEPTIBILITY 1 homolog","source_database":"reviewed","length":941,"source_organism":{"taxId":"3702","scientificName":"Arabidopsis
        thaliana","fullName":"Arabidopsis thaliana (Mouse-ear cress)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":4,"end":939,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":941,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q95153","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1878,"source_organism":{"taxId":"9615","scientificName":"Canis
        lupus familiaris","fullName":"Canis lupus familiaris (Dog)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":560,"end":1862,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1878,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]},{"metadata":{"accession":"Q9GKK8","name":"Breast
        cancer type 1 susceptibility protein homolog","source_database":"reviewed","length":1863,"source_organism":{"taxId":"9598","scientificName":"Pan
        troglodytes","fullName":"Pan troglodytes (Chimpanzee)"},"gene":"BRCA1","in_alphafold":true,"in_bfvd":false},"entries":[{"accession":"PTHR13763","entry_protein_locations":[{"fragments":[{"start":567,"end":1854,"dc-status":"CONTINUOUS"}],"representative":false,"model":"PTHR13763:SF0","score":0,"subfamily":{"accession":"PTHR13763:SF0","name":"BREAST
        CANCER TYPE 1 SUSCEPTIBILITY PROTEIN"}}],"protein_length":1863,"source_database":"panther","entry_type":"family","entry_integrated":"ipr031099"}]}]}'
    headers:
      Access-Control-Allow-Headers:
      - x-requested-with, Content-Type, origin, authorization, accept, client-security-token
      Access-Control-Allow-Methods:
      - GET, HEAD, OPTIONS, POST, PUT
      Access-Control-Allow-Origin:
      - '*'
      Access-Control-Expose-Headers:
      - Content-Length, InterPro-Version, Cached
      Access-Control-Max-Age:
      - '3600'
      Allow:
      - GET, HEAD
      Cached:
      - 'true'
      Connection:
      - Keep-Alive
      Content-Length:
      - '8326'
      Content-Type:
      - application/json
      Cross-Origin-Opener-Policy:
      - same-origin
      Date:
      - Mon, 09 Feb 2026 22:41:51 GMT
      InterPro-Version:
      - '108.0'
      InterPro-Version-Minor:
      - '0'
      Referrer-Policy:
      - same-origin
      Server:
      - gunicorn
      Server-Timing:
      - ''
      Strict-Transport-Security:
      - max-age=0
      Vary:
      - Accept,Cookie,origin
      X-Content-Type-Options:
      - nosniff
      X-Frame-Options:
      - DENY
    status:
      code: 200
      message: OK
version: 1
